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Erratum 
 
 
Erratum zur Dissertation „Crosstalk between autoreactive T cells and alveolar type II 
epithelial cells in inflammation and tolerance” vorgelegt von Marcus Gereke, 2006. 
 
Während des Verfassens meiner Dissertation sind trotz mehrfacher und unabhängiger 
Korrekturen unabsichtliche Zitationsfehler aufgetreten, die hier innerhalb dieses Erratums 
korrigiert wurden. Originalpassagen aus der Dissertationsschrift sind dabei durch 
Anführungszeichen kenntlich gemacht und mit der dazugehörigen Quelle ergänzt worden. 
 
 
Page 3 
The following paragraph includes substantial material taken from the publication of 
Bienenstock and McDermott, 2005. 
 
Bienenstock J, McDermott MR. Bronchus- and nasal-associated lymphoid tissues. 
Immunol Rev. 2005 Aug; 206:22-31. 
 
“The bronchus-associated lymphoid tissue (BALT) constitutes organized lymphoid 
aggregates of T and B cell that are capable to respond against to inhaled antigens. BALT, 
located mostly at bifurcations of the bronchus in animals and humans, is already present in 
the fetus and develops rapidly following birth, especially in the presence of antigens. 
Humoral immune responses elicited by BALT are based primarily in immunoglobulin A 
secretion, locally and by BALT-derived B cells that have trafficked to distant mucosal sites. 
Similarly, located T cell responses have been noted. On the basis of these findings, the 
BALT can be thought of as functionally analogous to mucosal lymphoid aggregates in the 
intestine and is deemed a member of the common mucosal immunologic system 
(Bienenstock and McDermott, 2005).” 
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Pages 7 and 8 
The following paragraph includes substantial material taken from the publication of Lipscomb 
and Maasten, 2002. However, the source was omitted in the text unintentionally.  
 
Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease.                       
Physiol Rev. 2002 Jan; 82(1):97-130. 
 
“In the lung, DC reside within and beneath airway epithelium, in alveolar septae, in the 
connective tissue surrounding pulmonary veins and airway vessels, and with the lung 
capillaries of the lung parenchyma (Lipscomb et al., 1995). DC in the airway epithelium have 
an immature phenotype and exhibit a rapid turnover (Holt et al., 1994). DC that are resident 
within alveolar septae and in connective tissue surrounding vessels have a more mature 
phenotype than airway DC (Gong et al., 1992). In contrast to DC that are resident within the 
lung, in the vascular compartment circulating precursor DC are present (Suda et al., 1998). 
One role of lung DC is to provide protection against infectious agents by initiating immune 
response. An equally important role is to generate tolerance to inhaled allergens in normal 
noninflamed lungs. In this regard, immature DC continuously leave the peripheral blood and 
take over a surveillance position in lung tissue, avidly sampling the antigenic environment. In 
the steady state, lung DC likely remain relatively immature and constitutively migrate in low 
numbers into regional lymph nodes where they induce anergy, deletion of T cells, or a weak 
TH2-like response to air-borne antigens that is eventually downregulated (Stumbles et al., 
1998). Active suppression of immature DC maturation by alveolar macrophages may explain 
why airway and intraepithelial DC remain immature during their steady-state migration to 
lung-associated lymph nodes (Holt, 1993; Lipscomb et al., 1993). Furthermore, autocrine 
production of IL-10 by immature DC can inhibit surface expression of MHC class-I and -II 
molecules and exert a generalized inhibitory effect on T cell proliferation (Stumbles et al., 
1998). On exposure to inhaled allergens, the antigen may simply be insufficient in providing a 
danger signal to overcome suppression by alveolar macrophages and IL-10. However, if a 
danger signal is present at the tissue site, DC mature and migrate in greater number to 
draining lymph nodes to stimulate CD4+ T cell clonal expansion and differentiation.” 
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Page 8 
The following paragraph includes substantial material taken from the publication of Tschernig 
et al 1999. However, the source was omitted in the text unintentionally. 
 
Tschernig T, Fliegert F, Westermann J, Pabst R. Increased expression of activation 
markers and adhesion molecules on lung T-cells compared with blood in the normal rat.                                            
Eur Respir J. 1999 Jan; 13(1):66-70. 
 
“Lymphocytes play a significant role in lung disorders, for example sarcoidosis, asthma, and 
rejection after transplantation (Berman et al., 1990). T cells, B cells, and NK cells are present 
in various lung compartments (Agostini et al., 1993; Holt and Schon-Hegrad, 1987; Pabst, 
1990; Stein-Streilein, 1988), for example the lung vascular bed, the lung interstitium, the 
epithelium and lamina propia of the bronchi and the bronchoalveolar space (Fliegert et al., 
1996; Pabst et al., 1995). Since the lung has no afferent lymphatic vessels, the blood is the 
starting point for lymphocyte immigration. Lymphocytes migrate to the lung vascular 
endothelium (marginal pool) and enter the interstitial lung tissue (interstitial pool), where the 
lymphocyte composition is different from blood and bronchoalveolar lavages (BAL) (Fliegert 
et al., 1996). In contrast to peripheral blood lymphocytes, mainly activated T cells are found 
in BAL of humans and mice (Curtis et al., 1995; Saltini et al., 1990). This immunological 
status confers lymphocytes appropriate defense mechanisms to such a vulnerable organ. 
The expression of adhesion molecules depends on the compartment from which the cells are 
recruited, indicating that local activation and expression of adhesion molecules is induced by 
the microenvironment. Possible candidates for such activators are dendritic cells and 
macrophages or components of the extracellular matrix (Holt, 1993; van Haarst et al., 1994).” 
 
 
Page 8 
In the bibliography of this thesis two publications “Holt, 1993” are listed. The mentioned 
reference “Holt, 1993” within this paragraph above describes the following publication listed 
in the bibliography. 
 
Holt PG. Regulation of antigen-presenting cell function(s) in lung and airway tissues.                          
Eur Respir J. 1993 Jan; 6(1):120-9. Review. 
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Page 9 and 10 
The following paragraphs include substantial material taken from the publication of Knight 
and Holgate, 2003. 
 
Knight DA, Holgate ST. The airway epithelium: structural and functional properties in health 
and disease. 
Respirology. 2003 Dec;8(4):432-46. 
 
“The epithelium constitutes the interface between the internal milieu and the external 
environment, and as such, it is the first point of contact for inhaled substances, in particular, 
respiratory viruses, airborne allergens, and environmental pollutants, as well as being a 
primary target for inhaled respiratory drugs (Folkerts et al., 1998; Gizycki et al., 1997).  
At least eight morphologically distinct epithelial cell types are present in human respiratory 
epithelium, which can be classified in three different categories: basal, ciliated and secretory 
epithelial cells (Spina, 1998). Columnar ciliated epithelial cells are the predominant cell type 
within the airways, constituting more than 50% of all epithelial cells (Spina, 1998). The 
primary role of the ciliated apical surface is highlighted by the directional transport of mucus 
from the lung to the throat (Harkema et al., 1991). Mucus cells (goblet cells) are responsible 
for the control of the correct amount of mucus and the viscoelasticity of mucus for efficient 
mucociliary clearance by releasing acid mucins from their granules. These cells are thought 
to be capable of self-renewal and may also differentiate into ciliated epithelial cells (Evans et 
al., 1988; Harkema et al., 1991). Serous cells are also secreting cells and produce neutral 
mucin and a yet unidentified non-mucoid substance (Knight and Holgate, 2003). Basal cells 
are ubiquitous in the conducting epithelium, although the number of these cells decreases 
with airway size and the increasing thickness of the basal cell layer correlates with increasing 
size of the airway (Evans et al., 1988; Evans et al., 1990). Similar to the skin, the basal cell is 
thought to be the primary stem cell, giving rise to the mucus and ciliated epithelial cells. In 
smaller airways, where basal cells are sparse or absent, Clara cells perform the primary 
stem cell role.  
In addition to their progenitor and structural roles, basal cells are also thought to secrete a 
number of bioactive molecules including neutral endopeptidase, 15-lipoxygenase products 
and cytokines (Knight and Holgate, 2003). In humans, Clara cells are located in large 
(bronchial) and small (bronchiolar) airways. The cells produce bronchiolar surfactant and are 
also characterized by agranular endoplasmic reticulum in the apical cytoplasm and granular 
endoplasmatic reticulum basally. In addition to their role in secretion, Clara cells are believed 
to metabolize xenobiotic compounds by the action of p450 mono-oxygenases and may also 
produce specific antiproteases such as secretory leukocyte protease inhibitor (De Water et 
e 
 
al., 1986). More recent evidence suggests that these cells play important role for stem cells, 
serving as a progenitor for both ciliated and mucus secreting cells (Hong et al., 2001). 
 
The major function of the respiratory epithelium was once thought to be primarily that of a 
physical barrier, but recent studies clearly indicate that it is metabolically very active with the 
capacity to modulate a variety of inflammatory processes through the agency of an array of 
receptor-mediated events. On activation, it has the capacity to produce a number of 
proinflammatory cytokines, proinflammatory or regulatory mediators including arachidonic 
acid products, nitric oxide, endothelin-1, transforming growth factor (TGF)-ß, tumour necrosis 
factor (TNF)-α, and cytokines such as interleukin (IL)-1, IL-6 and IL-8 (Knight and Holgate, 
2003).” 
 
 
Page 11 
The following paragraphs include substantial material taken from the publication Chen, 2004. 
However, the source was omitted in the text unintentionally.  
 
Chen J, Chen Z, Narasaraju T, Jin N, Liu L. Isolation of highly pure alveolar epithelial type I 
and type II cells from rat lungs.                                                                                                                             
Lab Invest. 2004 Jun;84(6):727-35. Erratum in: Lab Invest. 2005 Sep;85(9):1181.  
 
“Alveoli are the gas exchange units of the lung and the alveolar epithelium adapts to this 
functional role by developing two highly specialized alveolar epithelial cell types, which are 
morphologically and functionally different.” 
 
“AECII consist of about 15% of the distal lung cells and occupy 5% of the alveolar surface 
(Crapo et al., 1978; Crapo et al., 1982; Haies et al., 1981).” 
 
“AECII synthesize and secrete lung surfactant, a protein-lipid complex and surface-active 
material. Lung surfactant stabilizes alveoli by reducing the surface tension.” 
 
“AECII also maintain the alveolar epithelium by cell proliferation and differentiation, minimize 
alveolar fluid by transport of sodium from the apical to the basolateral side, and alter the 
inflammatory process by secretion of growth factors and cytokines.  
In contrast to AECII, AECI contribute 7% of total lung cells and cover more than 95% of the 
alveolar surface. This thin epithelium allows the easy diffusion of gases and forms a barrier 
against the indiscriminate leakage of fluid into alveolar spaces. It also regulates the 
f 
 
exchange of physiologically important solutes and water between circulating blood and the 
alveolar space.” 
 
 
Page 12  
The following sentence was taken from the publication of Fehrenbach et al, 2000. However, 
the source was omitted in the text unintentionally. 
 
Fehrenbach H, Kasper M, Koslowski R, Tan P, Schuh D, Müller M, Mason RJ. Alveolar 
epithelial type II cell apoptosis in vivo during resolution of keratinocyte growth factor-induced 
hyperplasia in the rat.  
Histochem Cell Biol 2000, 114:49–61. 
 
“Notably, apoptotic AECII appeared to be removed not only by alveolar macrophages but 
also by AECII cell neighbors.” 
 
 
Pages 12 
The following paragraph includes substantial material taken from the publication of 
Fehrenbach, 2001. However, the source was omitted in the text unintentionally. 
 
Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited.                              
Respir Res. 2001; 2(1):33-46. Review. 
 
“The alveolar epithelium can be classified as a continuously renewing tissue since it 
comprises a population of alveolar type II epithelial cells that are characterized by almost 
unlimited potential to proliferate. It is still a matter of debate whether all AECII or only a small 
population act as the alveolar epithelial stem cell population (Uhal, 1997). The concept of 
AECII as stem cells of the adult alveolar epithelium was proposed by Kapanci and 
colleagues, and is widely accepted today (Kapanci et al., 1969). During ontogenesis, the 
AECII may derive from precursor cell common to AECII and Clara cells (Wuenschell et al., 
1996). Furthermore AECII proliferate and differentiate to AECI to repair the damaged 
alveolar epithelium after lung injury or during fetal lung development, thus contributing to 
epithelial repair, whereas AECI are terminally differentiated, lack mitotic activity, and are 
easily injured. The programmed cell death or apoptosis is an important mechanism of cell 
removal or renewing of tissue. AECII are known to express the membrane receptor Fas 
(CD95, APO-1), the ligation of which may initiate the apoptotic cascade (Fine et al., 1997). 
g 
 
This can be achieved by binding of Fas-ligand or the Fas-stimulating antibodies. There is 
some evidence that apoptosis of AECII is an integral mechanism of alveolar septal modelling 
in lung morphogenesis (Scavo et al., 1998; Schittny et al., 1998). Notably, apoptotic AECII 
appeared to be removed not only by alveolar macrophages but also by AECII cell neighbours 
(Fehrenbach et al., 2001).” 
 
 
Pages 13, 14, 15, 16 and 17 
The following paragraphs include substantial material taken from the publication of 
Fehrenbach, 2001. However, the source was omitted in the text unintentionally. 
 
Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited.                              
Respir Res. 2001; 2(1):33-46. Review. 
 
“The best example for a cell-cell interaction between AECII and resident cells is the direct 
contact with AECI and during proliferation with AECII neighbours as well. These lateral cell-
cell contacts within the alveolar epithelium are maintained by cell junction complex that 
includes gap junctions (Kasper et al, 1996). Additionally, AECII have direct contact to 
fibroblasts at the basal membrane or with capillary endothelial cells (Marin et al., 1982). 
 
A strong evidence for a direct interaction of AECI and AECII was presented by Ashino and 
colleagues (Ashino et al., 2000). Mechanical stimulation of AECI is thought to result in Ca2+-
oscillations, which were transmitted via intraepithelial gap junctions to AECII and modulate 
exocytosis rate of lamellar bodies. Direct inhibitory interactions between AECI and AECII 
have been postulated to suppress AECII proliferation. Loss of AECI during injury might then 
trigger the release of AECII from growth inhibition (Mason and McCormack, 1994). E-
cadherin as a further candidate to mediate contact inhibition, has been localized to the 
basolateral membrane of AECII (Kasper et al., 1995; St. Croix et al., 1998).  
But even an indirect cell-cell interaction for AECII to other AECII is possible by the negative 
feedback loop by which surfactant protein A (SP-A) upon release into the alveolar space 
inhibits surfactant exocytosis in vitro (Dobbs et al., 1987). Although AECII are equipped with 
membrane receptors for SP-A (Strayer et al., 1996), the in vivo relevance of this autocrine 
mechanism by which AECII may regulate their own action remains elusive, because mice 
that are deficient in SP-A did not show any defect in surfactant secretion nor any respiratory 
deficiency (Ikegami et al., 1998). Thus, some alternative mechanism must compensate the 
negative SP-A feedback loop.  
h 
 
Another potential feedback mechanism that has been postulated is the inhibition of AECII 
proliferation via AECII derived transforming growth factor (TGF)-β in bleomycin-induced 
experimental lung fibrosis (Khali et al., 1994). A number of growth factors are released by 
AECII, which might act in an autocrine way via the corresponding receptors expressed by 
AECII. 
 
As mentioned before, fibroblasts are in contact to AECII. This reciprocal cell-cell interaction is 
relevant to the modelling of alveolus during lung morphogenesis as well as during 
remodelling associated with alveolar repair following lung injury (Kasper et al., 1996; O´Reilly 
et al., 1997; Shannon, et al., 1997). Both direct and indirect cell-cell interactions have been 
reported.” 
 
“The interaction of alveolar epithelial and capillary endothelial cells is well examined. It was 
reported that from pulmonary endothelial cells conditioned medium stimulate fetal lung 
epithelial cell growth (Smith et al., 1986) and that endothelin-1 increases AECII surfactant 
secretion in vitro via a protein kinase C and Ca2+-mediated pathway (Sen et al., 1994). As a 
source of endothelin-1, endothelial cells are therefore principally competent to act in a 
paracrine manner on AECII, which were reported to express the endothelin receptor A 
(Markewitz et al., 1995). 
Recently, a very special mechanism of indirect intercellular communication between AECII 
and endothelial cells has been suggested. Stimulation of alveolar epithelial cells with tumour 
necrosis (TNF)-α was reported to increase epithelial Ca2+ influx and to activate epithelial 
cytoplasmic phospholipase A2, and results in basolateral release of arachidonic acid. Free 
arachidonic acid is thought to increase endothelial Ca2+
 
influx and expression of P-selectin 
(Kuebler et al., 2000), which is known to be crucial for initiation of leukocyte adherence. 
Thus, AECII could act as transducers of an inflammatory signal from the alveolus to the 
capillary bed to recruit granulocytes to the site of inflammation.  
 
Alveolar macrophages are one of the mobile cell types that interact with AECII. Among the 
multitude of secretory products synthesized and released by alveolar macrophages (Kasper 
et al., 1996; Lohmann-Matthes et al., 1994) there are some factors that act as mitogens for 
AECII, such as hepatocyte growth factor (Mason et al., 1994) and heparin-binding epidermal 
growth factor (Leslie et al., 1997). Conversely, AECII were shown to express the chemokines 
RANTES and MCP-1, which chemotactically attract macrophages (O´Brien et al., 1998), as 
well as GM-CSF (Blau et al., 1994; Christensen et al., 1995), which in turn may stimulate 
macrophage growth (Worgall et al., 1999). Furthermore, SP-A released from AECII modulate 
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macrophage functions such as oxygen radical release (Weissbach et al. 1994) and nitric 
oxide production (Stamme et al., 2000).  
Interactions of AECII with leukocytes have just recently come into focus. AECII synthesize 
some cytokines affecting leukocytes, such as interleukin (IL)-6 or IL-8. Via these cytokines, 
AECII might be involved in the induction of differentiation of basophil, eosinphil, and 
neutrophil granulocytes and maintenance of inflammatory reactions. Recent data support the 
idea that AECII have an accessory function in T lymphocyte activation (Zissel et al., 2000). 
This has been suggested on the basis of the findings that the cells bear MHC class-II 
molecules (Schneeberger et al., 1986).” 
 
“Additionally, AECII were reported to inhibit lymphocyte proliferation in vitro without altering 
their activation state (Paine et al., 1991). Moreover, AECII derived TGF-β (Zissel et al., 2000) 
could indirectly inhibit T cell proliferation via blockade of activating factors, such as IL-2. In 
contrast, granulocyte macrophage-colony stimulating factor (GM-CSF) released at the 
basolateral surface of AECII could increase the potential of dendritic cells to induce T-cell 
proliferation (Christensen et al., 1995).” 
 
“The surface-active agent was characterized in numerous biochemical studies of BAL 
material and is now known to be composed of ∼90% lipids (with ∼80-90% phospholipids) 
and of ∼10% proteins (Griese, 1999). Unlike most other lipid-rich components of cells and 
organs, the surfactant lipids are characterized by an unusually high level of satured fatty acid 
chains, such as the predominant dipalmitoylphosphatidylcholines, which contribute 
substantially to the unique properties of pulmonary surfactant (van Golde et al., 1994). The 
protein fraction comprises a highly variable amount of serum proteins (Griese; 1999) and four 
apoproteins that are associated with surfactant and contribute to its specific function (Weaver 
and Whitsett, 1991).” 
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Page 17 
The following passage includes substantial material taken from the publication of Wright, 
2005. 
 
Wright JR. Immunoregulatory functions of surfactant proteins.                                            
Nat Rev Immunol. 2005 Jan; 5(1):58-68. Review. 
 
“SP-B is essential for the ability of surfactant to reduce surface tension (Nogee, 2004), and 
SP-C has recently been shown to bind lipopolysaccharide (LPS) (Augosto et al., 2002; 
Augosto et al., 2003). In the absence of surfactant, surface tension is extremely high at end 
expiration and tends to collapse the lung. This makes breathing difficult to the extent that 
respiration is frequently impossible without ventilatory support and surfactant replacement. A 
deficiency of surfactant – which can result in “Respiratory-Distress Syndrome (RDS)” – 
occurs when infants are born prematurely, before their surfactant biosynthetic machinery has 
matured. Treatment of these premature infants with exogenous surfactant replacement 
reduces mortality and morbidity, because of this disease (Wright, 2005).” 
 
 
Pages 17 and 18 
The following paragraphs include substantial material taken from the publication of 
Fehrenbach, 2001. 
 
Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited.                              
Respir Res. 2001; 2(1):33-46. Review. 
 
“The other function of alveolar surfactant relies on the nature of SP-A and SP-D as collectins. 
Both proteins are able to bind to the surface of various pathogens, thus acting as opsonins to 
facilitate their elimination by alveolar macrophages. Therefore, alveolar surfactant is also 
responsible for host defence (Crouch, 2000; Pison et al., 1994; Wright, 1998).  
Surfactant is synthesized by alveolar type II epithelial cells and released upon appropriate 
stimuli by exocytosis from special intracellular storage organelles termed lamellar bodies. 
Once released into the alveolar space, freshly secreted lamellar body material undergoes 
several steps of transformation that are necessary to establish the surface-active lining layer. 
Cyclic compression and expansion during ventilation result in a fraction of spent surfactant 
that will largely be recycled by AECII. Thus, single constituents of surfactant run through 
several cycles before being removed by alveolar macrophages and replaced by de novo 
synthesis (Fehrenbach, 2001).  
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Although the bronchiolar Clara cells and submucosal cells also synthesize and release the 
mature proteins SP-A, SP-B and SP-D (Kalina et al., 1992; Voorhout et al., 1992) the 
alveolar type II epithelial cell is the only type of pulmonary cell that produces all surfactant 
components including phospholipids as well as all four surfactant proteins. The mature 3.5 -
3.7kDa small SP-C is thought to be exclusively released by AECII cells (Beers et al., 1994; 
Phelps and Floros et al., 1991). About 85% of the secreted surfactant is taken up again, 
metabolised and re-secreted by AECII. Re-uptake and recycling have been demonstrated for 
all surfactant lipids and for all four surfactant proteins. The degradation of surfactant is 
accomplished by alveolar macrophages with only minimal contribution (Herbein et al., 2000; 
Nicholas, 1996; Young et al., 1993).” 
 
 
Pages 18, 19, 20, 21 and 22 
The following passages include substantial material taken from the publication of Wright, 
2005. However, the source was omitted in the text unintentionally. 
 
Wright JR. Immunoregulatory functions of surfactant proteins.                                             
Nat Rev Immunol. 2005 Jan; 5(1):58-68. Review. 
 
“2.3.1  Immunoregulatory functions of surfactant proteins 
 
As mentioned above, the host defence functions of surfactant are primarily mediated by SP-
A and SP-D, which are members of the collectin family of proteins. SP-A and SP-D have 
been also localized to non-pulmonary sites, including the trachea, brain, testes, salivary 
glands, lachrymal glands, heart, prostate, kidney, pancreas and the female urogenital tract 
(Leth-Larsen et al., 2004; Lin et al., 2000; Madsen et al., 2000; Rubio et al., 1995), although 
it is not yet clear whether all of these organs express sufficient amounts of protein for it to be 
physiologically effective.  
Among their well-established role as opsonins, SP-A and SP-D also have functions in 
initiating parturition, facilitating clearance of apoptotic cells and directly killing bacteria.” 
 
“ 2.3.2  Collectin structure  
 
In addition to the two lung collectins SP-A and SP-D, serum collectins have been identified in 
humans (mannose-binding lectin, MBL) and in bovidae (conglutinin, CL-43 and CL-46) 
(Hansen and Holmskov, 2002).  
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SP-A and SP-D are synthesized as primary translation products of approximately 26-36kDa 
and 43kDa, respectively (figure 3). The collagen-like domain is N-terminal to a coiled-coil 
structure that precedes the C-terminal lectin domain. The lectin domains mediate the 
interaction of collectins with a wide varity of pathogens. The collagen domains vary greatly in 
length (Holmskov et al., 2003).” 
 
“For example, both surfactant proteins, SP-A and SP-D, bind to mannose and glucose but 
bind only poorly to galactose (Haagsman et al., 1987; Lim et al.; 1994; Persson et al., 1990). 
The high affinity of the collectins for clustered oligosaccharides is thought to be important for 
their ability to distinguish non-self from self, as most carbohydrates in animals are terminated 
by sugars, such as galactose or sialic acid, that are poorly recognized by the collectins.” 
 
 
“2.3.3  Collectin regulation of immune cells 
 
Surfactant proteins A and D bind to a variety of bacteria, viruses, allergens and apoptotic 
cells and thereby function as opsonins to enhance the uptake of these cells and particles. 
Binding of the collectins to pathogens occurs by various mechanisms. Some pathogens are 
aggregated by SP-A and/or SP-D and were phagocytized by immune cells like macrophages. 
SP-A and SP-D also have direct effects on immune cells and modulate the production of 
cytokines and inflammatory mediators.  
 
Numerous studies have reported that SP-A mediates cellular functions through C1q 
receptors (Ferguson et al., 1999; Malholtra et al., 1994), including C1qR (also known as 
CD93) (Nepomuceno et al., 1997; Steinberger et al., 2002) and calreticulin (Malhotra et al., 
1990; Malholtra et al., 1993). SP-A and SP-D are able to bind Calreticulin, which in turn binds 
to CD91. CD91 is a component of the binding complex (Gardai et al., 2003).  
 
The binding of SP-A and/or SP-D to the signal-inhibitory regulatory protein-α (SIRP-α) 
modulates cellular functions in a similar way like the binding complex of surfactant proteins 
with the CD91-calreticulin complex. In the absence of a pathogen, SP-A binds through its 
lectin domain to SIRP-α, whereas in the presence of a foreign organism or cell debris, to 
which the lectin domain of SP-A binds, the free collagen-like region activates immune cells 
through CD91-calreticulin. Importantly, engagement of the different receptors elicits different 
responses. Upon binding of SP-A to SIRP-α, the inflammatory-mediator production is 
inhibited. By contrast, SP-A enhances inflammatory mediator like tumour-necrosis factor 
(TNF), CXCL12 and CCL2 production through its binding to the CD91-calreticulin complex. 
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Therefore, SP-A and SP-D both are able to enhance and inhibit inflammatory-mediator 
production to modulate the regulation of immune cells.  
Another receptor that binds surfactant protein A was identified by Chroneos and colleagues 
and termed SP-R210 (Chroneos et al., 1996). Blocking of this receptor with specific 
antibodies leads to a loss of SP-A mediated functions, including inhibition of lymphocyte 
proliferation (Borron et al., 1998), enhanced uptake of bacteria by macrophages (Weikert et 
al., 1997) and mycobacterial killing by a nitric-oxide-dependent pathway (Weikert et al., 
2000). Nevertheless, the molecular identity of SP-R210 is still unclear. 
Glycoprotein 340 (gp340) is also discussed as a protein that binds SP-D through its CRD 
(Holmskov et al., 1997). Because of its localisation at the cell surface of alveolar 
macrophages, gp340 was suggested to be a SP-D receptor. It is identical to salivary 
agglutinin, a high-molecular-weight component of saliva that binds Streptococcus mutans, a 
bacterium that causes dental caries (Prakobphol et al., 2000). This putative receptor gp340 
has no transmembrane domain so that it is suggested that it could interact with an adaptor 
molecule on the surface of the cell (Wright, 2005).  
Additionally, a family of conserved cellular receptors that recognize pathogen-associated 
molecular patterns (PAMP) are discussed as binding-partners for SP-A and SP-D. This 
family of Toll-like receptors (TLRs) is activated by ligands like flagellin and CpG-containing 
DNA from bacteria, peptidoglycan from Gram-positive bacteria, LPS from Gram-negative 
bacteria, RNA from viruses and zymosan from yeast (Takeda et al., 2003). All these 
activation mechanisms end up in a series of conserved responses that culminate in 
inflammation and the production of inflammatory cytokines, such as TNF and interleukin-1β.  
The SP-A dependent binding to TLR4 results in an activation of the nuclear factor κB (NF-κB) 
signalling pathway and upregulation of cytokine synthesis (Guillot et al., 2002), whereas 
interaction of SP-A with TLR2 attenuates stimulation of TLR2 signalling and also stimulation 
of TNF secretion induced by zymosan or peptidoglycan (Sato et al., 2003).  
 
In addition to phagocytosis, SP-A and SP-D have also the ability to regulate the production of 
inflammatory mediators by immune cells in a context-dependent manner. One example 
shows that inflammatory mediators, such as TNF, are both up- and downregulated by SP-A 
and SP-D (Crouch and Wright, 2001). The release of TNF that is induced by LPS or intact 
bacteria is inhibited by SP-A (Hickling et al., 1998; McIntosh et al., 1996; Rosseau et al., 
1999). In contrast, SP-A enhances TNF production either when alone (Kremlev et al., 1994, 
Kremlev et al., 1997) or in presence of “rough” LPS (Sano et al., 1999).  
A further effect of surfactant proteins SP-A and SP-D is the enhanced uptake of apoptotic 
cells by alveolar macrophages in vitro (Schagat, et al., 2001), which could be even shown for 
lungs of naïve mice in the case of SP-D (Vandivier et al., 2002). 
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Through the carbohydrate-recognition domains (CRD) and the collagen-like regions it is 
possible for SP-A and SP-D, as well as MBL, to bind DNA from a variety of origins, including 
mice and bacteria (Palaniyar et al., 2004). SP-D effectively binds and aggregates alveolar 
macrophages DNA and it enhances the uptake of DNA by human monocytic cells (Palaniyar 
et al., 2003). Binding of the collectins to cell-surface DNA might be one mechanism by which 
they mediate enhanced phagocytosis of apoptotic cells.  
Uptake of apoptotic cells by macrophages results in release of anti-inflammatory mediators, 
such as transforming growth factors-β (TGF-β), IL-10 and prostaglandin E2
 
(Fadok et al., 
1998). This response is in contrast to the release of pro-inflammatory cytokines that occurs 
when phagocytes ingest microorganisms. In addition to enhancing the uptake of apoptotic 
cells, SP-A also enhances the release of TGF-β by macrophages (Reidy and Wright, 2003), 
indicating that SP-A can promote resolution of inflammation at several levels of the apoptotic-
cell clearance process and that surfactant proteins can indirectly induce anti-inflammatory 
responses by phagocytes.  
As discussed above, surfactant is linked to innate immunity. However, surfactant is also 
linked to adaptive immunity in the lung by modulating functions of both dendritic cells and T 
cells.  
It has been shown that SP-A and SP-D have different effects on DC functions. The uptake 
and presentation of antigens is enhanced by SP-D (Brinker et al., 2001), but only SP-A can 
inhibit maturation of DC, as assessed by cell-surface marker expression, and functional 
activity, such as phagocytosis and chemotaxis (Brinker et al., 2003).  
The proliferation of T cells stimulated with plant lectins, CD3-specific antibodies or phorbol 
esters is inhibited by SP-A and SP-D. It has been suggested that the inhibition of IL-2 
production might mediate this process (Borron et al., 1996; Borron et al, 1998). In addition, 
both the collagen-like region and the CRD of SP-A have been implicated in the inhibition of 
lymphocyte function, probably due to inhibition of calcium signalling (Borron et al., 2002). 
These data indicate that SP-D and SP-A might provide an important link between innate and 
adaptive immunity, by modulation of both DC and T cell functions.” 
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Page 20 
In the bibliography of this thesis two publications “Borron, 1998” are listed. The mentioned 
reference “Borron, 1998” within these paragraphs above describes the following publication 
listed in the bibliography. 
 
Borron P, McCormack FX, Elhalwagi BM, Chroneos ZC, Lewis JF, Zhu S, Wright JR, 
Shepherd VL, Possmayer F, Inchley K, Fraher LJ. Surfactant protein A inhibits T cell 
proliferation via its collagen-like tail and a 210-kDa receptor.                                                
Am J Physiol. 1998 Oct;275(4 Pt 1):L679-86. 
 
“Blocking of this receptor with specific antibodies leads to a loss of SP-A mediated functions, 
including inhibition of lymphocyte proliferation (Borron et al., 1998), enhanced uptake of 
bacteria by macrophages (Weikert et al., 1997) and mycobacterial killing by a nitric-oxide-
dependent pathway (Weikert et al., 2000).” 
 
 
Page 22 
In the bibliography of this thesis two publications “Borron, 1998” are listed. The mentioned 
reference “Borron, 1998” within these paragraphs above describes the following publication 
listed in the bibliography. 
 
Borron PJ, Crouch EC, Lewis JF, Wright JR, Possmayer F, Fraher LJ. Recombinant rat 
surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 
production.                              
J Immunol. 1998 Nov 1;161(9):4599-603. 
 
„The proliferation of T cells stimulated with plant lectins, CD3-specific antibodies or phorbol 
esters is inhibited by SP-A and SP-D. It has been suggested that the inhibition of IL-2 
production might mediate this process (Borron et al., 1996; Borron et al, 1998).” 
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Page 24 
The following paragraph includes substantial material taken from the publication of Bell & 
Bird, 2005. However, the source was omitted in the text unintentionally. 
 
Elaine Bell & Lucy Bird. Autoimmunity 
Nature 435, 583 (2 June 2005) 
 
“3 Autoimmunity 
 
The concept of autoimmunity was first predicted by Paul Ehrlich at the beginning of the 
twentieth century, and he described it as “horror autotoxicus”. His experiments led him to 
conclude that the immune system is normally focused on responding to foreign materials and 
has an inbuilt tendency to avoid attacking self tissues. But when this process is disturbed, the 
immune system can attack self tissues resulting in autoimmune diseases.”  
 
 
Page 24 
The following paragraph includes substantial material taken from the publication of Marrack 
et al, 2001. However, the source was omitted in the text unintentionally. 
 
Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs.      
Nat Med. 2001 Aug; 7(8):899-905. Review. 
 
“Autoimmune diseases occur in up to 3-5% of the population (Jacobson et al., 1997). Many 
of these diseases are classified according to what organs and tissues are targeted by the 
damaging immune responses. There is an autoimmune disease specific for nearly every 
organ in the body, usually involving responses to an antigen expressed only in that specific 
organ. In other autoimmune diseases, such as systemic lupus erythematous (SLE), no 
particular cell type seems to be targeted; rather, the response seems to be directed against 
antigens that are widely expressed throughout the host. Nevertheless these diseases are 
antigen-specific; moreover, recognition of widely expressed antigens sometimes results 
unexpectedly in selective manifestations of the organ (Mathews et al., 1983; Yeaman et al., 
1988). Autoimmune organ damage can be mediated by T cells, as in multiple sclerosis (MS) 
and type 1 diabetes (Steinman, 1996) and, furthermore, CD4+ and/or CD8+ T cells can have 
crucial roles (Haskins and McDuffie, 1990; Hutchings et al., 1992). In these diseases, 
autoantibodies are also produced and serve as markers of the antigen-specific T-cell 
responses, for example, antibodies to insulin or other pancreatic islet-cell antigens in type 1 
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diabetes (Yu et al., 1996). In other diseases, damage is actually mediated by autoantibodies 
and requires CD4+
 
T-helper cells. For example, nearly all SLE patients have elevated levels 
of autoantibodies to nuclear antigens.” 
 
 
Page 27 
The following paragraph includes substantial material taken from the publication of O´Gara 
and Vieira, 2004. However, the source was omitted in the text unintentionally.  
 
O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control.         
Nat Med. 2004 Aug; 10(8):801-5. Review. 
 
“Regulatory T cells may be defined as CD4+ T cells that inhibit immunopathology or 
autoimmune disease in vivo. Specifically, Treg cells include those able to suppress naïve T 
cell proliferation in vitro and to control CD4+
 
or CD8+
 
T cell numbers in vivo, in lymphopenic 
hosts. Two major Treg
 
populations have been described so far, … .“ 
 
 
Page 27  
The following paragraph includes substantial material taken from the publication of Bluestone 
and Abbas, 2003. However, the source was omitted in the text unintentionally. 
 
Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells.                   
Nat Rev Immunol. 2003 Mar; 3(3):253-7. 
 
“The two subsets of regulatory T cells might function in different immunological settings, 
depending on the context of antigen exposure, the nature of the inflammatory response and 
the T cell receptor (TCR) repertoires of the individual cells. The natural Treg cells are probably 
most effective at suppressing autoreactive T cell responses locally, in non-inflammatory 
settings – circumstances in which antigen specific, self limiting reactions are required to 
achieve a fine homeostatic balance. In contrast, during self-damaging inflammatory reactions 
to microbes or transplanted tissue, or settings (for example inflammatory bowel disease), 
adaptive Treg
 
cells might be induced to suppress the pathological immune responses.” 
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Page 28  
The following paragraph includes substantial material taken from the publication of O´Gara 
and Vieira, 2004. However, the source was omitted in the text unintentionally. 
 
O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control.      
Nat Med. 2004 Aug; 10(8):801-5. Review. 
 
“4.1 Naturally occouring CD4+CD25+ regulatory T cells 
 
The CD4+CD25+
 
regulatory T cells are currently the focus of intensive research and were first 
described in the early 1970s by Gershon and colleagues (Gershon et al., 1974). These cells 
represent 5-10% of the CD4+ T lymphocytes in healthy adult mice and humans and are 
thought to perform a specialized role in controlling both the innate and the adaptive immune 
system. Although easily identified and isolated from unmanipulated mice and humans on the 
basis of CD25 expression, this chain of the IL-2(R) receptor is also expressed on activated T 
cells (Maloy et al., 2003; Sakaguchi et al., 2001; Shevach, 2002). So far, no characteristic 
stable surface marker has been assigned to Treg cells. Additional markers expressed by 
these cells include cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) (Read et al., 2000; 
Takahashi et al., 2000) and glucocorticoid induced tumor necrosis factor receptor 
(TNFSR18) (McHugh et al., 2002; Shimizu et al., 2002), which were initially implicated in the 
mechanism of Treg
 
action. However, both of these molecules are also expressed by 
nonregulatory T cells after activation. Various groups identified the forkhead/winged helix 
transcription factor Foxp3 as a marker for both CD25+
 
Treg
 
cells and CD25-
 
cell that have 
regulatory activity (Fontenot et al., 2003; Hori et al., 2003).”  
 
 
Page 28 
In the bibliography of this thesis two publications “Sakaguchi et al., 2001” are listed. The 
mentioned reference “Sakaguchi et al., 2001” within this paragraph above describes the 
following publication listed in the bibliography. 
 
Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, 
Nomura T, Toda M, Takahashi T. Immunologic tolerance maintained by CD25+ CD4+ 
regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and 
transplantation tolerance.                 
Immunol Rev. 2001 Aug;182:18-32. Review. 
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Pages 28, 29 and 30 
The following paragraphs include substantial material taken from the publication of Bluestone 
and Abbas, 2003. However, the source was omitted in the text unintentionally. 
 
Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells.                   
Nat Rev Immunol. 2003 Mar; 3(3):253-7. 
 
“The resident regulatory cells that develop in the thymus are generated in a burst of activity 
during the early stages of fetal and neonatal T cell development (Sakaguchi et al., 2001). 
They are polyclonal on the basis of diverse TCR usage (Shevach, 2002), and they are 
potentially capable of recognizing diverse self-antigens.  
The promiscuous gene expression of many self tissue-specific proteins in the medullar 
epithelial cells of the thymus is described as a potential mechanism to ensure central 
tolerance to peripheral self-antigens, because this self-antigen expression in the thymus 
might lead, among other things, to the deletion of immature autoreactive T cells (Derbinski et 
al., 2001). However, it is possible that these self proteins are expressed at low levels and, 
additionally, by only some of the epithelial cells, making clonal deletion a rather ineffective 
means of inducing tolerance to peripheral antigens. An alternative mechanism of inducing 
self tolerance in the thymus might be the localized antigen presentation, resulting in a more 
robust regulation of autoreactivity. Once generated, the thymic Treg
 
cells are exported in the 
peripheral tissues, where they may function normally to prevent the activation of other, self 
reactive T cells that have the potential of developing into effector cells (Salomon et al., 2000). 
 
These regulatory T cells were described as a “normal” population of suppressor cells, 
because they are always present in normal individuals and carry out their regulatory function 
during normal surveillance of self-antigens. Furthermore, because of their development in the 
thymus, the natural regulatory T cells are expected to be specific for self-antigens.  
 
Recent studies indicate that CD28 controls both thymic development and peripheral 
homeostasis of natural Treg
 
cells. Ligation of CD28 is expected to act at two stages during Treg
 
cell development (Boden et al., 2003). In addition, once the natural Treg
 
cells emerge from the 
thymus, costimulation through CD28 is required to maintain a stable pool of these cells in the 
periphery by promoting their self renewal through homeostatic proliferation and by supporting 
their survival (Boden et al., 2003; Salomon et al., 2000). The development and maintenance 
functions of CD28 are not mediated through IL-2. It is possible that signalling through CD28 
stimulates the production of a response to an yet unknown cytokine that functions as a 
growth and survival factor of these cells. The absence of CD80/CD86 or CD28 results in a 
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reduction of the number of regulatory cells in peripheral lymphoid tissues and an unexpected 
exacerbation of natural Treg
 
cells, which plays an important role controlling autoimmunity 
(Lenschow et al., 1996; Salomon et al., 2000).” 
 
“4.2 Adaptive regulatory T cells 
 
These cells are generated from mature T cell populations under certain conditions of 
antigenic stimulation, and they can be induced ex vivo by culturing mature CD4+ T cells with 
antigen or polyclonal activators in the presence of immunosuppressive cytokines, namely IL-
10 (Barrat et al., 2002; Levings et al., 2001). Similar to natural Treg
 
cells, adaptive Treg
 
cells 
originate from thymus, but they might be derived from classical T cell subsets or natural Treg
 
cells. The level of expression of CD25 by adaptive Treg
 
cell is variable, depending on the 
disease setting and the site of regulatory activity. Of note, adaptive Treg
 
cells function in vivo 
in a cytokine dependent manner (Barrat et al., 2002; Chatenoud et al., 1997; Maloy and 
Powrie, 2001), so that these regulatory T cells are distinguished from natural Treg
 
cells not by 
their origin (the thymus), but by their requirement for further differentiation as a consequence 
of exposure to antigen in a distinct immunological context.”  
 
“Another possibility to induce regulatory T cells is antigen exposure by certain routes, 
including intranasal or oral administration. This strategy seems to induce selectively the 
appearance of T cells with this regulatory phenotype (Chen et al., 1994)” 
 
 
Page 30 
The following paragraph includes substantial material taken from the publication of Shevach, 
2002. However, the source was omitted in the text unintentionally. 
 
Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers.                  
Nat Rev Immunol. 2002 Jun; 2(6):389-400. Review. 
 
“Several different in vitro protocols have been described over the past few years that result in 
the generation of suppressor T cells. The activation of mouse or human CD4+ T cells in vitro 
in the presence of IL-10 has been shown to result in the generation of T cell clones with a 
cytokine profile different from that of T helper 1 (TH1) or T helper 2 (TH2) cells. Functionally, 
these T cell clones have inhibitory effects on antigen specific activation of naïve T cells that 
are mediated partially by IL-10 and TGF-β, and were termed T regulatory 1 (TR1) cells 
(Groux et al., 1997). A related approach for the generation of suppressor T cells in vitro 
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involves the stimulation of naïve T cells with immature (im)DC. Surprisingly, although these 
cells produce IL-10, their suppressor phenotype resembles that of CD25+
 
T cells, as it is 
contact dependent, antigen non-specific and APC-independent. Immature DC are the ideal 
population to prime regulatory T cells as they are deficient in costimulatory molecules, and 
priming with antigen-imDC complexes might even be able to downregulate pre-existing 
antigen specific immune responses (Dhodapkar et al., 2001). Exposure to TGF-β has also 
been reported to facilitate the differentiation/expansion of suppressor T cell populations in 
vitro (Yamagiwa et al.; 2001).” 
 
 
Page 31 and 32 
The following paragraphs include substantial material taken from the publication of Bluestone 
and Abbas, 2003. However, the source was omitted in the text unintentionally. The 
subsequent figure and figure legend are adapted from Bluestone and Abbas, 2003. 
 
Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells.        
Nat Rev Immunol. 2003 Mar; 3(3):253-7. 
 
“Moreover, in contrast to natural Treg
 
cell, which are fully functional at the time of thymic 
export as a consequence of strong TCR engagement, the development of adaptive T cells in 
the periphery might be triggered by low-affinity antigen or altered TCR signal transduction. 
These antigen-stimulated adaptive T cells are not functional without activation by further 
exposure to antigens – such as during infection, organ transplantation under cover of certain 
immunomodulatory therapies, or ectopic expression of non-self-antigens (Apostolou et al.,  
2002; Belkaid et al., 2002; Fuss et al., 2002; Kingsley et al., 2002; Powrie, 2003). Concerning 
the antigen specificity of adaptive T cells, it is interesting to speculate that these cells have a 
diverse repertoire, which might be expanded as a consequence of fortuitous cross-
reactivities with foreign proteins. It is possible that the TCR repertoire of adaptive Tcells is 
self-antigen specific, but that these cells are triggered in an inflammatory environment to 
promote bystander suppression through the production of suppressive cytokines. 
It is important to note that unlike natural Treg
 
cells, adaptive Treg
 
cells might not require 
costimulation through CD28 for their development or function (Taylor et al., 2002). 
Interestingly, IL-2 might promote the development and function of both types of Treg
 
cells, on 
the basis of studies showing the total absence of Treg
 
cells in IL-2 receptor-deficient mice 
(Malek et al., 2002; Furtado et al., 2002). 
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4.3 Mechanism of suppression 
In addition to potential differences in terms of TCR repertoire and differentiation state, it is 
proposed that natural and adaptive subsets of Treg
 
cells differ in their mechanism of action. 
Adaptive Treg
 
cells mediate their inhibitory activities by producing immunosuppressive 
cytokines, such as TGF-ß and IL-10 (Kingsley et al., 2002; Nakamura et al., 2001). In 
contrast, natural Treg
 
cells, at least in vitro, function by a cytokine-independent mechanism, 
which presumably involves direct interactions with responding T cells or antigen-presenting 
cells (Shevach, 2002). This contact-dependent mechanism of suppression has been shown 
most convincingly by CD4+CD25+ natural Treg
 
cells employed in in vitro models of 
suppression, whereas cytokine-mediated suppression has been best established for 
peripheral adaptive Treg cells in vivo. However, the adaptive Treg
 
cell subset, although it 
suppresses in a cytokine-dependent manner, might still require direct cell-cell contact to 
initiate the suppressive cascade.” 
 
 
“Figure 6: Two classes of regulatory T cells can be envisioned. a In this hypothetical 
model, the natural regulatory T (Treg) cells (blue) suppress immune response in a contact-
dependent manner and function in general homeostasis to block the actions of autoimmune 
T cells (red) in noninflammatory settings. b The adaptive Treg
 
cell subset enhances the robust 
nature of suppression in an inflammatory milieu. Importantly, adaptive Treg
 
cells can develop 
either CD4+CD25+
 
natural Treg
 
cells (blue striped) or by altering the activity of T helper (TH) 
cells (red striped). APC, antigen presenting cell; interleukin (IL)-10, transforming growth 
factor (TGF)-β, regulatory T cell (Treg) (adapted from Bluestone and Abbas, 2003).” 
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Page 55  
The following paragraph includes substantial material taken from the publication of 
Fehrenbach, 2001. However, the source was omitted in the text unintentionally. 
 
Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited.                              
Respir Res. 2001; 2(1):33-46. Review. 
 
“Already 1977 Mason and Williams developed the concept of the alveolar type II epithelial 
cell (AECII) as a defender of the alveolus (Mason and Williams, 1977). AECII may act as 
immunoregulatory cells and can interact with resident and mobile cells, either directly by 
membrane contact or indirectly via cytokines/growth factors and their receptors. Thus 
alveolar type II epithelial cells represent an integrative unit of immune responses within the 
alveolus.” 
 
 
Page 57 
The following paragraphs include substantial material taken from the publication of Roper et 
al, 2003. However, the source was omitted in the text unintentionally. 
 
 
Roper JM, Staversky RJ, Finkelstein JN, Keng PC, O'Reilly MA. Identification and 
isolation of mouse type II cells on the basis of intrinsic expression of enhanced green 
fluorescent protein.                      
Am J Physiol Lung Cell Mol Physiol. 2003 Sep;285(3):L691-700. Epub 2003 May 9. 
 
“Alveolar type II epithelial cells (AECII) are critical for normal lung development, 
homeostasis, and repair after injury. AECII produce pulmonary surfactant lipids and proteins 
required for reducing alveolar surface tension (Finkelstein et al., 1983; Shannon et al., 2001). 
As essential progenitors for type I epithelial cells, they are also critical for normal alveolar 
development and tissue remodelling after injury (Adamson and Bowdenet, 1974; Adamson 
and Bowden, 1975). The ability to investigate organogenesis and disease progression by 
overexpressing and deleting genes in mice, particularly genes expressed by alveolar type II 
epithelial cells, has recently favoured the use of mouse models in pulmonary research.  
Although mice are advantageous for manipulating genes, they have not been useful for 
isolating alveolar type II epithelial cells for ex vivo study so far. In contrast, rat and rabbit 
AECII have successfully been isolated using velocity centrifugation through a gradient of 
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albumin (Dobbs and Mason, 1979 and Finkelstein et al., 1983). Isolation of mouse AECII by 
this method has been less successful.” 
 
 
Page 57 
In the bibliography of this thesis two publications “Adamson and Bowden, 1974” are listed. 
The mentioned reference “Adamson and Bowden, 1974” within this paragraph above 
describes the following publication listed in the bibliography. 
 
Adamson IY, Bowden DH. The type 2 cell as progenitor of alveolar epithelial regeneration. 
A cytodynamic study in mice after exposure to oxygen.                                                        
Lab Invest. 1974 Jan;30(1):35-42.  
 
 
Pages 79 and 80 
The following paragraphs include substantial material taken from the publication of Wright, 
2005. However, the source was omitted in the text unintentionally.  
 
Wright JR. Immunoregulatory functions of surfactant proteins.                   
Nat Rev Immunol. 2005 Jan; 5(1):58-68. Review. 
 
„Pulmonary surfactant was initially identified as a lipoprotein complex that reduces surface 
tension at the air-liquid interface of the lung (Clements, 1957; Pattle, 1955). This definition 
has been reassessed in light of recent studies that show that surfactant also functions in 
pulmonary host defence and that surfactant proteins are expressed also in non-pulmonary 
sites. The host defence functions of surfactant are primarily mediated by SP-A and SP-D, 
which are members of the collectin family of proteins. An emphasis is placed on recent 
studies showing that, in addition to their well-established role as opsonsins, SP-A and SP-D 
also have novel functions in initiating parturition, facilitating clearance of apoptotic cells and 
directly killing bacteria. Furthermore, immunoregulatory functions of the surfactant proteins A 
und D on T cells are discussed (Wright, 2005).” 
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Page 86  
The following paragraph includes substantial material taken from the publication of Boyton 
and Openshaw, 2002. 
 
Boyton RJ, Openshaw PJ. Pulmonary defences to acute respiratory infection.         
Br Med Bull. 2002;61:1-12. 
 
“The respiratory tract is a fragile tissue with architecture that is finely designed for gas 
exchange. Due to this main function the lung is exposed to numerous pathogens and other 
harmful air pollutions and developed many mechanisms to prevent infectious and 
inflammations. In the first line of defence are structural mechanisms coming from barriers 
such as epithelial cell layers, mucus and cilia, which avoid the invasion of pathogens or 
antigens. A battery of mediators that constitute the innate response including lactoferin, 
lysozyme, collectins and defensins is followed. Activation of these molecules can lead 
directly to lysis of pathogens, or to destruction through opsonisation or the recruitment of 
inflammatory cells (Boyton et al., 2002).” 
 
 
Page 90 
The following sentence includes substantial material taken from the publication of Herrath 
and Harrison, 2003. However, the source was omitted unintentionally. 
 
von Herrath MG1, Harrison LC. Antigen-induced regulatory T cells in autoimmunity.      
Nat Rev Immunol. 2003 Mar;3(3):223-32. 
 
“Therefore, physiological regulatory functions cannot be distinguished easily from effects that 
are caused by homeostatic proliferation and clonal expansion of transferred cells (Bach, 
2003; Barthlott et al., 2003).” 
 
Page 90 
In the bibliography of this thesis two publications “Bach, 2003” are listed. The mentioned 
reference “Bach, 2003” within this paragraph above describes the following publication listed 
in the bibliography. 
 
Bach JF. Regulatory T cells under scrutiny.  
Nat Rev Immunol. 2003 Mar;3(3):189-98. Review. Erratum in: Nat Rev Immunol. 2003 Jun; 3 
(6): 509. 
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Page 93 
The following paragraphs include substantial material taken from the publication of Moyron-
Quiroz et al, 2004. 
 
Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, Hartson L, Sprague F, Goodrich S, 
Woodland DL, Lund FE, Randall TD. Role of inducible bronchus associated lymphoid 
tissue (iBALT) in respiratory immunity.            
Nat Med. 2004 Sep;10(9):927-34. Epub 2004 Aug 15. 
 
“The role of BALT in mouse and humans are controversialy discussed and it is reported that 
infection or inflammation triggers the organization of lymphoid structures in the lung of both 
species (Chvatchko et al., 1996; Delventhal et al., 1992; Tschernig and Pabst, 2000). These 
structures do not fit the classical definition of BALT, as they are not formed independently of 
antigen (Bienenstock and Johnston, 1976; Plesch et al., 1983). Because the inducible BALT 
(iBALT) appears in the lung only after infection or inflammation, it is generally assumed that 
iBALT is simply an accumulation of effector cells that were initially primed in conventional 
lymphoid organs. The neo-formation of iBALT is caused by inflammatory responses, which 
directly promote the recruitment, priming and expansion of antigen-specific lymphocytes 
(Moyron-Quiroz et al., 2004).” 
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Als zweiten Teil meines Erratums möchte ich folgende Abbildungen innerhalb meiner 
Dissertation ersetzen bzw. zur Untermauerung der in der Dissertation getroffenen Aussage 
ergänzen. Diese Ersetzungen und Ergänzungen haben keinen Einfluss auf die 
Gesamtaussage meiner Dissertation. 
 
Figure 11 (continued) page 41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 (continued): HA-specific CD4+ T cells are present in the periphery of SPC-HA x TCR-
HA mice. SPC-HA x TCR-HA and TCR-HA control mice were sacrificed. Lung, BLN, MLN, Spleen, 
AXLN, INLN and CVLN were isolated and stained for CD4 and 6.5 expression to measure the 
percentage of transgenic T cells in the different compartments. These results are representative of two 
experiments with similar outcome. 
 
In the original figure 11 two identical dot plots for mesenteric lymphnodes (MLN) were used 
unintentionally. In the revised figure 11 above the two identical dot plots were replaced by 
new dot plots from a similar experiment with a similar outcome suggesting no physiological 
relevant difference in the relative numbers of HA-specific CD4+ T cells in peripheral tissues 
between chronic diseased mice or healthy control mice. These data were generated 
following the protocols described in the chapter Materials and Methods.  
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Figure 13 page 47 
 
Figure 13: Semi-quantitaive RT-PCR analysis of ex vivo isolated 6.5+CD4+
 
lung lymphocytes 
from SPC-HA x TCR-HA mice and TCR-HA control mice. (A) The expression of different molecular 
marker genes for regulatory T cells as CTLA4, Neuropilin-1, GITR (TNFRSF18), Galectin, PD-1 and 
ICOS was analyzed. RPS9 was used as a housekeeping gene. (B) In addition the expression of Foxp3 
and alphaEbeta7, CD103 were analyzed by flow cytometry on isolated 6.5+CD4+
 
lung lymphocytes from 
SPC-HA x TCR-HA mice (black line) and TCR-HA control mice (grey line). 
 
In the original figure 13 the pictures of the semi-quantitative RT-PCR analysis of Foxp3 and 
CD103 in ex vivo isolated 6.5+CD4+ lung lymphocytes from SPC-HA x TCR-HA mice and 
TCR-HA control mice were interchanged unintentionally. These pictures were replaced in the 
revised figure 13 by histograms representing flow cytometric analysis of Foxp3 and CD103 
expression in 6.5+CD4+ lung lymphocytes derived from SPC-HA x TCR-HA mice and TCR-
HA control mice (Figure 13 B). Isolation of lung lymphocytes and surface staining for flow 
cytometry follows the instructions described in the chapter Materials and Methods and the 
manual of instructions by eBioscience for surface target staining for flow cytometry1. The 
used antibody clone for CD103 (alphaEbeta7) is 2E7. The intracellular Foxp3 staining follows 
cc 
 
the instructions described by eBioscience for intracellular (nuclear) proteins2 with the 
Foxp3/Transcription Factor Staining Buffer Set and the Foxp3 antibody clone FJK-16s. 
References: 
1 Staining Cell Surface Antigens for Flow Cytometry Protocol – Protocol A: Cell 
Suspensions http://www.ebioscience.com/resources/best-protocols/flow-cytometry-
protocols.htm) 
2 Staining Intracellular Antigens for Flow Cytometry Protocol - Protocol B: One step 
protocol for (nuclear) intracellular proteins 
http://www.ebioscience.com/resources/best-protocols/flow-cytometry-protocols.htm) 
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Figure 21 page 60 
 
Figure 21: Analysis of hematopoetic cell contamination of post-sorted AECII population by 
PCR. (A) RNA from freshly isolated alveolar type II epithelial cells was compared with RNA obtained 
from complete lung tissue. Primer pairs for CD3, CD19 and CD14 were chosen to test for 
hematopoetic cells in the type II cell preparation. (B) Primer pairs for SP-A, SP-C, SP-D and alkaline 
phosphatase (Figure 21 A) were chosen to test the RNA for AECII-specific genes. (C) Quantitative RT-
PCR analysis on cDNA of freshly isolated alveolar type II epithelial cells were performed to 
demonstrate the enriched expression of AECII marker genes SP-C, SP-A and SP-D in comparison to 
cDNA of whole lung tissue. RPS9 represents the housekeeping gene expression and was used in all 
cases to poof cDNA quality. 
 
In the original figure 21 the picture of the semi-quantitative RT-PCR analysis of SP-C with 
cDNA derived from alveolar type II epithelial cells were interchanged with the RPS9 control 
from figure 24 unintentionally. This picture was replaced by new pictures of a semi-
quantitative RT-PCR analysis of AECII specific genes (SP-C, SP-A and SP-D) with cDNA 
derived from freshly isolated AECII shown in figure 21 B. Moreover, the quantitative RT-PCR 
analyses of AECII-specific genes (SP-C, SP-A and SP-D) with cDNA from freshly isolated 
AECII in comparison with cDNA of whole lung homogenates (figure 21 C) were added. 
Isolation of RNA and cDNA synthesis follows the protocols described in chapter Materials 
and Methods. Figure 21 C clearly shows the elevated level of AECII-specific gene transcripts 
in comparison to whole lung homogenates suggesting a successful AECII isolation.  
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Figure 24 page 68 
 
Figure 24: Gene expression in AECII derived from SPC-HA x TCR-HA double transgenic mice 
and SPC-HA transgenic mice. Different genes were selected to analyze their expression level in 
AECII by RT-PCR. (A) Genes encoding costimulatory molecules (PD1-L, ICOS-L, MHC II, CD80 and 
CD86) were used to determine the stimulatory capacity of AECII on the molecular level. (B) represents 
selected genes for Matrix metalloproteinase (MMP-9, MMP-2 and MMP-3) and (C) MCP-1 and TGF-β. 
The housekeeping gene RPS9 was used to estimate the quality and quantity of used cDNA. (D) 
Quantitative RT-PCR analysis of AECII derived from diseased SPC-HA x TCR-HA and healthy SPC-
HA control mice reveal elevated expression levels of MHC II, CD80, CD86, PD1L and TGF-β in AECII 
isolated from SPC-HA x TCR-HA mice. 
 
To underline the relative expression data from figure 24 A-C selected genes (MHCII, CD80, 
CD86, PD1L and TGF-β) were analyzed again by quantitative RT-PCR. Isolation of RNA and 
cDNA synthesis follows the descriptions in chapter Material & Methods. All tested genes 
show an increased expression in AECII derived from SPC-HAxTCR-HA mice in comparison 
to SPC-HA mice suggesting an inflammation mediated gene expression profile in AECII from 
ff 
 
chronic diseased SPC-HAxTCR-HA mice. Isolation of RNA and cDNA synthesis follows the 
protocols described in chapter Materials and Methods.  
 
Figure 34 page 82 
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Figure 34: Semi-quantitative RT-PCR analysis of re-isolated CD4+T cells after prior coculture 
with AECII from SPC-HA x TCR-HA, SPC-HA and BALB/c mice. (A) To assess the effect of AECII 
derived from SPC-HA x TCR-HA double transgenic mice, SPC-HA transgenic mice and BALB/c 
control mice on the phenotype of antigen-specific CD4+
 
T cells the expression of different molecular 
marker genes for regulatory T cells including CD103 (alphaEbeta7), Neuropilin-1, GITR (TNFRSF18), 
Galectin and PD-1 were analyzed. RPS9 was used as a housekeeping gene. Different amounts of 
cDNA (undiluted (1) and diluted (1:6) were used for the semi-quantitative RT-PCR analyses. (B) In 
parallel re-isolated HA-specific CD4+ T cells after prior coculture with AECII were analyzed by flow 
cytometry for the regulatory marker proteins CD103 (alphaEbeta7), PD-1, GITR (TNFRSF18) and 
Foxp3. 
 
In the original figure 34 the corresponding water controls of each semi-quantitative RT-PCR 
has been pasted in together with pictures of the corresponding SPC-HA (AECII/T cell) 
coculture experiment. In the new figure 34 (see above) the corresponding water controls 
were depicted from the corresponding SPC-HA (AECII/T cell) coculture experiment 
separately to indicate the different gels. 
Moreover, the results for Foxp3 and IL10 in the original figure were removed since the results 
of the SPC-HA (AECII/T cell) coculture were interchanged unintentionally. As a substitute 
flow cytometric analysis of cocultred CD4+6.5+ T cells from a similar experiment were shown 
in figure 34 B. Here, the expression pattern of the regulatory marker proteins CD103 
(alphaEbeta7), PD-1, GITR (TNFRSF18) and Foxp3 were analyzed for CD4+6.5+ T cells after 
coculture with the indicated AECII. The results show no differences within the groups and 
underline the findings from the original figure 34 A. Surface staining for flow cytometry follows 
the instructions described by the chapter Materials and Methods and the manual of 
instructions by eBioschience for surface target staining for flow cytometry1. The used 
antibody clones are for CD103 (alphaEbeta7) / 2E7, PD-1 / J43 and GITR (TNFRSF18) / 
108,619. The intracellular Foxp3 staining follows the instructions described by eBioscience 
for intracellular (nuclear) proteins2 with the Foxp3/Transcription Factor Staining Buffer Set 
and the Foxp3 antibody clone FJK-16s. 
References: 
1 Staining Cell Surface Antigens for Flow Cytometry Protocol – Protocol A: Cell 
Suspensions http://www.ebioscience.com/resources/best-protocols/flow-cytometry-
protocols.htm) 
2 Staining Intracellular Antigens for Flow Cytometry Protocol - Protocol B: One step 
protocol for (nuclear) intracellular proteins 
http://www.ebioscience.com/resources/best-protocols/flow-cytometry-protocols.htm) 
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1    The mucosal immune system 
 
The mucosal surfaces of gastrointestinal and respiratory tracts, like the skin, are 
colonized by lymphocytes and accessory cells in order to respond optimally to 
ingested and inhaled antigens. Although the presence of lymphocytes in the mucosa 
and submucosa of the gastrointestinal and respiratory tracts has been recognized for 
many decades, the idea of a specialized mucosal immune system is relatively new. 
Like the skin, these mucosal epithelia are barriers between the internal and external 
environments and are, therefore, an important first line of defence against infections. 
 
Much of our knowledge of mucosal immunity is based on studies of the 
gastrointestinal tract. In comparison, little is known about immune responses in the 
respiratory mucosa, even though the airways are a major portal of antigen entry. It is 
likely, however, that the features of immune responses are similar in all mucosal 
lymphoid tissues. The two major functions of the lung are the transport of air and 
subsequent gas exchange. The air-conducting parts are covered by a barrier-forming 
mucosa, while the gas-exchange parts, such as the alveoli, are devoid of such a 
barrier, as a mucosa would severely impede the rapid and effective gas exchange. 
Thus, the protective mechanisms are essentially different in these two compartments 
of the lung. The mucosa has a further function, which is to take up antigen in order to 
initiate an effective immune response against possible infections by tolerance, 
humoral or cellular immune reactions (Brandtzaeg, 1992; Brandtzaeg et al., 1997; 
Ogra et al., 1994). 
In the intestine exists specialized structures for antigen uptake. These comprise 
Peyer´s patches (PP) and other compartments for the effector side of the immune 
system, such as plasma cells in the lamina propria and effector T lymphocytes in the 
epithelium. The immune system of the lung can be compared with that of the 
intestine; even when major differences exist (see also table 1). 
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Table 1: Lymphocyte compartments: a comparison between lung and gut. 
Lung Gut 
  
Central airways (mucosal lining) 
   Intraepithelial lymphocytes (IEL) 
   Lamina propria  
   Bronchus-associated lymphoid tissue (BALT) 
All parts of the gut 
   Intraepithelial lymphocytes (IEL) 
   Lamina propria 
   Peyer´s patches (gut-associated lymphoid  
    tissue-GALT) 
  
Peripheral airways (without mucosa) 
   Intestinal lymphocytes 
   Lymphoid aggregations 
   Lymphocytes in the bronchoalveolar space 
 
   No real equivalent 
   No real equivalent 
   No real equivalent 
Large intravascular lymphocyte pool Undefined intravascular lymphocyte pool 
 
(adapted from Pabst, 2000) 
 
The bronchus-associated lymphoid tissue (BALT) constitutes organized lymphoid 
aggregates of T and B cell that are capable to respond against to inhaled antigens. 
BALT, located mostly at bifurcations of the bronchus in animals and humans, is 
already present in the fetus and develops rapidly following birth, especially in the 
presence of antigens. Humoral immune responses elicited by BALT are based 
primarily in immunoglobulin A secretion, locally and by BALT-derived B cells that 
have trafficked to distant mucosal sites. Similarly, located T cell responses have 
been noted. On the basis of these findings, the BALT can be thought of as 
functionally analogous to mucosal lymphoid aggregates in the intestine and is 
deemed a member of the common mucosal immunologic system (Bienenstock and 
McDermott, 2005). 
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Figure 1: The basic structure of BALT and their distribution of lymphocyte subsets and 
macrophages. In BALT the most prominent structure is a follicular-like accumulation of lymphocytes, 
partly forming a classical germinal centre. This is surrounded by more mature, small lymphocytes. 
High endothelial venuels (HEV) are located even more peripherally. In the walls of the HEV, 
lymphocytes can be seen leaving the blood and thus entering BALT. As there are no afferent 
lymphatic vessels, these HEV are the only site of entry for lymphocytes to migrate into the BALT. In 
the direction of the bronchial epithelium, a dome-like protrusion (similar to Peyer´s Patches) into the 
bronchial lumen is sometimes obvious. This basic structure seems to be valid for all species, but there 
are many differences in details (adapted from Tschernig and Pabst, 2000). 
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2    The respiratory tract in context of immunity 
 
Due to its function, i.e. to allow gas-exchange in organisms, the lung has a very 
exposed position to the external environment. The human lung is exposed daily to 
over 10,000 litres of inspired, ambient air and the continuous aspiration of small 
amounts of nasopharyngeal secretions during sleep. Depending on the quality of air 
in the environment or the resident flora in the nasopharynx, the respiratory tree faces 
the enormous task of oxygenating blood across a moist, thin alveolar-capillary wall 
(approximately 1µm) and yet resisting infection. Mechanical mechanisms and other 
innate host defences and adaptive immune responses are important in preventing 
infection. 
The lung, similar to other epithelial surfaces that face with the environment, has 
developed several strategies to avoid infection. One important feature of the host 
immune system is the ability to downregulate both non-specific and immune-
mediated inflammation. Hence, the immune apparatus of the lung, as the lung itself, 
represents a sensitive system that coordinates immune responses to avoid 
immunological collapses by creating a tolerant and suppressive milieu. 
 
 
2.1    Immune cells and structures of the lung 
 
Considering the development of pulmonary immunity in a spatial context, it is useful 
to divide the progression of an immune response in the lung into three distinct but 
overlapping phases: (1) in the afferent phase, the antigen reaches the lung, is taken 
up by antigen-presenting cells (APC), and is presented to naïve T cells expressing 
the relevant T cell receptors (TCR); (2) in the central processing phase, specific 
lymphocyte clones expand and differentiate; and (3) in the effector phase, effector T 
cells and B lymphoblasts find their way to pulmonary sites requiring expression of a 
specific immune response. At each phase, events must be tightly regulated to allow 
an effective immune response yet to avoid excess or a potentially destructive 
inflammation (Lipscomb et al., 1995). The place in the respiratory tract, where each 
of these phases occurs, is somewhat controversial. The majority of evidences 
indicate that in the normal host after reaching the lungs, antigen is carried on APC, in 
phagocytes, or free in lymphatic fluid to draining lung-associated lymph nodes 
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(Lauweryns and Baert, 1976-1977; Lehnert, 1992) where central processing occurs. 
Effector cells are released into the efferent lymph and reach the blood stream 
recruiting from the vasculature into the lung (Berman et al., 1990). 
The cells that are the major initiators and regulators of immunity in the lung include 
macrophages, dendritic cells (DC), and lymphocytes. However, other cells in the 
milieu, for example epithelial cells, fibroblasts, mast cells and various recruited blood 
leukocytes also play important regulatory roles. 
 
 
2.1.1    Macrophages 
 
Lung macrophages reside within the airways at all levels of the respiratory tract, in 
the lamina propria, the interstitium, the alveolar regions and pleura, and within pleural 
spaces (Brain, 1992; Lehnert, 1992). All lung macrophages originate from the bone 
marrow. Most of the clearance of small inhaled particles and microorganisms 
reaching the periphery of the lung relies on the phagocytic system (Jonsson et al., 
1985). Macrophages are the primary phagocytes in the healthy lung. The 
macrophages interact with other cells and molecules through the release of 
numerous secretory products and the expression of several surface receptors 
(Delacourt et al., 1997). Pulmonary macrophages are both phenotypically and 
functionally diverse, so that at least three different groups of pulmonary macrophages 
can be observed: alveolar macrophages (AM), intraluminal macrophages and 
interstitial macrophages. Many in vitro studies examined the role of AM in pulmonary 
immunity and in particular their capacity to support T and B cell activation. 
Nevertheless, AM are inefficient in providing accessory cell activity in vitro compared 
to macrophages derived from other sources or monocytes (Holt, 1993). In fact, AM 
have been shown to be efficient suppressors of T cell activation and antibody 
production by B cells (Thepen et al., 1994). Furthermore, intraepithelial DC from lung 
have shown a downmodulation of antigen-presenting capacities of DC in the 
bronchial and alveolar environment by the respective macrophage population (Bilyk 
and Holt, 1993). Therefore, not only T cells, but also DC are maintained in a 
downmodulated state in the airways, tightly controlled by high numbers of nearby 
macrophages.  
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The factors involved in T cell and DC downmodulation by AM are partly known: In 
mice, nitric oxide (NO) produced by AM is the major source of this 
immunomodulation (Strickland et al., 1996). Several other immunomodulating factors 
produced by AM have been isolated, the most important being prostaglandins and 
cytokines. Prostaglandin E2 (PGE2) enhances interleukin (IL)-10 transcription and 
protein production by peripheral blood lymphocyte (Huang et al., 1996) which offers 
possibilities for potent immunomodulation. Finally, PGE2 has been ascribed as 
substance deactivating AM and T cell, and it is produced by AM (Kawano et al., 
1999). 
 
 
2.1.2    Dendritic cells 
 
The other important group of APC include the pulmonary dendritic cells (DC). DC 
play a critical role in sampling and presenting antigen in the lung, which leads to 
activation and expansion of CD4+ T cells and preferential production of T helper 
subset 2 (TH2)-based adaptive immune responses (Kearney et al., 1994; Lambrecht 
et al., 2000). In the lung, DC reside within and beneath airway epithelium, in alveolar 
septae, in the connective tissue surrounding pulmonary veins and airway vessels, 
and with the lung capillaries of the lung parenchyma (Lipscomb et al., 1995). DC in 
the airway epithelium have an immature phenotype and exhibit a rapid turnover (Holt 
et al., 1994). DC that are resident within alveolar septae and in connective tissue 
surrounding vessels have a more mature phenotype than airway DC (Gong et al., 
1992). In contrast to DC that are resident within the lung, in the vascular 
compartment circulating precursor DC are present (Suda et al., 1998). One role of 
lung DC is to provide protection against infectious agents by initiating immune 
response. An equally important role is to generate tolerance to inhaled allergens in 
normal noninflamed lungs. In this regard, immature DC continuously leave the 
peripheral blood and take over a surveillance position in lung tissue, avidly sampling 
the antigenic environment. In the steady state, lung DC likely remain relatively 
immature and constitutively migrate in low numbers into regional lymph nodes where 
they induce anergy, deletion of T cells, or a weak TH2-like response to air-borne 
antigens that is eventually downregulated (Stumbles et al., 1998). Active suppression 
of immature DC maturation by alveolar macrophages may explain why airway and 
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intraepithelial DC remain immature during their steady-state migration to lung-
associated lymph nodes (Holt, 1993; Lipscomb et al., 1993). Furthermore, autocrine 
production of IL-10 by immature DC can inhibit surface expression of MHC class-I 
and -II molecules and exert a generalized inhibitory effect on T cell proliferation 
(Stumbles et al., 1998). On exposure to inhaled allergens, the antigen may simply be 
insufficient in providing a danger signal to overcome suppression by alveolar 
macrophages and IL-10. However, if a danger signal is present at the tissue site, DC 
mature and migrate in greater number to draining lymph nodes to stimulate CD4+ T 
cell clonal expansion and differentiation. 
 
 
2.1.3    Lymphocytes 
 
Lymphocytes play a significant role in lung disorders, for example sarcoidosis, 
asthma, and rejection after transplantation (Berman et al., 1990). T cells, B cells, and 
NK cells are present in various lung compartments (Agostini et al., 1993; Holt and 
Schon-Hegrad, 1987; Pabst, 1990; Stein-Streilein, 1988), for example the lung 
vascular bed, the lung interstitium, the epithelium and lamina propia of the bronchi 
and the bronchoalveolar space (Fliegert et al., 1996; Pabst et al., 1995). Since the 
lung has no afferent lymphatic vessels, the blood is the starting point for lymphocyte 
immigration. Lymphocytes migrate to the lung vascular endothelium (marginal pool) 
and enter the interstitial lung tissue (interstitial pool), where the lymphocyte 
composition is different from blood and bronchoalveolar lavages (BAL) (Fliegert et al., 
1996). In contrast to peripheral blood lymphocytes, mainly activated T cells are found 
in BAL of humans and mice (Curtis et al., 1995; Saltini et al., 1990). This 
immunological status confers lymphocytes appropriate defense mechanisms to such 
a vulnerable organ. The expression of adhesion molecules depends on the 
compartment from which the cells are recruited, indicating that local activation and 
expression of adhesion molecules is induced by the microenvironment. Possible 
candidates for such activators are dendritic cells and macrophages or components of 
the extracellular matrix (Holt, 1993; van Haarst et al., 1994). 
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2.1.4    Airway epithelium 
 
In addition to the aforementioned migrating cells of the respiratory tract, the resident 
structural cells building the airway epithelium have important functions in modulation 
of immune responses in the lung (figure 2). The epithelium constitutes the interface 
between the internal milieu and the external environment, and as such, it is the first 
point of contact for inhaled substances, in particular, respiratory viruses, airborne 
allergens, and environmental pollutants, as well as being a primary target for inhaled 
respiratory drugs (Folkerts et al., 1998; Gizycki et al., 1997). 
At least eight morphologically distinct epithelial cell types are present in human 
respiratory epithelium, which can be classified in three different categories: basal, 
ciliated and secretory epithelial cells (Spina, 1998). Columnar ciliated epithelial cells 
are the predominant cell type within the airways, constituting more than 50% of all 
epithelial cells (Spina, 1998). The primary role of the ciliated apical surface is 
highlighted by the directional transport of mucus from the lung to the throat (Harkema 
et al., 1991). Mucus cells (goblet cells) are responsible for the control of the correct 
amount of mucus and the viscoelasticity of mucus for efficient mucociliary clearance 
by releasing acid mucins from their granules. These cells are thought to be capable 
of self-renewal and may also differentiate into ciliated epithelial cells (Evans et al., 
1988; Harkema et al., 1991). Serous cells are also secreting cells and produce 
neutral mucin and a yet unidentified non-mucoid substance (Knight and Holgate, 
2003). Basal cells are ubiquitous in the conducting epithelium, although the number 
of these cells decreases with airway size and the increasing thickness of the basal 
cell layer correlates with increasing size of the airway (Evans et al., 1988; Evans et 
al., 1990). Similar to the skin, the basal cell is thought to be the primary stem cell, 
giving rise to the mucus and ciliated epithelial cells. In smaller airways, where basal 
cells are sparse or absent, Clara cells perform the primary stem cell role. 
In addition to their progenitor and structural roles, basal cells are also thought to 
secrete a number of bioactive molecules including neutral endopeptidase, 15-
lipoxygenase products and cytokines (Knight and Holgate, 2003). In humans, Clara 
cells are located in large (bronchial) and small (bronchiolar) airways. The cells 
produce bronchiolar surfactant and are also characterized by agranular endoplasmic 
reticulum in the apical cytoplasm and granular endoplasmatic reticulum basally. In 
addition to their role in secretion, Clara cells are believed to metabolize xenobiotic 
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compounds by the action of p450 mono-oxygenases and may also produce specific 
antiproteases such as secretory leukocyte protease inhibitor (De Water et al., 1986). 
More recent evidence suggests that these cells play important role for stem cells, 
serving as a progenitor for both ciliated and mucus secreting cells (Hong et al., 2001). 
 
The major function of the respiratory epithelium was once thought to be primarily that 
of a physical barrier, but recent studies clearly indicate that it is metabolically very 
active with the capacity to modulate a variety of inflammatory processes through the 
agency of an array of receptor-mediated events. On activation, it has the capacity to 
produce a number of proinflammatory cytokines, proinflammatory or regulatory 
mediators including arachidonic acid products, nitric oxide, endothelin-1, transforming 
growth factor (TGF)-ß, tumour necrosis factor (TNF)-α, and cytokines such as 
interleukin (IL)-1, IL-6 and IL-8 (Knight and Holgate, 2003). 
 
 
Table 2: Immunomodulatory cell-cell interactions in the lower respiratory tract. 
Effector cell Target cell Target cell function Effector cell 
mechanism 
Stimulation (+) 
Suppression (-) 
     
Macrophage T cell 
T cell 
T cell 
B cell 
DC 
DC 
macrophage 
proliferation 
IL-10 secretion 
cytokine production 
antibody production 
antigen presentation 
maturation 
apoptosis 
NO secretion 
PGE2 secretion 
TGF-β secretion 
NO secretion 
NO secretion 
NO secretion 
IL-10 & TGF-β 
- 
- 
- 
- 
- 
- 
- 
     
Epithelial cell T cell 
eosinophil 
macrophage 
macrophage 
proliferation 
apoptosis 
apoptosis 
TNF-α secretion 
NO secretion 
NO secretion 
TGF-β secretion 
NO secretion 
- 
- 
- 
- 
     
T helper 2 cell macrophage 
macrophage 
macrophage 
T helper 2 cell 
metalloproteinase 
PGE2 secretion 
apoptosis 
IL-12 secretion 
IL-4 secretion 
IL-4 secretion 
IL-10 secretion 
IL-4 secretion 
- 
- 
- 
- 
     
T helper 1 cell macrophage 
T helper 2 cell 
NO secretion 
IL-4 secretion 
IFN-γ secretion* 
IFN-γ secretion 
+ 
- 
     
AM & epithelial T helper 1 cell IFN-γ secretion NO secretion - 
 
Summary of immunomodulatory cell-cell interactions, which can occur in lower respiratory tract. *IFN-γ 
secretion by T helper 1 cells is not a directly immunomodulatory interaction between T helper 1 cells 
and macrophages. This mechanism has been included for its pivotal role activating NOS2 transcription 
via STAT1 in macrophages and epithelial cells (adapted from Bingisser and Holt, 2001). 
 
 -10-
CHAPTER I  Introduction 
2.1.5    Alveolar epithelium – Type II and Type I alveolar epithelial cells 
 
Alveoli are the gas exchange units of the lung and the alveolar epithelium adapts to 
this functional role by developing two highly specialized alveolar epithelial cell types, 
which are morphologically and functionally different. Alveolar epithelial type II cells 
(AECII, granular pneumocyte, type II pneumocyte, giant corner cell) are cuboidal, 
with a diameter of ∼10µm and a volume of ∼450-900µm3. Alveolar epithelial type I 
cells (AECI) are squamous in shape, with a diameter of ∼50-100µm and a volume of 
∼2000-3000µm3 (Crandall et al., 2001). AECII consist of about 15% of the distal lung 
cells and occupy 5% of the alveolar surface (Crapo et al., 1978; Crapo et al., 1982; 
Haies et al., 1981). The alveolar type II cells perform a variety of important functions 
within the lung, including regulation of surfactant metabolism, ion transport, and 
alveolar repair in response to injury. AECII synthesize and secrete lung surfactant, a 
protein-lipid complex and surface-active material. Lung surfactant stabilizes alveoli by 
reducing the surface tension. Ultrastructural criteria to identify alveolar type II 
epithelial cells are the presence of lamellar bodies, apical microvilli and cell-cell 
junctions. AECII also maintain the alveolar epithelium by cell proliferation and 
differentiation, minimize alveolar fluid by transport of sodium from the apical to the 
basolateral side, and alter the inflammatory process by secretion of growth factors 
and cytokines. 
 
In contrast to AECII, AECI contribute 7% of total lung cells and cover more than 95% 
of the alveolar surface. This thin epithelium allows the easy diffusion of gases and 
forms a barrier against the indiscriminate leakage of fluid into alveolar spaces. It also 
regulates the exchange of physiologically important solutes and water between 
circulating blood and the alveolar space. Recent studies indicate the presence of 
transport proteins such as Na+-K+-ATPases, epithelial sodium channels and 
aquaporin (Aqp) water channels in AECI, therefore implying an active role in 
regulation of lung fluid homeostasis (Borok et al., 2002; Johnson et al., 2002; 
Matthay et al., 2002). These cells also might be involved in the transport of 
macromolecules due to the abundance of mircovesicles (caveolae) (Gumbleton et al., 
2003).  
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The alveolar epithelium can be classified as a continuously renewing tissue since it 
comprises a population of alveolar type II epithelial cells that are characterized by 
almost unlimited potential to proliferate. It is still a matter of debate whether all AECII 
or only a small population act as the alveolar epithelial stem cell population (Uhal, 
1997). The concept of AECII as stem cells of the adult alveolar epithelium was 
proposed by Kapanci and colleagues, and is widely accepted today (Kapanci et al., 
1969). During ontogenesis, the AECII may derive from precursor cell common to 
AECII and Clara cells (Wuenschell et al., 1996). Furthermore AECII proliferate and 
differentiate to AECI to repair the damaged alveolar epithelium after lung injury or 
during fetal lung development, thus contributing to epithelial repair, whereas AECI 
are terminally differentiated, lack mitotic activity, and are easily injured. The 
programmed cell death or apoptosis is an important mechanism of cell removal or 
renewing of tissue. AECII are known to express the membrane receptor Fas (CD95, 
APO-1), the ligation of which may initiate the apoptotic cascade (Fine et al., 1997). 
This can be achieved by binding of Fas-ligand or the Fas-stimulating antibodies. 
There is some evidence that apoptosis of AECII is an integral mechanism of alveolar 
septal modelling in lung morphogenesis (Scavo et al., 1998; Schittny et al., 1998). 
Notably, apoptotic AECII appeared to be removed not only by alveolar macrophages 
but also by AECII cell neighbours (Fehrenbach et al., 2001). 
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Figure 2: Schematic structure of airway and alveolus and their host-defence mechanisms. The 
lung is constantly challenged by inhaled pathogens, pollutans and particles. Several different defence 
mechanisms contribute to lung defence. These include filtration in the naso-oropharynx and 
conducting airways, sneezing, coughing and mucociliary clearance. Small particles might reach the 
alveolar gas-exchange regions of the lung. Host-defence functions in the peripheral air-spaces include 
surfactant, other opsonins (such as immunoglobulins) and innate immune cells (including alveolar 
macrophages and neutrophiles). Surfactant protein A (SP-A); surfactant protein D (SP-D) (adapted 
from Wright, 2005). 
 
 
2.2    The alveolar type II epithelial cell as an integrative unit of the 
alveolus 
 
It is essential for AECII to interact with its resident as well as its mobile neighbour 
cells. AECII express a number of molecules necessary for the perception as well as 
the generation of signals involved in cell-cell as well as in cell-matrix interactions. 
Cell-cell interactions may be direct via contact of the cell membranes, or indirect via 
secreted and diffusible signals. Consequently, alveolar type II epithelial cells were 
termed as integrative units of the alveolus (Fehrenbach, 2001). 
The best example for a cell-cell interaction between AECII and resident cells is the 
direct contact with AECI and during proliferation with AECII neighbours as well. 
These lateral cell-cell contacts within the alveolar epithelium are maintained by cell 
junction complex that includes gap junctions (Kasper et al, 1996). Additionally, AECII 
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have direct contact to fibroblasts at the basal membrane or with capillary endothelial 
cells (Marin et al., 1982). 
A strong evidence for a direct interaction of AECI and AECII was presented by 
Ashino and colleagues (Ashino et al., 2000). Mechanical stimulation of AECI is 
thought to result in Ca2+-oscillations, which were transmitted via intraepithelial gap 
junctions to AECII and modulate exocytosis rate of lamellar bodies. Direct inhibitory 
interactions between AECI and AECII have been postulated to suppress AECII 
proliferation. Loss of AECI during injury might then trigger the release of AECII from 
growth inhibition (Mason and McCormack, 1994). E-cadherin as a further candidate 
to mediate contact inhibition, has been localized to the basolateral membrane of 
AECII (Kasper et al., 1995; St. Croix et al., 1998).  
But even an indirect cell-cell interaction for AECII to other AECII is possible by the 
negative feedback loop by which surfactant protein A (SP-A) upon release into the 
alveolar space inhibits surfactant exocytosis in vitro (Dobbs et al., 1987). Although 
AECII are equipped with membrane receptors for SP-A (Strayer et al., 1996), the in 
vivo relevance of this autocrine mechanism by which AECII may regulate their own 
action remains elusive, because mice that are deficient in SP-A did not show any 
defect in surfactant secretion nor any respiratory deficiency (Ikegami et al., 1998). 
Thus, some alternative mechanism must compensate the negative SP-A feedback 
loop. 
Another potential feedback mechanism that has been postulated is the inhibition of 
AECII proliferation via AECII derived transforming growth factor (TGF)-β in 
bleomycin-induced experimental lung fibrosis (Khali et al., 1994). A number of growth 
factors are released by AECII, which might act in an autocrine way via the 
corresponding receptors expressed by AECII. 
 
As mentioned before, fibroblasts are in contact to AECII. This reciprocal cell-cell 
interaction is relevant to the modelling of alveolus during lung morphogenesis as well 
as during remodelling associated with alveolar repair following lung injury (Kasper et 
al., 1996; O´Reilly et al., 1997; Shannon, et al., 1997). Both direct and indirect cell-
cell interactions have been reported. Secreted factors from fibroblasts or AECII or the 
direct cell-cell contact from fibroblasts to AECII had influence to proliferation 
behaviour of AECII or fibroblasts (Adamson et al., 1991). 
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The interaction of alveolar epithelial and capillary endothelial cells is well examined. It 
was reported that from pulmonary endothelial cells conditioned medium stimulate 
fetal lung epithelial cell growth (Smith et al., 1986) and that endothelin-1 increases 
AECII surfactant secretion in vitro via a protein kinase C and Ca2+-mediated pathway 
(Sen et al., 1994). As a source of endothelin-1, endothelial cells are therefore 
principally competent to act in a paracrine manner on AECII, which were reported to 
express the endothelin receptor A (Markewitz et al., 1995). Furthermore, alveolar 
type II epithelial cells themselves may synthesize endothelin-1 and stimulate 
endogenous prostaglandin E2 synthesis in an autocrine fashion (Markewitz et al., 
1995). 
Recently, a very special mechanism of indirect intercellular communication between 
AECII and endothelial cells has been suggested. Stimulation of alveolar epithelial 
cells with tumour necrosis (TNF)-α was reported to increase epithelial Ca2+ influx and 
to activate epithelial cytoplasmic phospholipase A2, and results in basolateral release 
of arachidonic acid. Free arachidonic acid is thought to increase endothelial Ca2+ 
influx and expression of P-selectin (Kuebler et al., 2000), which is known to be crucial 
for initiation of leukocyte adherence. Thus, AECII could act as transducers of an 
inflammatory signal from the alveolus to the capillary bed to recruit granulocytes to 
the site of inflammation. 
 
Alveolar macrophages are one of the mobile cell types that interact with AECII. 
Among the multitude of secretory products synthesized and released by alveolar 
macrophages (Kasper et al., 1996; Lohmann-Matthes et al., 1994) there are some 
factors that act as mitogens for AECII, such as hepatocyte growth factor (Mason et 
al., 1994) and heparin-binding epidermal growth factor (Leslie et al., 1997). 
Conversely, AECII were shown to express the chemokines RANTES and MCP-1, 
which chemotactically attract macrophages (O´Brien et al., 1998), as well as GM-
CSF (Blau et al., 1994; Christensen et al., 1995), which in turn may stimulate 
macrophage growth (Worgall et al., 1999). Furthermore, SP-A released from AECII 
modulate macrophage functions such as oxygen radical release (Weissbach et al. 
1994) and nitric oxide production (Stamme et al., 2000). 
 
Interactions of AECII with leukocytes have just recently come into focus. AECII 
synthesize some cytokines affecting leukocytes, such as interleukin (IL)-6 or IL-8. Via 
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these cytokines, AECII might be involved in the induction of differentiation of basophil, 
eosinphil, and neutrophil granulocytes and maintenance of inflammatory reactions. 
Recent data support the idea that AECII have an accessory function in T lymphocyte 
activation (Zissel et al., 2000). This has been suggested on the basis of the findings 
that the cells bear MHC class-II molecules (Schneeberger et al., 1986). Furthermore, 
the expression of costimulatory molecules by human type II alveolar cells and their 
ability to deliver costimulatory signals for T cells could be demonstrated, providing 
evidence that AECII are able to act as antigen-presenting and immunoregulatory 
cells of the lung. Additionally, the accessory function of AECII is under the control of 
endogenously released TGF-β (Zissel et al., 2000). 
For murine type II alveolar epithelial cells it was demonstrated that after infection with 
pulmonary pathogens AECII became activated and had increased cell surface 
expression of MHC class-II, CD54, and CD95. AECII used the MHC class-II pathway 
to process and present mycobacterial antigens to primed CD4+ T cells and indicating 
participation in the effector phase of the immune response (Debbabi et al., 2005). 
 
Additionally, AECII were reported to inhibit lymphocyte proliferation in vitro without 
altering their activation state (Paine et al., 1991). Moreover, AECII derived TGF-β 
(Zissel et al., 2000) could indirectly inhibit T cell proliferation via blockade of 
activating factors, such as IL-2. In contrast, granulocyte macrophage-colony 
stimulating factor (GM-CSF) released at the basolateral surface of AECII could 
increase the potential of dendritic cells to induce T-cell proliferation (Christensen et 
al., 1995). 
 
 
2.3    The alveolar type II epithelial cell as the source of alveolar  
surfactant 
 
Pulmonary surfactant was initially identified as a lipoprotein complex that reduces 
surface tension at the air-liquid interface of the lung (Clements, 1957; Pattle, 1955). 
The surface-active agent was characterized in numerous biochemical studies of BAL 
material and is now known to be composed of ∼90% lipids (with ∼80-90% 
phospholipids) and of ∼10% proteins (Griese, 1999). Unlike most other lipid-rich 
components of cells and organs, the surfactant lipids are characterized by an 
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unusually high level of satured fatty acid chains, such as the predominant 
dipalmitoylphosphatidylcholines, which contribute substantially to the unique 
properties of pulmonary surfactant (van Golde et al., 1994). The protein fraction 
comprises a highly variable amount of serum proteins (Griese; 1999) and four 
apoproteins that are associated with surfactant and contribute to its specific function 
(Weaver and Whitsett, 1991). These surfactant associated proteins were termed 
surfactant proteins (SP) -A, -B, -C and -D whereas SP-B and SP-C are extremely 
hydrophobic. SP-B is essential for the ability of surfactant to reduce surface tension 
(Nogee, 2004), and SP-C has recently been shown to bind lipopolysaccharide (LPS) 
(Augosto et al., 2002; Augosto et al., 2003). In the absence of surfactant, surface 
tension is extremely high at end expiration and tends to collapse the lung. This 
makes breathing difficult to the extent that respiration is frequently impossible without 
ventilatory support and surfactant replacement. A deficiency of surfactant – which 
can result in “Respiratory-Distress Syndrome (RDS)” – occurs when infants are born 
prematurely, before their surfactant biosynthetic machinery has matured. Treatment 
of these premature infants with exogenous surfactant replacement reduces mortality 
and morbidity, because of this disease (Wright, 2005). 
The other function of alveolar surfactant relies on the nature of SP-A and SP-D as 
collectins. Both proteins are able to bind to the surface of various pathogens, thus 
acting as opsonins to facilitate their elimination by alveolar macrophages. Therefore, 
alveolar surfactant is also responsible for host defence (Crouch, 2000; Pison et al., 
1994; Wright, 1998). 
Surfactant is synthesized by alveolar type II epithelial cells and released upon 
appropriate stimuli by exocytosis from special intracellular storage organelles termed 
lamellar bodies. Once released into the alveolar space, freshly secreted lamellar 
body material undergoes several steps of transformation that are necessary to 
establish the surface-active lining layer. Cyclic compression and expansion during 
ventilation result in a fraction of spent surfactant that will largely be recycled by AECII. 
Thus, single constituents of surfactant run through several cycles before being 
removed by alveolar macrophages and replaced by de novo synthesis (Fehrenbach, 
2001). 
Although the bronchiolar Clara cells and submucosal cells also synthesize and 
release the mature proteins SP-A, SP-B and SP-D (Kalina et al., 1992; Voorhout et 
al., 1992) the alveolar type II epithelial cell is the only type of pulmonary cell that 
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produces all surfactant components including phospholipids as well as all four 
surfactant proteins. The mature 3.5 -3.7kDa small SP-C is thought to be exclusively 
released by AECII cells (Beers et al., 1994; Phelps and Floros et al., 1991). 
About 85% of the secreted surfactant is taken up again, metabolised and re-secreted 
by AECII. Re-uptake and recycling have been demonstrated for all surfactant lipids 
and for all four surfactant proteins. The degradation of surfactant is accomplished by 
alveolar macrophages with only minimal contribution (Herbein et al., 2000; Nicholas, 
1996; Young et al., 1993). 
 
 
2.3.1    Immunoregulatory functions of surfactant proteins 
 
As mentioned above, the host defence functions of surfactant are primarily mediated 
by SP-A and SP-D, which are members of the collectin family of proteins. SP-A and 
SP-D have been also localized to non-pulmonary sites, including the trachea, brain, 
testes, salivary glands, lachrymal glands, heart, prostate, kidney, pancreas and the 
female urogenital tract (Leth-Larsen et al., 2004; Lin et al., 2000; Madsen et al., 2000; 
Rubio et al., 1995), although it is not yet clear whether all of these organs express 
sufficient amounts of protein for it to be physiologically effective.  
Among their well-established role as opsonins, SP-A and SP-D also have functions in 
initiating parturition, facilitating clearance of apoptotic cells and directly killing bacteria. 
 
 
2.3.2    Collectin structure 
 
In addition to the two lung collectins SP-A and SP-D, serum collectins have been 
identified in humans (mannose-binding lectin, MBL) and in bovidae (conglutinin, CL-
43 and CL-46) (Hansen and Holmskov, 2002).  
SP-A and SP-D are synthesized as primary translation products of approximately 26-
36kDa and 43kDa, respectively (figure 3). The collagen-like domain is N-terminal to a 
coiled-coil structure that precedes the C-terminal lectin domain. The lectin domains 
mediate the interaction of collectins with a wide varity of pathogens. The collagen 
domains vary greatly in length (Holmskov et al., 2003). 
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The collectins are assembled as trimeric subunits, which multimerize to varying 
degrees. SP-A is mainly an octadecamer and forms a bouquet-like structure that is 
similar to MBL, whereas SP-D forms a dodecamer (Wright, 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Collectin and C1q structure. Surfactant protein A (SP-A) and SP-D are members of a 
family of proteins known as collectins. a Collectins have collagen-like amino (N)-terminal regions and 
C-type (calcium dependent) carbohydrate-recognition domains (CRDs). Collectins consist of structural 
subunits that are composed of trimeric polypeptide chains, which are identical except for human SP-A. 
The trimers are assembled into oligomers. b SP-A and mannose-binding lectin (MBL) are 
octadecamers (18-mers), consisting of six trimeric subunits. SP-D is a dodecamer (12-mer), consisting 
of four trimeric subunits. Although C1q is structurally homologous to SP-A and MBL, it is not a collectin 
as it does not have a lectin domain (CRD) (adapted from Wright, 2005). 
 
 
The lung collectins have both distinct and common carbohydrate-binding activities 
(Wright, 2005). For example, both surfactant proteins, SP-A and SP-D, bind to 
mannose and glucose but bind only poorly to galactose (Haagsman et al., 1987; Lim 
et al.; 1994; Persson et al., 1990). The high affinity of the collectins for clustered 
oligosaccharides is thought to be important for their ability to distinguish non-self from 
self, as most carbohydrates in animals are terminated by sugars, such as galactose 
or sialic acid, that are poorly recognized by the collectins. 
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2.3.3    Collectin regulation of immune cells 
 
Surfactant proteins A and D bind to a variety of bacteria, viruses, allergens and 
apoptotic cells and thereby function as opsonins to enhance the uptake of these cells 
and particles. Binding of the collectins to pathogens occurs by various mechanisms. 
Some pathogens are aggregated by SP-A and/or SP-D and were phagocytized by 
immune cells like macrophages. SP-A and SP-D also have direct effects on immune 
cells and modulate the production of cytokines and inflammatory mediators. 
Numerous studies have reported that SP-A mediates cellular functions through C1q 
receptors (Ferguson et al., 1999; Malholtra et al., 1994), including C1qR (also known 
as CD93) (Nepomuceno et al., 1997; Steinberger et al., 2002) and calreticulin 
(Malhotra et al., 1990; Malholtra et al., 1993). SP-A and SP-D are able to bind 
Calreticulin, which in turn binds to CD91. CD91 is a component of the binding 
complex (Gardai et al., 2003). 
The binding of SP-A and/or SP-D to the signal-inhibitory regulatory protein-α (SIRP-α) 
modulates cellular functions in a similar way like the binding complex of surfactant 
proteins with the CD91-calreticulin complex. In the absence of a pathogen, SP-A 
binds through its lectin domain to SIRP-α, whereas in the presence of a foreign 
organism or cell debris, to which the lectin domain of SP-A binds, the free collagen-
like region activates immune cells through CD91-calreticulin. Importantly, 
engagement of the different receptors elicits different responses. Upon binding of SP-
A to SIRP-α, the inflammatory-mediator production is inhibited. By contrast, SP-A 
enhances inflammatory mediator like tumour-necrosis factor (TNF), CXCL12 and 
CCL2 production through its binding to the CD91-calreticulin complex. Therefore, SP-
A and SP-D both are able to enhance and inhibit inflammatory-mediator production to 
modulate the regulation of immune cells. 
 
Another receptor that binds surfactant protein A was identified by Chroneos and 
colleagues and termed SP-R210 (Chroneos et al., 1996). Blocking of this receptor 
with specific antibodies leads to a loss of SP-A mediated functions, including 
inhibition of lymphocyte proliferation (Borron et al., 1998), enhanced uptake of 
bacteria by macrophages (Weikert et al., 1997) and mycobacterial killing by a nitric-
oxide-dependent pathway (Weikert et al., 2000). Nevertheless, the molecular identity 
of SP-R210 is still unclear. 
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Glycoprotein 340 (gp340) is also discussed as a protein that binds SP-D through its 
CRD (Holmskov et al., 1997). Because of its localisation at the cell surface of 
alveolar macrophages, gp340 was suggested to be a SP-D receptor. It is identical to 
salivary agglutinin, a high-molecular-weight component of saliva that binds 
Streptococcus mutans, a bacterium that causes dental caries (Prakobphol et al., 
2000). This putative receptor gp340 has no transmembrane domain so that it is 
suggested that it could interact with an adaptor molecule on the surface of the cell 
(Wright, 2005). 
 
Additionally, a family of conserved cellular receptors that recognize pathogen-
associated molecular patterns (PAMP) are discussed as binding-partners for SP-A 
and SP-D. This family of Toll-like receptors (TLRs) is activated by ligands like flagellin 
and CpG-containing DNA from bacteria, peptidoglycan from Gram-positive bacteria, 
LPS from Gram-negative bacteria, RNA from viruses and zymosan from yeast 
(Takeda et al., 2003). All these activation mechanisms end up in a series of 
conserved responses that culminate in inflammation and the production of 
inflammatory cytokines, such as TNF and interleukin-1β. The SP-A dependent 
binding to TLR4 results in an activation of the nuclear factor κB (NF-κB) signalling 
pathway and upregulation of cytokine synthesis (Guillot et al., 2002), whereas 
interaction of SP-A with TLR2 attenuates stimulation of TLR2 signalling and also 
stimulation of TNF secretion induced by zymosan or peptidoglycan (Sato et al., 2003). 
 
In addition to phagocytosis, SP-A and SP-D have also the ability to regulate the 
production of inflammatory mediators by immune cells in a context-dependent 
manner. One example shows that inflammatory mediators, such as TNF, are both 
up- and downregulated by SP-A and SP-D (Crouch and Wright, 2001). The release 
of TNF that is induced by LPS or intact bacteria is inhibited by SP-A (Hickling et al., 
1998; McIntosh et al., 1996; Rosseau et al., 1999). In contrast, SP-A enhances TNF 
production either when alone (Kremlev et al., 1994, Kremlev et al., 1997) or in 
presence of “rough” LPS (Sano et al., 1999). 
A further effect of surfactant proteins SP-A and SP-D is the enhanced uptake of 
apoptotic cells by alveolar macrophages in vitro (Schagat, et al., 2001), which could 
be even shown for lungs of naïve mice in the case of SP-D (Vandivier et al., 2002). 
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Through the carbohydrate-recognition domains (CRD) and the collagen-like regions it 
is possible for SP-A and SP-D, as well as MBL, to bind DNA from a variety of origins, 
including mice and bacteria (Palaniyar et al., 2004). SP-D effectively binds and 
aggregates alveolar macrophages DNA and it enhances the uptake of DNA by 
human monocytic cells (Palaniyar et al., 2003). Binding of the collectins to cell-
surface DNA might be one mechanism by which they mediate enhanced 
phagocytosis of apoptotic cells. 
Uptake of apoptotic cells by macrophages results in release of anti-inflammatory 
mediators, such as transforming growth factors-β (TGF-β), IL-10 and prostaglandin 
E2 (Fadok et al., 1998). This response is in contrast to the release of pro-
inflammatory cytokines that occurs when phagocytes ingest microorganisms. In 
addition to enhancing the uptake of apoptotic cells, SP-A also enhances the release 
of TGF-β by macrophages (Reidy and Wright, 2003), indicating that SP-A can 
promote resolution of inflammation at several levels of the apoptotic-cell clearance 
process and that surfactant proteins can indirectly induce anti-inflammatory 
responses by phagocytes. 
 
As discussed above, surfactant is linked to innate immunity. However, surfactant is 
also linked to adaptive immunity in the lung by modulating functions of both dendritic 
cells and T cells. 
It has been shown that SP-A and SP-D have different effects on DC functions. The 
uptake and presentation of antigens is enhanced by SP-D (Brinker et al., 2001), but 
only SP-A can inhibit maturation of DC, as assessed by cell-surface marker 
expression, and functional activity, such as phagocytosis and chemotaxis (Brinker et 
al., 2003). 
The proliferation of T cells stimulated with plant lectins, CD3-specific antibodies or 
phorbol esters is inhibited by SP-A and SP-D. It has been suggested that the 
inhibition of IL-2 production might mediate this process (Borron et al., 1996; Borron et 
al, 1998). In addition, both the collagen-like region and the CRD of SP-A have been 
implicated in the inhibition of lymphocyte function, probably due to inhibition of 
calcium signalling (Borron et al., 2002). These data indicate that SP-D and SP-A 
might provide an important link between innate and adaptive immunity, by modulation 
of both DC and T cell functions. 
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Figure 4: Collectin receptors. Surfactant protein A (SP-A) and SP-D potentially bind several 
receptors, including SP-R210, Toll-like receptor 2 (TLR2), TLR4, signal-inhibitory regulatory protein-α 
(SIRP-α) and CD91-calreticulin. SP-A binds SIRP-α and inhibits production of inflammatory mediators. 
In contrast, when SP-A is bound to a pathogen or cellular debris, its collagen-like region is bound to 
CD91-calreticulin and induces inflammatory-mediator production. Nuclear factor κB, (NF-κB); protein 
kinase C (PKC); SRC homology 2 (SH2)-domain-containing protein tyrosine phosphatase 1 (SHP1) 
(adapted from Wright, 2005). 
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3    Autoimmunity 
 
The concept of autoimmunity was first predicted by Paul Ehrlich at the beginning of 
the twentieth century, and he described it as “horror autotoxicus”. His experiments 
led him to conclude that the immune system is normally focused on responding to 
foreign materials and has an inbuilt tendency to avoid attacking self tissues. But 
when this process is disturbed, the immune system can attack self tissues resulting 
in autoimmune diseases. 
Autoimmune diseases occur in up to 3-5% of the population (Jacobson et al., 1997). 
Many of these diseases are classified according to what organs and tissues are 
targeted by the damaging immune responses. There is an autoimmune disease 
specific for nearly every organ in the body, usually involving responses to an antigen 
expressed only in that specific organ. In other autoimmune diseases, such as 
systemic lupus erythematous (SLE), no particular cell type seems to be targeted; 
rather, the response seems to be directed against antigens that are widely expressed 
throughout the host. Nevertheless these diseases are antigen-specific; moreover, 
recognition of widely expressed antigens sometimes results unexpectedly in selective 
manifestations of the organ (Mathews et al., 1983; Yeaman et al., 1988). 
Autoimmune organ damage can be mediated by T cells, as in multiple sclerosis (MS) 
and type 1 diabetes (Steinman, 1996) and, furthermore, CD4+ and/or CD8+ T cells 
can have crucial roles (Haskins and McDuffie, 1990; Hutchings et al., 1992). In these 
diseases, autoantibodies are also produced and serve as markers of the antigen-
specific T-cell responses, for example, antibodies to insulin or other pancreatic islet-
cell antigens in type 1 diabetes (Yu et al., 1996). In other diseases, damage is 
actually mediated by autoantibodies and requires CD4+ T-helper cells. For example, 
nearly all SLE patients have elevated levels of autoantibodies to nuclear antigens. 
Examples for organ-specific and systemic autoimmune diseases with known auto 
antigen targets are shown in table 3. 
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Table 3: Examples for organ-specific and systemic autoimmune diseases with known  
   autoantigen targets. 
Diseases Organ Examples of known 
autoantigens 
Mechanism of 
damage 
Prevalence 
(%) 
 
Organ-specific autoimmune diseases
Thyroiditis 
(autoimmune) 
thyroid thyroglobulin, thyroid 
preoxidase 
T cells/antibody 1.0 - 2.0 
Gastritis stomach H+/K+ ATPase, intrinsic 
factor 
T cells/antibody 1 - 2% in > 
60-y old 
Celiac disease small bowel transglutaminase T cells/antibody 0.2 - 1.1 
Type 1 diabetes pancreas ß 
cells 
insulin, glutamic acid 
decarboxylase 
T cells 0.2 – 0.4 
Mutiple sclerosis brain/spinal 
cord 
myelin basic protein, 
proteolipid protein 
T cells 0.01 – 0.15 
Hepatitis 
(autoimmune) 
liver hepatocyte antigens 
(cytochrome P450) 
T cells/antibody < 0.01 
 
Systemic autoimmune diseases
Rheumatoid arthritis joint, lung, 
heart etc. 
IgG, filaggrin, fibrin etc. T cells/antibody 0.8 
Systemic lupus (SLE) skin, joint, 
kidney 
nuclear antigens 
(DNA, histones, 
ribonuceloproteins), 
others 
antibody 0.1 
Polymyositis/dermato-
myositis 
skeletal 
muscle 
(predominant), 
lung, heart, 
joint, others 
muscle antigens, 
aminoacyl-tRNA 
synthetases, other 
nuclear antigens 
T cells/antibody < 0.01 
 
Diseases are listed by category (organ-specifc versus systemic) and then by prevalence (adapted 
from Marrack et al., 2001). 
 
 
The potential for autoimmunity exists in all individuals because during their 
development lymphocytes may express receptors specific for self-antigens and many 
self-antigens are readily accessible to the immune system. Tolerance to self-antigens 
is normally maintained by selection processes in the thymus that prevent the 
maturation of some self-antigen-specific lymphocytes (Sakaguchi et al., 2000) and, in 
addition, by mechanisms in the periphery those inactivate or delete self-reactive 
lymphocytes that do mature. Loss of self-tolerance may result from abnormal 
selection or regulation of self-reactive lymphocytes and by abnormalities in that way 
that self-antigens are presented to the immune system. Self tolerance can be divided 
into central tolerance and peripheral tolerance. In central tolerance, immature 
lymphocytes that happen to recognize self-antigens in generative lymphoid organs 
die by apoptosis. In contrast, in peripheral tolerance, mature self-reactive 
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lymphocytes encounter self-antigens in peripheral tissues and are killed or shut off. 
The principle mechanisms of peripheral tolerance are anergy (functional 
unresponsiveness) (Schwartz, 1996), deletion (apoptotic cell death) (Miller and 
Basten, 1996), and suppression by regulatory T cells (Piccirillo and Shevach, 2004).  
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Figure 5: Schematic representation of T cell development. T cells originate from the common 
lymphoid progenitor cells in the bone marrow. They migrate as immature precursor T cells via 
bloodstream into thymus, which they populate as thymocytes. The thymocytes go through a series of 
maturation steps including distinct changes in the expression of cell surface receptors, such as the 
CD3 signalling complex (not shown) and the coreceptors CD4 and CD8, as well as the arrangement of 
their antigen receptor (T cell receptor, TCR) genes. More than 98% of the thymocytes die during 
maturation by apoptosis (†), as they undergo positive selection for their TCR´s compatibility with self-
major histocompatibility molecules, and negative selection against those T cells that express TCRs 
reactive to autoantigenic peptides. In humans, the vast majority of peripheral blood T cells express 
TCRs consisting of α and β chains (αβ T cells). A small group of peripheral T cells bear an alternative 
TCR composed of γ and δ chains (γδ T cells). αβ and γδ T cells diverge early in T cell development. 
Whereas αβ T cells are responsible for the classical helper or cytotoxic T cell response, the function of 
the γδ T cells within the immune system is largely unknown. αβ T cells that survive thymic selection 
lose expression of either CD4 or CD8, increase the level of expression of the TCR, and leave the 
thymus to form the peripheral T cell repertoire (adapted from Skapenko et al., 2005). 
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4    Regulatory T lymphocytes  
 
As mentioned above, many possibilities exist to regulate immune responses 
mediated by T cells, by cytokine release and cell-cell interaction to effector cells with 
immune modulating ability like macrophages and DC. The following sections deal 
with the suppression of autoimmune responses by regulatory T (Treg) lymphocytes 
and will give an overview about the subpopulations of Treg cells and their mechanism 
to suppress autoreactive immune responses. 
 
The immune system employs several strategies to maintain its own homeostatic 
balance. The thymus plays an important role in this regulation, because of its 
particular role in clonal deletion of self-reactive T cells, but other mechanisms 
preventing immunological self attacks are also involved in the maintenance of self 
tolerance. These latter mechanisms occur in the periphery and include - among other 
things - T cell anergy and the effects of regulatory cells. Regulatory T cells may be 
defined as CD4+ T cells that inhibit immunopathology or autoimmune disease in vivo. 
Specifically, Treg cells include those able to suppress naïve T cell proliferation in vitro 
and to control CD4+ or CD8+ T cell numbers in vivo, in lymphopenic hosts. Two major 
Treg populations have been described so far, one part is termed naturally occurring 
Treg and includes anergic T cells that require cell-cell contact for their function, and 
the other part is designated adaptive Treg cells including TR1 and TH3 cells, 
functioning by the secretion of inhibitory cytokines (Roncarolo and Levings, 2000). 
 
The two subsets of regulatory T cells might function in different immunological 
settings, depending on the context of antigen exposure, the nature of the 
inflammatory response and the T cell receptor (TCR) repertoires of the individual 
cells. The natural Treg cells are probably most effective at suppressing autoreactive T 
cell responses locally, in non-inflammatory settings – circumstances in which antigen 
specific, self limiting reactions are required to achieve a fine homeostatic balance. In 
contrast, during self-damaging inflammatory reactions to microbes or transplanted 
tissue, or settings (for example inflammatory bowel disease), adaptive Treg cells might 
be induced to suppress the pathological immune responses. 
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4.1    Naturally occurring CD4+CD25+ regulatory T cells 
 
The CD4+CD25+ regulatory T cells are currently the focus of intensive research and 
were first described in the early 1970s by Gershon and colleagues (Gershon et al., 
1974). These cells represent 5-10% of the CD4+ T lymphocytes in healthy adult mice 
and humans and are thought to perform a specialized role in controlling both the 
innate and the adaptive immune system. Although easily identified and isolated from 
unmanipulated mice and humans on the basis of CD25 expression, this chain of the 
IL-2(R) receptor is also expressed on activated T cells (Maloy et al., 2003; Sakaguchi 
et al., 2001; Shevach, 2002). So far, no characteristic stable surface marker has 
been assigned to Treg cells. Additional markers expressed by these cells include 
cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) (Read et al., 2000; Takahashi 
et al., 2000) and glucocorticoid induced tumor necrosis factor receptor (TNFSR18) 
(McHugh et al., 2002; Shimizu et al., 2002), which were initially implicated in the 
mechanism of Treg action. However, both of these molecules are also expressed by 
nonregulatory T cells after activation. Various groups identified the forkhead/winged 
helix transcription factor Foxp3 as a marker for both CD25+ Treg cells and CD25- cell 
that have regulatory activity (Fontenot et al., 2003; Hori et al., 2003). In the mouse, 
Foxp3 is preferentially expressed by CD25+ cells, and mutations of the Foxp3 gene 
are associated with a broad range of hypersensitivity conditions in both mouse and 
man (Ramsdell, 2003). Additional markers are required, and it has been shown, that 
Neuropilin-1 could be used to distinguish CD25+ Treg cells from recently activated 
CD25+ non-regulatory cells (Bruder et al., 2004). 
 
The resident regulatory cells that develop in the thymus are generated in a burst of 
activity during the early stages of fetal and neonatal T cell development (Sakaguchi 
et al., 2001). They are polyclonal on the basis of diverse TCR usage (Shevach, 2002), 
and they are potentially capable of recognizing diverse self-antigens.  
The promiscuous gene expression of many self tissue-specific proteins in the 
medullar epithelial cells of the thymus is described as a potential mechanism to 
ensure central tolerance to peripheral self-antigens, because this self-antigen 
expression in the thymus might lead, among other things, to the deletion of immature 
autoreactive T cells (Derbinski et al., 2001). However, it is possible that these self 
proteins are expressed at low levels and, additionally, by only some of the epithelial 
 -28-
CHAPTER I  Introduction 
cells, making clonal deletion a rather ineffective means of inducing tolerance to 
peripheral antigens. An alternative mechanism of inducing self tolerance in the 
thymus might be the localized antigen presentation, resulting in a more robust 
regulation of autoreactivity. Once generated, the thymic Treg cells are exported in the 
peripheral tissues, where they may function normally to prevent the activation of 
other, self reactive T cells that have the potential of developing into effector cells 
(Salomon et al., 2000). 
These regulatory T cells were described as a “normal” population of suppressor cells, 
because they are always present in normal individuals and carry out their regulatory 
function during normal surveillance of self-antigens. Furthermore, because of their 
development in the thymus, the natural regulatory T cells are expected to be specific 
for self-antigens. 
Recent studies indicate that CD28 controls both thymic development and peripheral 
homeostasis of natural Treg cells. Ligation of CD28 is expected to act at two stages 
during Treg cell development (Boden et al., 2003). In addition, once the natural Treg 
cells emerge from the thymus, costimulation through CD28 is required to maintain a 
stable pool of these cells in the periphery by promoting their self renewal through 
homeostatic proliferation and by supporting their survival (Boden et al., 2003; 
Salomon et al., 2000). The development and maintenance functions of CD28 are not 
mediated through IL-2. It is possible that signalling through CD28 stimulates the 
production of a response to an yet unknown cytokine that functions as a growth and 
survival factor of these cells. The absence of CD80/CD86 or CD28 results in a 
reduction of the number of regulatory cells in peripheral lymphoid tissues and an 
unexpected exacerbation of natural Treg cells, which plays an important role 
controlling autoimmunity (Lenschow et al., 1996; Salomon et al., 2000). 
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4.2    Adaptive regulatory T cells 
 
These cells are generated from mature T cell populations under certain conditions of 
antigenic stimulation, and they can be induced ex vivo by culturing mature CD4+ T 
cells with antigen or polyclonal activators in the presence of immunosuppressive 
cytokines, namely IL-10 (Barrat et al., 2002; Levings et al., 2001). Similar to natural 
Treg cells, adaptive Treg cells originate from thymus, but they might be derived from 
classical T cell subsets or natural Treg cells. The level of expression of CD25 by 
adaptive Treg cell is variable, depending on the disease setting and the site of 
regulatory activity. Of note, adaptive Treg cells function in vivo in a cytokine 
dependent manner (Barrat et al., 2002; Chatenoud et al., 1997; Maloy and Powrie, 
2001), so that these regulatory T cells are distinguished from natural Treg cells not by 
their origin (the thymus), but by their requirement for further differentiation as a 
consequence of exposure to antigen in a distinct immunological context. Several 
different in vitro protocols have been described over the past few years that result in 
the generation of suppressor T cells. The activation of mouse or human CD4+ T cells 
in vitro in the presence of IL-10 has been shown to result in the generation of T cell 
clones with a cytokine profile different from that of T helper 1 (TH1) or T helper 2 (TH2) 
cells. Functionally, these T cell clones have inhibitory effects on antigen specific 
activation of naïve T cells that are mediated partially by IL-10 and TGF-β, and were 
termed T regulatory 1 (TR1) cells (Groux et al., 1997). A related approach for the 
generation of suppressor T cells in vitro involves the stimulation of naïve T cells with 
immature (im)DC. Surprisingly, although these cells produce IL-10, their suppressor 
phenotype resembles that of CD25+ T cells, as it is contact dependent, antigen non-
specific and APC-independent. Immature DC are the ideal population to prime 
regulatory T cells as they are deficient in costimulatory molecules, and priming with 
antigen-imDC complexes might even be able to downregulate pre-existing antigen 
specific immune responses (Dhodapkar et al., 2001). Exposure to TGF-β has also 
been reported to facilitate the differentiation/expansion of suppressor T cell 
populations in vitro (Yamagiwa et al.; 2001). Another possibility to induce regulatory 
T cells is antigen exposure by certain routes, including intranasal or oral 
administration. This strategy seems to induce selectively the appearance of T cells 
with this regulatory phenotype (Chen et al., 1994). These induced TH3 cells produce 
high concentration of TGF-β and can inhibit the development of immune pathology in 
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several animal models (Chen et al., 1994; Neurath et al., 1996). Moreover, in 
contrast to natural Treg cell, which are fully functional at the time of thymic export as a 
consequence of strong TCR engagement, the development of adaptive Treg cells in 
the periphery might be triggered by low-affinity antigen or altered TCR signal 
transduction. These antigen-stimulated adaptive Treg cells are not functional without 
activation by further exposure to antigens – such as during infection, organ 
transplantation under cover of certain immunomodulatory therapies, or ectopic 
expression of non-self-antigens (Apostolou et al., 2002; Belkaid et al., 2002; Fuss et 
al., 2002; Kingsley et al., 2002; Powrie, 2003). Concerning the antigen specificity of 
adaptive Treg cells, it is interesting to speculate that these cells have a diverse 
repertoire, which might be expanded as a consequence of fortuitous cross-
reactivities with foreign proteins. It is possible that the TCR repertoire of adaptive Treg 
cells is self-antigen specific, but that these cells are triggered in an inflammatory 
environment to promote bystander suppression through the production of 
suppressive cytokines.  
It is important to note that unlike natural Treg cells, adaptive Treg cells might not 
require costimulation through CD28 for their development or function (Taylor et al., 
2002). Interestingly, IL-2 might promote the development and function of both types 
of Treg cells, on the basis of studies showing the total absence of Treg cells in IL-2 
receptor-deficient mice (Malek et al., 2002; Furtado et al., 2002). 
 
 
4.3    Mechanism of suppression 
 
In addition to potential differences in terms of TCR repertoire and differentiation state, 
it is proposed that natural and adaptive subsets of Treg cells differ in their mechanism 
of action. Adaptive Treg cells mediate their inhibitory activities by producing 
immunosuppressive cytokines, such as TGF-ß and IL-10 (Kingsley et al., 2002; 
Nakamura et al., 2001). In contrast, natural Treg cells, at least in vitro, function by a 
cytokine-independent mechanism, which presumably involves direct interactions with 
responding T cells or antigen-presenting cells (Shevach, 2002). This contact-
dependent mechanism of suppression has been shown most convincingly by 
CD4+CD25+ natural Treg cells employed in in vitro models of suppression, whereas 
cytokine-mediated suppression has been best established for peripheral adaptive Treg 
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cells in vivo. However, the adaptive Treg cell subset, although it suppresses in a 
cytokine-dependent manner, might still require direct cell-cell contact to initiate the 
suppressive cascade. 
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Figure 6: Two classes of regulatory T cells can be envisioned. a In this hypothetical model, the 
natural regulatory T (Treg) cells (blue) suppress immune response in a contact-dependent manner and 
function in general homeostasis to block the actions of autoimmune T cells (red) in noninflammatory 
settings. b The adaptive Treg cell subset enhances the robust nature of suppression in an inflammatory 
milieu. Importantly, adaptive Treg cells can develop either CD4+CD25+ natural Treg cells (blue striped) or 
by altering the activity of T helper (TH) cells (red striped). APC, antigen presenting cell; interleukin (IL)-
10, transforming growth factor (TGF)-β, regulatory T cell (Treg) (adapted from Bluestone and Abbas, 
2003). 
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5    SPC-HA transgenic mouse model 
 
To get further insights into the mechanisms underlying the induction and regulation of 
T cell mediated immune reactions in the lung, a new SPC-HA transgenic mouse line 
has been established prior to this work (Bruder et al., 2004).  
The SPC-HA transgenic mouse expresses hemagglutinin (HA) of the influenza strain 
A/PR8/34 under the transcriptional control of the surfactant protein C (SP-C) 
promoter specifically in type II alveolar epithelial cells. High levels of HA expression 
could be detected in the lung and relatively low levels in the thymus of SPC-HA mice, 
but not in other organs. Immunohistochemical stainings of lung sections from 
transgenic mice and non-transgenic littermates revealed HA expression exclusively 
in surfactant protein C producing type II alveolar epithelial cells in SPC-HA transgenic 
mice. This expression of the neo-self-antigen HA specifically in the lung tissue 
represents the basic condition to establish a new mouse model for autoimmune-
mediated lung disease. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Targeted expression of hemagglutinin in the lung. (A) Construct used for the generation 
of surfactant protein C (SPC)-hemagglutinin (HA) transgenic mice. PolyA = polyadenylic acid (B) Real-
time RT-polymerase chain reaction (PCR) to detect HA mRNA expression in different tissues of SPC-
HA transgenic mice (He: heart; Lu: lung; Sp: spleen; Ki: Kidney; Th: thymus; sln: small intestine; lIn: 
large intestine; St: stomach; Li: Liver). RPS9 housekeeping gene specific primer served as internal 
control. (C) Quantification of HA mRNA expression levels in selected tissues by RT-PCR. (D) 
Immunohistochemical detection of influenza HA antigen on lung sections taken from SPC-HA 
transgenic (upper panel) and wild type (lower panel) animals using DAB stain (brown) as chromogen 
and hematoxylin (blue) as nuclear counterstain. Bar = 30µm (adapted from Bruder et al., 2004). 
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Crossing SPC-HA transgenic mice into TCR-HA mice, which bear a major 
histocompatibility complex class-II-restricted T cell receptor specific for the peptide 
HA110-120 (Kirberg et al., 1994) results in the development of a progressive 
interstial pneumonitis characterized by a massive lymphocytic and plasmacytic 
infiltration of interalveolar septa of SPC-HA x TCR-HA double transgenic mice. 
 
Figure 8: Immunohistology analysis 
of lung from SPC-HA x TCR-HA 
double transgenic mouse compared 
to SPC-HA transgenic mouse. Lung 
of a healthy SPC-HA transgenic 
mouse (a) compared with a SPC-HA x 
TCR-HA double transgenic mouse (b). 
Alveolar emphysema in a SPC-HA x 
TCR-HA mouse (c). Lymphocytic 
infiltration in a double transgenic 
mouse (d) distinct lymphocytic 
infiltration patterns in the interalveolar 
(e), around bronchi (f), veins (g) and 
arteries (h). Normal interalveolar septa 
of a SPC-HA control mouse (I; 
compare with e). Lymphocytic 
aggregates containing brownish 
pigment-loaded macrophages (j) 
suggestive of hemosiderin. Turnbull 
blue stain for iron revaled significant 
iron deposition (k; blue color). Lung of 
a 9-days-old double transgenic mouse 
(l) with acute tissue damage. H&E 
stain (a-j, l) and turnball blue stain for 
the detection of iron (k). Bars = 500µm 
(a-c), 200µm (d) 100µm (e-i) and 50µm 
(j-l) (adapted from Bruder et al., 2004). 
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Despite the fact that HA is expressed not only in the lung but also to some extent in 
the thymus of SPC-HA mice, no reduction in the frequency of HA-specific 6.5+ CD4+ 
autoreactive T cells was observed in the periphery of SPC-HA x TCR-HA double 
transgenic mice. These findings are indicative for inefficient thymic deletion of 
potentially autoreactive T cells. In addition, the proliferative capacity of CD4+ T cells 
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from double transgenic mice in response to in vitro antigenic stimulation was 
comparable to that of CD4+ T cells from TCR-HA single transgenic T cells, 
suggesting that peripheral autoreactive T cells in double transgenic SPC-HA x TCR-
HA mice are fully functional, thus having the potential to cause lung inflammation. 
 
 
Figure 9: Increased number of HA-specific CD4+ T 
The lung inflammation observed in SPC-HA x TCR-HA double transgenic mice did 
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Percentages of 6.5+CD4+ T cells isolated from the lung 
were determined by fluorescence-activated cell sorter 
(FACS) analysis. Proliferative capacity of lung 
lymphocytes from single and double transgenic mice was 
compared in an in vitro stimulation assay; cpm = counts 
per minute (adapted from Bruder et al., 2005). 
 
 
 
 
not progress in an uncontrolled way, i.e. inflammation did not result in complete 
tissue destruction or death. Thus, although multifocal acute alveolar necrosis occur 
with hemorrhage, intraalveolar fibrin deposition, consistent with acute tissue damage, 
which could be observed in 9-day-old SPC-HA x TCR-HA double transgenic mice, 
inflammation reached a plateau, which was characterized by primarily diffuse to 
follicular lymphocytic infiltration in elder mice. These findings suggested a regulatory 
mechanism that may exist and/or develop under autoimmune conditions to 
counteract the progression of inflammatory processes in the lung, thus preventing 
uncontrolled tissue destruction and lethal physiological derangement. 
Detailed analysis of HA-specific 6.5+CD4+ lung lymphocytes obtained
SPC-HA x TCR-HA double transgenic mice exhibited a regulatory phenotype. It could 
be shown that the proliferative capacity of lung lymphocytes from SPC-HA x TCR-HA 
mice was reduced by approximately 50% when compared with lung T cells from 
healthy TCR-HA control mice (Bruder et al., 2004). 
Moreover, cytokine and gene expression profiling o
T cell from diseased mice demonstrated a changed phenotype compared to cells 
derived from TCR-HA control mice. This phenotype resembles a TR1 regulatory 
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phenotype and suggested the in vivo induction of these suppressor T cells during the 
progress of lung inflammation in SPC-HA x TCR-HA mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Cluster analysis of genes differentially expressed in 6.5+CD4+ T cells isolated from 
ngs and spleens of diseased SPC-HA x TCR-HA as well as healthy TCR-HA mice. Red 
dicates induction of gene expression, green indicates repression (+3: bright red; -3: bright green). 
ndicates no changes. Genes in which expression was at least twofold increased were 
nsidered to be regulated. Lu (infl.), lung inflamed, genes differentially expressed in 6.5+CD4+ T cell 
om the inflamed lung of SPC-HA x TCR-HA mice compared with the lung of healthy TCR-HA donors. 
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Sp (infl.), spleen inflamed, represents genes differentially expressed in 6.5+CD4+ T cells from spleen of 
SPC-HA x TCR-HA mice compared with TCR-HA. Lu versus Sp, lung versus spleen, defines basal 
expression level of genes in the lung. The left lanes represent an overview and the middle and right 
lanes are an enlarged view outlining clusters of special interest. Cluster A: genes downregulated in 
the lung of SPC-HA x TCR-HA mice upon airway inflammation, although being, in part, higher 
expressed in the lung than periphery in healthy mice. Cluster B: genes with high basal expression 
level in the lung of healthy donors, being upregulated during pulmonary disease. Cluster C: genes 
being expressed at lower levels in the lung than in the spleen under normal conditions, which are 
upregulated in lung CD4+ T cells, but downregulated in self-reactive CD4+ T cells in the inflamed lung, 
but partially downregulated in the periphery (adapted from Bruder et al., 2004). 
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CHAPTER I  Introduction 
The SPC-HA x TCR-HA double transgenic mouse model combines important 
features of a variety of lung diseases and will contribute to a better understanding of 
the requirements for, and consequences of chronic T cell-mediated lung injury. 
Further analysis will clarify the mechanisms for the induction of peripheral tolerance 
and the development of adaptive regulatory T cells. Additionally, the role of the self-
antigen expressing type II alveolar epithelial cells in the progression of disease in 
SPC-HA x TCR-HA double transgenic mice and the induction of a tolerogenic 
environment have to be studied. 
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1 Aims of the study 
 
To dissect the immunologic and molecular mechanisms of autoantigen-specific CD4+ 
T cell dysregulation, a transgenic mouse expressing hemagglutinin A/PR8/34 (HA) 
under the control of the lung-specific surfactant protein C promoter in type II alveolar 
epithelial cells (AEC II) was generated (Bruder et al., 2004). Breedings of these 
transgenic mice with TCR-HA mice bearing a major histocompatibility complex class-
II-restricted T cell receptor specific for the peptide HA110-120 (Kirberg et al., 1994) 
results in the development of a progressive interstial pneumonitis characterized by a 
massive lymphocytic and plasmacytic infiltration of interalveolar septa. Pulmonary 
inflammation reached a plateau state in older mice with prominent formation of 
lymphoid follicles, but reduced interstial infiltration. Extensive immunologic 
characterization and molecular analysis of self-reactive CD4+ T cells isolated from 
the inflamed lung suggested the induction of regulatory T cells in the site of 
inflammation. To study the impact of naturally occurring and induced regulatory T 
cells on disease progression and prevention of autoimmunity in more detail, the 
following studies should be performed: 
 
• Isolation of peripheral self-reactive T cells from SPC-HA x TCR-HA double 
transgenic mice and TCR-HA control mice to characterize their activation 
status in different compartments. 
 
• Analysis of the gene expression pattern of lung lymphocytes derived from 
SPC-HA x TCR-HA double transgenic and TCR-HA control mice with focus on 
marker molecules specific for regulatory T cells. 
 
• Analyzing the impact of naturally occurring regulatory T cells on the outcome 
of disease in an adoptive transfer system based on the transfer of HA-specific 
CD4+ T cells into SPC-HA single transgenic mice. 
 
• Examinations regarding the effects of in vivo induced regulatory T cells on the 
proliferation of autoreactive T cells in an adoptive transfer system based on 
the transfer of HA-specific CD4+ T cells into SPC-HA x TCR-HA double 
transgenic mice. 
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2 Results 
 
2.1 HA-specific CD4+ T cells are present in the periphery of SPC-HA x TCR- 
 HA mice 
 
The prerequisite for the development of autoimmune diseases is inefficient deletion 
of autoreactive T cells during the process of T cell maturation in the thymus. Self-
antigen specific T cells that escaped thymic deletion are present in the periphery of 
every individuum and therefore represent a potential risk for the organism. 
 
In the above described SPC-HA x TCR-HA mouse model the HA-specific (6.5+) CD4+ 
T cells play a key role for the establishment of autoimmunity. Despite the fact that HA 
is expressed not only in the lung epithelium but also to some extent in the thymus of 
SPC-HA transgenic mice, autoreactive CD4+ T cells were detectable in the spleen 
and mesenteric lymph nodes (MLN) of SPC-HA x TCR-HA double transgenic mice 
(Bruder et al, 2004). 
To analyze the presence of 6.5+CD4+ T cells in the periphery of SPC-HA x TCR-HA 
double transgenic mice in more detail, T cells from lung, spleen, MLN and in addition 
from bronchial lymph nodes (BLN), inguinal lymph nodes (INLN), cervical lymph 
nodes (CVLN) and axillary lymph nodes (AXLN) of SPC-HA x TCR-HA and TCR-HA 
control mice were isolated and analyzed by flow cytometry for the expression of the 
transgenic T cell receptor (figure 11). 
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Figure 11: HA-specific CD4+ T cells 
are present in periphery of SPC-HA x 
TCR-HA mice. SPC-HA x TCR-HA and 
TCR-HA control mice were sacrificed, 
lung and BLN, MLN, Spleen, AXLN, 
INLN, CVLN were isolated and stained 
for CD4 and 6.5 expression to measure 
the percentage of transgenic T cells in 
the different compartments. These 
results are a representative of two 
similar experiments. 
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Figure 11 (continued): HA-specific 
CD4+ T cells are present in the 
periphery of SPC-HA x TCR-HA mice. 
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In any case no reduction in the frequency of 6.5+CD4+ T cells could be observed in 
peripheral lymphoid tissues of double transgenic SPC-HA x TCR-HA mice compared 
to TCR-HA control mice, thus indicating inefficient thymic deletion of potentially 
autoreactive T cells. 
The percentage of 6.5+CD4+ T cells in the lung of SPC-HA x TCR-HA mice was even 
found to be increased. This is directly linked to infiltration of antigen-specific T cells to 
this tissue which was confirmed by morphologic changes observed in the lungs of 
double transgenic mice (Bruder et al., 2004). Also, the BLN draining the lung 
contained elevated numbers of 6.5+CD4+ T cells in double transgenic mice. 
In the other compartments analyzed no remarkable increase of transgenic T cells 
could be detected. Therefore, spleen, MLN, AXLN, CVLN and INLN from SPC-HA x 
TCR-HA mice exhibit comparable amounts of 6.5+CD4+ T cells like TCR-HA control 
mice. 
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Figure 11 (continued): HA-specific 
CD4+ T cells are present in the 
periphery of SPC-HA x TCR-HA mice.  
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2.2 HA-specific CD4+ T lymphocytes from SPC-HA x TCR-HA mice have an 
activated phenotype 
 
Antigen encounter by specific T cells should result in changes of the expression 
pattern of certain activation and/or memory markers. To characterize HA-specific 
6.5+CD4+ T cells from the inflamed lung and surrounding lymphoid organs of SPC-
HA x TCR-HA mice in more detail, these cells were analyzed for the expression of 
the activation and memory markers CD69, CD25, CD45RB and CD62L by flow 
cytometry (figure 12). As already shown before, comparing the expression patterns 
on 6.5+CD4+T cells isolated from the inflamed lung of SPC-HA x TCR-HA mice and 
healthy lungs of TCR-HA control mice, autoreactive CD4+ T cells from SPC-HA x 
TCR-HA mice exhibit an activated and memory phenotype. The activation markers 
CD25 and CD69 on the surface of 6.5+CD4+ T cells are upregulated and accordingly 
the memory makers CD45RB and CD62L on the surface of autoreactive T cells are 
downregulated. Surprisingly, 6.5+CD4+ T cells isolated from the BLN draining the 
inflamed lung show no activation/memory phenotype (figure 12). 
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Figure 12: Activation/memory phenotype of HA-specific CD4+ T cells from double transgenic 
SPC-HA x TCR-HA mice compared to healthy TCR-HA control mice. T cells were isolated from 
lung and BLN, spleen, MLN, AXLN, INLN and CVLN of SPC-HA x TCR-HA and TCR-HA mice, 
respectively. Lymphocytes were stained with 6.5 and CD4 antibodies as well as CD25, CD69, 
CD45RB and CD62L antibodies. 6.5+CD4+ T cells were gated and analyzed regarding the expression 
of CD25, CD69, CD45RB and CD62L by FACS. These results are a representative of two similar 
experiments. 
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Figure 12 (continued): Activation/memory phenotype of HA-specific CD4+ T cells from double 
transgenic SPC-HA x TCR-HA mice compared to healthy TCR-HA control mice.  
 
 
Also, in contrast to the lung the expression of CD25 and CD69 was not increased 
when the peripheral compartments spleen and MLN from SPC-HA x TCR-HA mice 
and control mice were compared. However, the expression of the memory markers 
CD45RB and CD62L was downregulated in these compartments on 6.5+CD4+ T cells 
from double transgenic mice (figure 12). 
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Figure 12 (continued): Activation/memory phenotype of HA-specific CD4+ T cells from double 
transgenic SPC-HA x TCR-HA mice compared to healthy TCR-HA control mice.  
 
 
In INLN, CVLN and AXLN no obvious changes in the expression level of CD25, 
CD69, CD45RB and CD62L could be detected on autoreactive T cells from SPC-HA 
x TCR-HA mice when compared to TCR-HA controls. 
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Figure 12 (continued): Activation/memory pattern 
of HA-specific CD4+ T cells from double 
transgenic SPC-HA x TCR-HA mice compared to 
healthy TCR-HA control mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In summary, FACS data suggest that in SPC-HA x TCR-HA mice in which the lung 
epithelium expresses the self-antigen hemagglutinin, the lung is the place were the 
inflammation starts and extends out in the lung tissue due to autoreactive CD4+ T cell 
antigen recognition. The autoreactive 6.5+CD4+ T cells proliferate in and/or infiltrate 
the lung and exhibit a strongly activated phenotype in the presence of the self-
antigen HA.  
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2.3 Marker genes for regulatory T cells are expressed in 6.5+CD4+ lung 
 lymphocytes isolated from SPC-HA x TCR-HA double transgenic mice 
 
It has been shown previously that expression of HA under the control of the Ig κ 
promoter by hemapoetic cells resulting in permantent antigen expression both in 
thymus and in the periphery leads to tolerance rather than inflammation (Buer et al. 
1998). Therefore, it was reasonable to analyze whether mature 6.5+CD4+ T cells 
found in peripheral lymphoid organs of SPC-HA x TCR-HA double transgenic mice 
are still functional with respect to their proliferative capacity upon antigen encounter. 
In previous works it could be shown that the proliferative capacity of lung 
lymphocytes from SPC-HA x TCR-HA mice was reduced by approximately 50% 
when compared with lung T cells from TCR-HA control mice (Bruder et al., 2004). 
Moreover, data from this study suggested an important role of Treg cells for the 
development and progression of CD4+ T cell meditated lung disease in the SPC-HA x 
TCR-HA mouse model. Cytokine and gene expression profiling on isolated 6.5+CD4+ 
autoreactive T cells from diseased mice demonstrated a changed phenotype 
compared to cells derived from TCR-HA control mice. This phenotype resembled a 
Treg1 regulatory phenotype and suggested the in vivo induction of these suppressor T 
cells during the progress of lung inflammation in SPC-HA x TCR-HA mice. 
To corrobate and extent the observed differences of the gene expression pattern 
between naïve 6.5+CD4+ lung lymphocytes and primed 6.5+CD4+ lung lymphocytes 
from SPC-HA x TCR-HA, autoreactive T cells were isolated from lung tissues of 
diseased and healthy mice for semi-quantitative analysis by PCR.  
 
 
Figure 13: Semi-quantitaive RT-PCR 
analysis of ex vivo isolated 6.5+CD4+ 
lung lymphocytes from SPC-HA x 
TCR-HA mice and TCR-HA control 
mice. The expression of different 
molecular marker genes for regulatory 
T cells as CD103 (alphaEbeta7), CTLA4, 
Neuropilin-1, GITR (TNFRSF18), Foxp3, 
Galectin, PD-1 and ICOS was analyzed. 
RPS9 was used as a housekeeping 
gene. 
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In line with results obtained by Affymetrix Arrays, PCR analysis revealed elevated 
expression of CTLA4, PD-1, ICOS, GITR and alphaEbeta7 (CD103) in autoreactive T 
cells from double transgenic mice compared to naïve T cells from the TCR-HA mice 
(figure 13). Whereas these genes are known to be expressed not only on regulatory 
but in addition on activated T cells, also strong upregulation of Neuropilin-1 and 
Foxp3 was detectable. These genes are activation independent and exclusively 
linked to regulatory T cells, thus clearly indicating the induction of self-antigen 
specific regulatory T cells in the lung of diseased SPC-HA x TCR-HA mice.  
 
 
2.4 Progressive infiltration of HA-specific CD4+ T cells in the lung of SPC-HA  
 mice after adoptive transfer 
 
As mentioned above, HA expression in the lung of SPC-HA mice leads, despite the 
fact of HA expression in the thymus, to strong inflammatory reactions in the lung of 
double transgenic SPC-HA x TCR-HA mice. Consistent with the FACS data shown in 
figure 12, the inflammation is restricted exclusively to the lung. Importantly, although 
the early inflammatory lesions observed in the lungs of newborn and young SPC-HA 
x TCR-HA mice were quite severe, there was no evidence for uncontrolled 
progression of the inflammation leading to complete tissue destruction or death in 
elder mice (Bruder et al., 2004), but data suggest the induction of regulatory 
mechanisms counter-regulating disease progression. With intent to analyze the 
impact of regulatory T cells on the outcome of autoimmunity and to clarify whether 
the small proportion of naturally occurring HA-specific Treg cells is able to suppress 
the proliferative and inflammatory capacity of 6.5+CD4+CD25- T cells in vivo, adoptive 
transfer experiments were performed. 
To this end, first of all SPC-HA and BALB/c control mice were adoptively transferred 
with autoreactive CD4+ T cells. 1 x 107 CD4+ T cells from TCR-HA mice prior 
activated in vitro were injected i.v. in transgenic SPC-HA mice and BALB/c control 
mice. At days 1, 3 and 7 mice from each group were sacrificed and the lungs were 
dissected for histological examination (figure 14). 
This analysis revealed rapid and distinct lymphocytic infiltration, thus clearly 
demonstrating the strong impact of autoreactive CD4+ T cells on disease 
development and progression. After establishing the conditions for the adoptive 
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transfer, the transfer model was used for further analyzing the influence of antigen-
specific naturally occurring T cells and in vivo induced antigen specific regulatory T 
cells. 
 
Figure 14: Progressive infiltration of HA-specific 
CD4+ T cells in the lung of SPC-HA mice after 
adoptive transfer. 1 x 107 CD4+ T cells from TCR-HA 
transgenic mice prior activated in vitro were injected i.v. 
in transgenic SPC-HA or BALB/c mice, respectively. At 
day 1 (A), 3 (B) and 7 (C) the mice were sacrificed and 
lungs were dissected to perform histological analysis. 
From day 1 to day 7 a rapid progressive infiltration of 
lymphocytes was documented as shown here for arteries. 
Hematoxylin and eosin (H&E) stain, bar = 50.0µm. These 
results are a representative of two similar experiments. 
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2.5 Adoptive transfer of 6.5+CD4+ and 6.5+CD4+ depleted of CD25+ regulatory 
T cells into SPC-HA transgenic mice 
 
HA-specific lung lymphocytes from double transgenic SPC-HA x TCR-HA mice have 
an activation/memory phenotype and show a reduced proliferative capacity when 
stimulated in vitro with the corresponding peptide. The autoreactive 6.5+CD4+ T cells 
from the lung of SPC-HA x TCR-HA mice secreted drastically reduced amounts of 
the proinflammatory cytokines interferon (INF)-γ  and IL-2, but an increased level of 
IL-5 upon in vitro stimulation. 
Elevated levels of IL-10  and no detectable IL-4 production and moreover the global 
gene expression profiling of alveolar HA-specific CD4+ T cells from diseased mice, 
which revealed many genes associated with regulatory CD4+ T cells like the surface 
markers CTLA-4, PD-1, Nrp1 and αEβ7 suggested a TR1 regulatory T cell phenotype. 
Data were underlined by histological evidence in elder diseased mice which showed 
a controlled inflammation in the lung of double transgenic SPC-HA x TCR-HA mice 
(Bruder et al., 2004).  
CD4+CD25+ T cells derived in the thymus constitute a major population of regulatory 
T cells that are able to suppress T cell responses in vitro (Read et al., 1998; Thornton 
& Sevach, 1998) as well as in vivo (Read et al., 2000; Suri-Payer et al., 1998). 
To clarify whether the small proportion of naturally occurring HA-specific 
6.5+CD4+CD25+ regulatory T cells is able to suppress the proliferative and 
inflammatory capacity of 6.5+CD4+CD25- T cells in vivo, adoptive transfer 
experiments were performed following the conditions described above. Naïve CD4+ 
and CD4+CD25- T cells were isolated from spleen and lymph nodes of TCR-HA 
transgenic mice by negative selection using AutoMACS. The percentages of 
6.5+CD4+ T cells were analyzed by FACS and CFSE labelling was performed. 2 x 106 
6.5+CD4+ T cells or 6.5+CD4+ depleted from CD25+ Treg cells (6.5+CD4+CD25-) were 
injected i.p. into SPC-HA transgenic mice. 7 days after adoptive transfer the in vivo 
proliferation of 6.5+CD4+ transgenic T cells was investigated by estimating the loss of 
CFSE dye in proliferating HA-specific CD4+ T cells from lung, BLN and spleen (figure 
15). 
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Figure 15: Proliferative response of 6.5+CD4+ T cells in vivo to tissue derived antigen after 
adoptive transfer into SPC-HA recipients. 2 x 106 CFSE labelled 6.5+CD4+ or 6.5+CD4+CD25- T 
cells were adoptively transferred into SPC-HA recipients. 7 days later cells from lung, BLN and spleen 
were isolated and stained for 6.5 and CD4 expression. CFSE profiles gated for 6.5+CD4+ T cells were 
estimated. These results are a representative of two similar experiments. 
 
In lung and BLN it could be shown that in the absence of naturally occurring 
regulatory T cells the proportion of 6.5+CD4+ transgenic T cells underwent a strong 
proliverative activity in response to the lung-derived self-antigen HA. The proliferation 
of 6.5+CD4+ T cells containing the regulatory CD25+ HA-specific T cell population 
was less prominent suggesting that naturally occurring CD25+ T cells suppress 
antigen specific proliferation of lung-specific CD4+ T cells.  
The percentages of 6.5+CD4+ transgenic T cells obtained after re-isolation from the 
recipient mice underline this hypothesis. As summarized in Figure 16 the percentage 
of 6.5+CD4+ transgenic T cells is increased in the lungs of SPC-HA mice that 
received 6.5+CD4+ depleted from naturally occurring CD25+ T cells. Together, these 
data suggest the active suppression of proliferation of autoreactive T cells in the lung 
after antigen encounter by HA specific 6.5+CD4+CD25+ regulatory T cells, pointing 
out the importance of Treg cells for the control of autoimmune mediated T cell 
responses in the lung. 
Antigen specificity of T cell proliferation was underlined by the fact that no 
proliferation was observed in transferred cells re-isolated from the spleen of SPC-HA 
mice, which does not express the HA antigen. 
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Figure 16: Clonal expansion in 
response to self-antigen. 2 x 106 
6.5+CD4+ or 6.5+CD4+CD25- T cells 
were adoptively transferred i.p. into 
SPC-HA recipients. 7 days later T cells 
from lung, BLN and spleen were 
isolated and stained for 6.5 and CD4 
expression to measure the percentage 
of transgenic T cells in the different 
compartments. These results are a 
representative of three similar 
experiments. 
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2.6 Adoptive transfer of 6.5+CD4+ T cells in SPC-HA x TCR-HA double  
 transgenic mice 
 
To analyze whether in addition to naturally occurring regulatory T cells also the 
proportion of in vivo induced HA-specific regulatory T cells has the potential to 
suppress antigen specific expansion of adoptively transferred 6.5+CD4+ T cells, an 
adoptive transfer of 6.5+CD4+ T cells was performed into SPC-HA x TCR-HA double 
transgenic mice as well as into SPC-HA transgenic mice as control. It could be 
hypothesized, that only in SPC-HA x TCR-HA mice regulatory T cells were induced 
upon chronic self-antigen stimulation in the lung, whereas this in vivo induced HA-
specific Treg should be absent in the lung of SPC-HA single transgenic mice. T cells 
were isolated from spleen of TCR-HA transgenic mice and were activated in vitro 
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with the corresponding peptide. The proportion of 6.5+CD4+ T cells was analyzed by 
FACS and CFSE labelling was performed. 2.5 x 106 6.5+CD4+ transgenic T cells 
were injected i.p. into SPC-HA x TCR-HA double transgenic and SPC-HA transgenic 
control mice. 10 days after adoptive transfer the in vivo proliferation of 6.5+CD4+ 
transgenic T cells was investigated by analyzing the loss of CFSE dye in proliferating 
HA-specific CD4+ T cells from lung, BLN and spleen (figure 17). 
 
SPC-HA x TCR-HA SPC-HA
Lu
ng
B
LN
Sp
le
en
75.6%88.0%
63.4%94.9%
95.8%97.3%
CFSE
Lu
ng
B
LN
Sp
le
en
 
Figure 17: Proliferative response of 6.5+CD4+ T cells in vivo to tissue derived antigen after 
adoptive transfer in SPC-HA x TCR-HA and SPC-HA recipients. 2.5 x 106 CFSE labelled 6.5+CD4+ 
T cells were adoptively transferred into SPC-HA x TCR-HA and SPC-HA recipients. 10 days later cells 
from lung, BLN and spleen were isolated and stained for 6.5 and CD4 expression. CFSE profile gated 
for 6.5+CD4+ T cells were estimated. These results are a representative of three similar experiments.  
 
The data summarized in figure 17 clearly indicate a strong inhibition/suppression of 
the proliferation of adoptively transferred 6.5+CD4+ T cells in lung and BLN of SPC-
HA x TCR-HA double transgenic mice. In contrast, 6.5+CD4+ T cells adoptively 
transferred into SPC-HA transgenic control mice underwent a strong proliferation in 
these compartments. These data strongly suggest the capability of in vivo induced 
regulatory T cells to suppress the proliferation of autoreactive T cells in vivo. 
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3 Aims of the study 
 
Immune regulation is a dynamic process based on many already known as well as 
undefined factors. Many cells are involved in triggering or regulation of immune 
responses and more and more details about the mechanisms underlying 
inflammation and tolerance are known. However, less is known about the function of 
cells expressing self-antigens and being the target for autoreactive T cells in the 
progress of initiation and/or regulation of autoimmunity.  
The SPC-HA x TCR-HA double transgenic mouse represents an autoimmune 
disease model that offers the possibilities to examine both sides of the immune 
response, i.e. the autoreactive effector cells on the one hand as well as the self-
antigen expressing cells on the other hand. In the SPC-HA transgenic mouse the 
alveolar type II epithelial cells do express the self-antigen hemagglutinin and 
represent the target for autoreactive T cells. Already 1977 Mason and Williams 
developed the concept of the alveolar type II epithelial cell (AECII) as a defender of 
the alveolus (Mason and Williams, 1977). AECII may act as immunoregulatory cells 
and can interact with resident and mobile cells, either directly by membrane contact 
or indirectly via cytokines/growth factors and their receptors. Thus alveolar type II 
epithelial cells represent an integrative unit of immune responses within the alveolus. 
To investigate the role of hemagglutinin expressing AECII in SPC-HA x TCR-HA 
double transgenic mice on the outcome of autoimmunity, extensive analysis should 
be performed including: 
 
• Establishing a protocol to isolate murine type II alveolar epithelial cells 
exhibiting a high purity and vitality. 
 
• Gene expressing profiling of type II alveolar epithelial cells from diseased 
double transgenic SPC-HA x TCR-HA mice compared to healthy SPC-HA 
control mice. 
 
• Characterization of the antigen presenting capacity of AECII from healthy 
SPC-HA and diseased SPC-HA x TCR-HA mice to rule out their possible role 
in the initiation and regulation of autoreactive T cell responses leading to lung 
inflammation. 
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• Characterization of the impact of AECII on the induction of regulatory T cells. 
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4 Results 
 
4.1 Isolation of murine alveolar type II epithelial cells 
 
Alveolar type II epithelial cells (AECII) are critical for normal lung development, 
homeostasis, and repair after injury. AECII produce pulmonary surfactant lipids and 
proteins required for reducing alveolar surface tension (Finkelstein et al., 1983; 
Shannon et al., 2001). As essential progenitors for type I epithelial cells, they are also 
critical for normal alveolar development and tissue remodelling after injury (Adamson 
and Bowdenet, 1974; Adamson and Bowden, 1975). The ability to investigate 
organogenesis and disease progression by overexpressing and deleting genes in 
mice, particularly genes expressed by alveolar type II epithelial cells, has recently 
favoured the use of mouse models in pulmonary research. 
Although mice are advantageous for manipulating genes, they have not been useful 
for isolating alveolar type II epithelial cells for ex vivo study so far. In contrast, rat and 
rabbit AECII have successfully been isolated using velocity centrifugation through a 
gradient of albumin (Dobbs and Mason, 1979 and Finkelstein et al., 1983). Isolation 
of mouse AECII by this method has been less successful. In order to isolate highly 
pure and vital AECII, a fluorescence-activated cell sorting protocol was established 
based on the use of anti-CD32, anti-CD16, anti-CD45, anti-CD11b and anti-F4/80 
antibodies. Using this antibody cocktail, all hemapoetic cell types were labelled. 
Moreover, further cell populations could be distinguished by cell granularity (sideward 
scatter, SSC) and size (forward scatter, FSC). Using a MoFlow cell sorter 
(Cytomation, Fort Collins, CO) a cell population could be purified (figure 18) that was 
identified by immune fluorescence staining as alveolar type II epithelial cells (figure 
19). 
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Figure 18: Purification of alveolar type II epithelial cells by fluorescence-activated cell sorting. 
Cells obtained after enzymatic lung digestion were labelled using a CD45, CD16, CD32, CD11b, and 
F4/80 antibody cocktail. After exclusion of antibody negative cells, AECII were identified by size and 
granularity. Reanalysis of sorted cells have shown a contamination of as few as 1% other cells. 
 
The reanalysis of the sorted cells demonstrated an extremely high purity of an 
unlabelled AECII population. Positive immunostaining for the surfactant proteins A, B, 
C and D verified that the sorted cells were alveolar type II epithelial cells.  
 
Figure 19: Identification of sorted cells as alveolar 
type II epithelial cells by immunofluorescence 
staining for surfactant proteins A, B, C and D. 
Cytospins of post-sorted cells were stained for the 
surfactant proteins A, B, C and D. Almost 100% of fixed 
post-sorted cells were positive for the surfactant protein 
staining. Picture A, B, C and D represent the phase 
contrast of fixed cells. Pictures A´, B´, C´, and D´ 
represent the corresponding surfactant protein 
immunostainings. 
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Tissue disintegration and FACS-sorting represents physical stress for the cells which 
could lead to apoptosis and cell death during the purification procedure. To assure 
vitality of sorted cells, trypan blue staining and propidium iodide staining were 
performed. Visually counting of trypan blue positive AECII resulted in a proportion of 
only 10% dead cells. The fluorescence-activated measurement of propidium iodide 
positive AECII resulted in a vitality of 90% (figure 20). Thus, both methods 
demonstrated that only a small portion of AECII cells did not survive the isolation 
procedure. 
 
 
Figure 20: Determination of vitality of 
sorted alveolar type II epithelial cells. 
Vitality of freshly isolated type II alveolar 
epithelial cells was determined by FACS 
analysis by using propidium iodide (A → 
A´) and visually counting of trypan blue (B) 
staining. Both methods indicated  a vitality 
of 90%. 
 
 
 
 
 
 
 
 
 
Reanalysis of the sorted alveolar type II epithelial cells showed a minor 
contamination (1%) with CD45+/CD32+/CD16+/CD11b+/F4/80+ cells. To determine in 
more detail which hemapoetic cell type was present within the alveolar type II cell 
preparation, PCR analysis were performed using CD3 (T cells), CD19 (B cells) and 
CD14 (macrophages) specific primers. Furthermore the sorted cells were tested by 
PCR analysis for the presence of AECII specific marker RNA (surfactant protein A, D 
and C and Alkaline phosphatase) (figure 21). 
 
propidium iodide 
10%0%
without PI with PI
A A´
B
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Figue 21: Analysis of hemapoetic 
cell contamination of post-sorted 
AECII population by PCR. RNA from 
freshly isolated alveolar type II 
epithelial cells was compared with 
RNA obtained from complete lung 
tissue. Primer pairs CD3, CD19 and 
CD14 were chosen to test for 
hemapoetic cells in the type II cell 
preparation. Primer pairs SP-A, SP-C, 
SP-D and alkaline phosphatase were 
chosen to test the RNA for specific 
AECII expressed genes. RPS9 
represents a housekeeping gene 
expression.  
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As shown before by (figure 19) immunofluorescence stainings for surfactant proteins, 
PCR analysis verified a highly pure population of alveolar type II epithelial cells 
(Figure 21). In addition, the AECII marker gene alkaline phosphatase (Edelson et al., 
1988) could be detected. Only PCR analysis using CD14 specific primers resulted in 
a weak PCR amplification product in the purified AECII cDNA sample, but no 
products were obtained with CD19 or CD3 specific primer pairs. Thus, the 
contamination by hemapoetic cells was neglected for subsequent experiments and 
the AECII cells were considered to be highly pure. 
As expected, the expression analysis for type II epithelial cell specific proteins was 
positive for every gene analyzed (figure 21). 
 
Together these data show that the newly established protocol represents a highly 
efficient method to obtain pure and vital murine alveolar type II cells. 
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4.2 Global gene expression profiling of murine alveolar type II epithelial cells 
 
In the SPC-HA transgenic mouse the alveolar type II epithelial cells are the cells 
expressing the self-antigen and therefore represent the target for HA-specific T cell 
reactivities. As previous data describe, the 6.5+CD4+ T cells in elder SPC-HA x TCR-
HA mice have a TR1 phenotype. The questions raised by this finding are: a) how do 
activated autoreactive T cells change their features to a more regulatory phenotype 
and b) which role do the self-antigen expressing AECII play in this process? To shed 
more light into the role of AECII in the induction of T cell tolerance in the lung, 
comparative global gene expressing profiling of alveolar type II epithelial cells from 
diseased SPC-HA x TCR-HA double transgenic mice and healthy SPC-HA mice was 
performed. Therefore, RNA was prepared from AECII and subjected to differential 
gene expression analysis using Affimetrix MG U74Av2 oligonucleotide arrays. The 
advantage of this technology is that every analyzed gene is represented by sixteen 
independent probe pairs which together establish the basis for statistical evaluations 
of the respective signals. Therefore, only those genes that are reproducibly regulated 
are included in the analysis. For each gene fulfilling these criteria, the average fold 
change in expression for AECII from SPC-HA x TCR-HA and SPC-HA mice was 
calculated and the ratio was depicted on a base-2 logarithmic scale. To get an 
impression of basal expression level of analyzed genes in AECII under normal 
conditions, an alignment of AECII derived from SPC-HA single transgenic and 
diseased SPC-HA x TCR-HA double transgenic mice was necessary to include. This 
approach led to a comprehensive overview about the functional gene classes that 
are found to be regulated in type II pneumocytes upon inflammation including for 
example regulators of transcription and translation, secreted or signalling molecules, 
genes involved in cell cycle, apoptosis and survival. 
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Figure 22: Genes differentially expressed in type II alveolar epithelial cells isolated from 
diseased SPC-HA x TCR-HA compared to cells from healthy SPC-HA mice. 418 genes were 
identified as differentially expressed in AECII and regarding their function divided into eleven major 
groups. 
 
 
Table 4: Gene expression levels of selected genes from different major groups. 
 
Gene Functional Group Fold Induction Reference 
    
CCL11 (Eotaxin) -8.48 
-4.06 
- Matthews et al.,  
  2005 
- Sebastiani et al.,  
  2001 
CCL20 (MIP-3α) 17.12 
11.53 
- Dieu-Nosjean et  
  al., 2000 
CCL9/10 (MIP-1γ) 4.09 
2.53 
- Maurer and  
  Stebut, 2004 
CXCL13 
 
-4.52 
-5.88 
- Ebert et al., 2004 
CXCL12 
 
-6.71 
-7.40 
- Balabanian et al.,  
  2005 
CXCL2 (MIP-2α) 
 
immune response 
3.08 
2.37 
- Matzer et al.,  
  2004 
TGF-b2 
 
 -3.00 
-2.21 
- Buckley et al.,  
  1996 
TGF-b3 
 
 -2.40 
-2.75 
- Buckley et al.,  
  1996 
Psmb8 Proteasome subunit beta 
type 8 
 2.15 
4.51 
- Niedermann et al., 
  1999 
Psmb9 
Proteasome subunit beta type 9 
 2.78 
2.53 
- Niedermann et al., 
  1999 
 
Results were obtained by two independent experiments. Basal gene expression level of AECII derived 
from healthy SPC-HA mice were compared with gene expression levels of AECII from diseased SPC-
HA x TCR-HA mice. 
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Table 4 (continued): Gene expression levels of selected genes from different major groups. 
 
Gene Functional Group Fold Induction Reference 
    
H2-Ea (major histocompatibility 
complex, class II, DR alpha) 
2.17 
2.39 
- Krawczyk et al.,  
  2004 
H2-Ab1 
(HLA class II histocompatibility 
antigen, DQ beta 1) 
2.05 
2.91 
- Larhammar et al., 
  1983 
TAP1 
 
immune response 
2.37 
2.95 
- Lankat-Buttgereit  
  and Tampe, 1999 
- Uebel and  
  Tampe, 1999 
    
Cyclin A2 
 
1.88 
3.42 
- Bui et al., 1993 
Cyclin D2 
cell cycle 
-2.12 
-2.06 
 
- Wu et al., 1995 
    
MMP-2 
(matrix metalloproteinase 2) 
-10.79 
-10.34 
- Chakrabarti and  
  Patel, 2005 
- Hayashi et al.,  
  1996 
- Xu et al., 2002  
- Corry, et al., 2004 
MMP-11 
(matrix metalloproteinase 11) 
-2.76 
-1.67 
- Hayashi et al.,  
  1996 
MMP-23  
(matrix metalloproteinase 23) 
-6.24 
-3.78 
- Hayashi et al.,  
  1996 
MMP-3  
(matrix metalloproteinase 3) 
 
-11.59 
-10.88 
- Hayashi et al.,  
  1996 
- Atkinson et al.,  
  2005 
MMP-14  
(matrix metalloproteinase 14) 
-2.51 
-2.45 
- Hayashi et al., 
  1996 
TIMP1  
(Tissue inhibitor of 
metalloproteinase 1) 
-11.06 
-8.62 
- Hayashi et al.,  
  1996 
TIMP2  
(Tissue inhibitor of 
metalloproteinase 2) 
-5.33 
-9.50 
- Hayashi et al.,  
  1996 
TIMP3  
(Tissue inhibitor of 
metalloproteinase 3) 
proteolysis & 
peptidolysis 
-4.03 
-4.43 
- Hayashi et al.,  
  1996 
 
Aqp1 (Aquaporin 1) 
 
transport 
 
-5.99 
-4.26 
 
 
- Effros et al., 1997 
 
Egfr  
(Epidermal growth factor receptor) 
 
cell differentiation & 
development 
 
 
-2.06 
-2.61 
 
- Klein et al., 1995 
 
Fibronectin 1 
 
 
cell adhesion 
 
-9.88 
-8.60 
 
- Crouch and  
  Longmore, 1987 
- Maniscalco et al., 
  1994 
 
Results were obtained by two independent experiments. Basal gene expression level of AECII derived 
from healthy SPC-HA mice were compared with gene expression levels of AECII from diseased SPC-
HA x TCR-HA mice. 
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Data from figure 22 and table 4 demonstrate broad changes in the gene expression 
profile within alveolar type II epithelial cells upon T cell mediated airway inflammation. 
418 genes could be identified as being differentially expressed in AECII from 
diseased SPC-HA x TCR-HA double transgenic mice. The classification of the 
regulated genes in functional groups demonstrate, that many genes that are 
described to be part of the immune response, cell cycle and proteolysis & 
peptidolysis appear to be functionally involved in the progression and/or regulation of 
lung diseases. 
 
 
Data summarized in table 5 underline the purity of the isolated AECII population, as 
signal intensities obtained for AECII specific genes were extraordinary high. The 
signal intensities for hemapoetic cell specific genes are declared as absent or were 
considerable lower than the signal intensities for AECII specific genes. This is line 
with the PCR results to analyze the purity of isolated AECII (figure 21). 
 
 
Table 5: Gene expression levels of selected AECII and hemapoetic cell specific genes to  
    control purity of isolated AECII. 
 
Cell type/gene Control expression 
SPC-HA  
Array1/Array2 
present or  
absent  
classified* 
AECII 
Surfactant associated protein A (Sftpa) 
 
7034/7152 PP 
 
Surfactant associated protein B (Sftpb) 
 
2106/8597 PP 
 
Surfactant associated protein C (Sftpc) 
 
450/1208 
 
PP 
 
Surfactant associated protein D (Sftpd) 
 
13297/16424 
 
PP 
 
Hemapoetic cells 
CD3 
 
15/3 AA 
CD11b (ITGAM) 
 
4/22 AA 
CD45 (PRPTC) 
 
183/87 PP 
CD11c (ITGAX) 
 
44/55 AA 
 
Represented is the signal intensity of indicated genes specific for AECII or hemapoetic cells on 
Affymetrix MG U74Av2 oligonucleotide array. Results are from pooled individuals (n>3). Present or 
absent is defined by Affymetrix software logarithm. 
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4.3 Analysis of genes differentially expressed in AECII from SPC-HA x TCR-
HA mice double transgenic mice and SPC-HA transgenic mice. 
 
The global gene expression profiling of murine alveolar type II epithelial cells from 
SPC-HA x TCR-HA double transgenic mice and SPC-HA control mice resulted in 
identification of numerous regulated genes. To confirm these results for selected 
genes the expression levels of platelet factor 4 (PF-4), CCL11 and CCL20 were 
analysed by real time RT-PCR. These genes have all been discussed before in the 
context of regulation or modulation of immune responses. It was shown, that platelet 
factor 4 has suppressor function by downregulating the proliferation and cytokine 
release of activated T cells (Fleischer et al., 2002). For CCL20 (MIP-3α) and CCL11 
(eotaxin), which are both members of the chemokine ligand family, it is described, 
that CCL20 plays a critical role for attracting immature dendritic cells to the airway 
(Reibman et al., 2003) and CCL11 is responsible for eosinophil recruitment 
(Chvatchko et al., 2003). 
To asses the expression level of platelet factor 4 (PF-4), CCL11 and CCL20 total 
RNA was purified form sorted AECII isolated from SPC-HA x TCR-HA double 
transgenic mice and SPC-HA mice. Real-time RT-PCR analyses were performed 
with specific primer pairs for RPS9, PF-4, CCL11 and CCL20 to determine the level 
of gene expression in comparison with the housekeeping gene expression RPS9 
(figure 23). 
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Figure 23: Gene expression level of 
CCL11, PF-4 and CCL20 in AECII 
derived from SPC-HA x TCR-HA 
double transgenic mice and SPC-HA 
transgenic mice. Real-time RT-PCR 
analyses for CCL11, PF-4 and CCL20 
expression in sorted AECII from SPC-
HA x TCR-HA double transgenic mice 
and SPC-HA transgenic mice. Relative 
mRNA amounts were normalized with 
respect to expression levels in AECII 
derived from SPC-HA transgenic mice 
(fold change = 1). The mean regulation 
is indicated.  
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In line with the results obtained with cDNA arrays the real-time RT-PCR analyses 
demonstrate an increased mRNA expression for CCL20 and PF-4 in AECII from 
SPC-HA x TCR-HA double transgenic mice compared to AECII from SPC-HA 
transgenic mice. Also, analysis of the relative mRNA expression level for CCL11 
indicates a significant downregulation in AECII of SPC-HA x TCR-HA double 
transgenic mice when diseased and healthy mice were compared. 
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These data suggest that during the inflammatory process in the lung of SPC-HA x 
TCR-HA double transgenic mice the alveolar type II epithelial cells may have an 
active immune modulating role which is indicated by increased expression of CCL20 
and PF-4 and decreased CCL11 expression. 
 
To further complement the results of the gene expression profile obtained by cDNA 
array analysis, several other genes of interest were selected and tested by semi-
quantitative RT-PCR (figure 24). 
For costimulatory or regulatory function of antigen presenting cells the expression of 
MHC class-II, CD80 (B7.1), CD86 (B7.2), PD1-L (B7-H1) and ICOS-L is necessary. 
MHC class-II molecules present antigens to effector cells whereas CD80 and CD86 
have a costimulatory function and are needed to induce the complete activation of 
effector cells by binding to their ligand CD28 (Greenwald et al., 2005). PD1-L and 
ICOS-L are ligands for the receptors PD1 and ICOS expressed on T cells. Binding of 
ICOS-L or PD1-L by T cells are discussed to be involved in the suppressor function 
of Treg cells, T cell tolerance, and autoimmunity (Greenwald et al., 2005). 
Matrix metalloproteinases (MMP) are a major group of proteinases known to regulate 
the extracellular matrix (ECM) remodelling and thus they are hypothesized to be 
important in the process of lung fibrosis or tissue damage in the lung (Corbel et al., 
2001).  
TGF-β and MCP-1 (CCL2) are important immune regulatory molecules, which are 
known to be expressed by AECII (Zissel et al., 2000; Paine et al., 1993). 
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Figure 24: Gene expression in AECII derived from SPC-HA x TCR-HA double transgenic mice 
and SPC-HA transgenic mice. Different genes were selected to analyze their expression level in 
AECII by RT-PCR. (A) Genes encoding costimulatory molecules (PD1-L, ICOS-L, MHC II, CD80 and 
CD86) were used to determine the stimulatory capacity of AECII on the molecular level. (B) represents 
selected genes for Matrix metalloproteinase (MMP-9, MMP-2 and MMP-3) and (C) MCP-1 and TGF-β. 
The housekeeping gene RPS9 was used to estimate the quality and quantity of used cDNA. 
 
 
RT-PCR results clearly indicate a potentially costimulatory function of AECII derived 
from SPC-HA x TCR-HA double transgenic mice. MHC class-II molecules were 
constitutively expressed on AECII, whereas CD80 and CD86 were exclusively 
expressed on AECII from diseased mice. These data suggest that under 
inflammatory conditions found in SPC-HA x TCR-HA double transgenic mice the 
expression of costimulatory molecules is upregulated. Furthermore, ICOS-L and 
PD1-L were both expressed in AECII from healthy and diseased mice, suggesting 
the putative ability of AECII to regulate T cell responses by binding to their receptors. 
Regarding RT-PCR data for Matrix metalloproteinases-2 (MMP-2) and MMP-3 both 
genes were equally present in AECII from SPC-HA x TCR-HA and SPC-HA mice 
whereas for MMP-9 an upregulation could be detected in AECII isolated from SPC-
HA x TCR-HA mice. These data suggest that under inflammatory conditions AECII 
actively counteract tissue destruction by remodelling the airways at least in part in a 
MMP dependent process. 
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As described for AECII they are able to express and release TGF-β to control their 
accessory cell function (Zissel et al., 2000) and RT-PCR data confirm TGF-β 
expression by AECII. However, no clear difference in the TGF-β expression level was 
observed when comparing AECII from diseased and healthy mice. 
RT-PCR results for the macrophage inflammatory protein-1 (MCP-1) indicated a 
decreased expression of MCP-1 in SPC-HA x TCR-HA double transgenic mice. The 
data were confirmed on protein level by analyzing the culture supernatants of AECII 
by cytokine bead array (CBA) (data not shown). 
 
 
4.4 Antigen presentation in the lung 
 
The epithelial surfaces of the lungs and conducting airways are continuously 
exposed to mixtures of antigens present in ambient air. The adaptive immune system 
in the lung is faced with the task of accurately categorizing these stimuli, such that T 
cell responses that are qualitatively appropriate for neutralization of each agent are 
selected. Secondarily, it must tightly control the intensity and duration of these 
responses, in order to preserve the integrity of the fragile, highly vascularized 
epithelial surfaces in the organ, particularly those at which gas exchange occurs.  
 
The epithelial surfaces within the major conducting airways in which the majority of 
inhaled antigen is deposited are protected via the scrubbing action of the overlying 
mucociliary escalator, and the small proportion of inhaled antigen that escapes this 
mechanism and penetrates into the underlying epithelial layer is then dealt with via 
specialized antigen-presenting cells (APC), in particular Dendritic cell (DC) 
populations, within and below the epithelium. The alveolar surfaces in the deep lung 
are policed instead by macrophage populations, again backed up to APC population 
below the alveolar epithelium. 
 
The mechanism for the uptake or presentation of endogenous or self-antigens like 
the HA in the SPC-HA mouse model is still unclear. Dendritic cells and macrophages 
are discussed to act as professional APC which are able to take up and cross-
present self-antigens from surrounding cells to other immune cells. The interesting 
question was now, which kind of APC are able and/or essential to present the 
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hemagglutinin to autoreactive CD4+ T cells in SPC-HA x TCR-HA double transgenic 
mouse and importantly, whether the antigen expressing AECII themselves are able 
to present the self antigen to the 6.5+CD4+ T cells. To test whether AECII cells 
directly present antigen to specific CD4+ T cells, or whether AECII derived HA has to 
be taken up by DC or macrophages to be is cross-presented to specific T cells, 
different types of professional antigen-presenting cells were generated or isolated 
and cocultured together with freshly isolated antigen expressing AECII derived from 
SPC-HA mice. 
 
 
4.5 Presentation of AECII expressed self-antigen mediated by Dendritic cells 
 
To investigate whether Dendritic cells do crosspresent AECII expressed 
hemagglutinin to autoreactive CD4+ T cells, 2.5 x 104 immature bone marrow derived 
Dendritic cells (BMDC) were cocultured with 1 x 105 freshly isolated type II epithelial 
cells from the lung of SPC-HA transgenic mice and BALB/c control mice. After 48h 
2.5 x 105 CD4+ T cells isolated from TCR-HA mice were added as responder cells. 
The proliferation of 6.5+CD4+ T cells was measured by 3[H]-thymidine incorporation 
after further 48h coculture with AECII and BMDC (figure 25). Alternatively, the assay 
was performed in the presence of LPS to initiate the maturation of BMDC. In this 
case, 24h after coculture of immature DC with AECII LPS was supplemented. 
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Figure 25: Endogenous self-antigen 
presentation to autoreactive CD4+ T 
cells mediated by DC. 1 x 105 freshly 
isolated AECII from SPC-HA or BALB/C 
mice were cocultured with 2.5 x 104 
immature bone marrow derived DC for 
48h. After 48h 2.5 x 105 CD4+ T cells 
from TCR-HA mice were added and 
incubated for further 48h. The 
proliferation of responder cells was 
determined by 3[H]-thymidine 
incorporation. (A) DC-AECII coculture 
without LPS treatment. (B) After 24h of 
DC-AECII coculture, LPS was added to 
initiate the maturation of BM DC. 
Results are expressed as mean counts 
per minute + SD (error bars) of triplicate 
wells and are representative of two 
independent experiments. 
 
 
 
 
 
 
 
As indicated in figure 25, coculture of AECII with immature and mature Dendritic cells 
and HA-specific T cells resulted in antigen-specific T cell proliferation, suggesting 
that Dendritic cells were able to take up and cross present the self-antigen 
hemagglutinin expressed by AECII from SPC-HA transgenic mice to autoreactive 
CD4+ T cells. LPS treatment during the coculture experiment lead to even stronger 
proliferation of responder T cells, probably because DC maturation induced by LPS 
results in upregulation of costimulatory molecules on DC and thus in enhanced T cell 
activation.  
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4.6 Peritoneal exudate cells (PEC) as antigen presenting cells can not  
mediate self-antigen presentation to autoreactive T cells 
 
Macrophages and B lymphocytes are also professional antigen presenting cells, 
which are able to take up antigens and present it to responder cells. To clarify 
whether macrophages and B lymphocytes contribute to the presentation of the 
hemagglutinin expressed by AECII in SPC-HA x TCR-HA double transgenic mice to 
autoreactive CD4+ T cells, PEC isolated from BALB/c mice were cocultured together 
with AECII from SPC-HA transgenic mice and BALB/c control mice. Peritoneal 
exudate cells (PEC) were used as a cellular source for macrophages and B 
lymphocytes. 2.5 x 104 PEC were cocultured with 1 x 105 freshly isolated AECII from 
SPC-HA and BALB/c mice. After 48h 2.5 x 105 CD4+ T cells from TCR-HA mice were 
added as responder cells. After further 48h proliferation of the responder cells was 
measured by 3[H]-thymidine incorporation. 
 
Figure 26: PEC were not able to 
cross present the AECII expressed 
hemagglutinin to responder cells. 2.5 
x 104 PEC were cocultured together 
with freshly isolated AECII from SPC-
HA transgenic mice and BALB/c mice. 
After 48h 2.5 x 105 CD4+ T cells from 
TCR-HA mice were supplemented. 
Corresponding HA-peptide was added 
as positive control. Proliferation of 
responder cells was measured by 3[H]-
thymidine incorporation. Results are 
expressed as mean counts per minute 
+ SD (error bars) of triplicate wells and 
are representative of two independent 
experiments. 
0
10000
20000
30000
40000
50000
60000
Peptide (µg/ml)
0 10
Pr
ol
ife
ra
tio
n
(c
pm
)
BALB/c
SPC-HA
Pr
ol
ife
ra
tio
n
(c
pm
)
Pr
ol
ife
ra
tio
n
(c
pm
)
 
 
Macrophages as well as B lymphocytes were not able to present the AECII derived 
hemagglutinin to 6.5+CD4+ T cells and to activate them (figure 26). No significant 
antigen specific proliferation was detectable in this coculture assay without addition 
of exogenous HA-peptide. This could be an indication that macrophages and B 
 -72-
CHAPTER II  Results Part II 
lymphocytes might not be involved in the hemagglutinin antigen presentation and 
activation of autoreactive T cells in SPC-HA x TCR-HA double transgenic mice. 
 
 
4.7 The antigen presenting capacity of alveolar type II epithelial cells 
 
Data summarized in figure 25 suggest that the presentation of the self-antigen 
hemagglutinin in SPC-HA x TCR-HA mice could be mediated by Dendritic cells. It is 
well established, that epithelial cells themselves have the capacity to function as APC 
and that they are able to trigger MHC class-I-restricted immune responses 
(Cunningham et al., 1994; Shao et al., 2005). To demonstrate whether alveolar type 
II epithelial cells from murine lung are able to present a MHC class-I-restricted 
peptide to CD8 T cells, 1 x 105 freshly isolated AECII from BALB/c mice were loaded 
with different concentration of the corresponding HA-peptide and incubated together 
with 2 x 105 CD8+ responder T cells isolated from Clone-4 mice bearing a major 
histocompatibility complex class-I-restricted T cell receptor specific for an H-2Kd 
restricted HA peptide (Morgan et al., 1996). T cell proliferation was measured by 3[H]-
thymidine incorporation. 
Figure 27: AECII mediate CD8+ T cell 
proliferation. 1 x 105 freshly isolated 
AECII from BALB/c mice were loaded 
with different concentrations of the 
corresponding HA-peptide and co-
cultured together with 2 x 105 CD8+ T 
cells from CL4 mice. Proliferation of 
responder T cells was measured by 
3[H]-thymidine incorporation. Results 
are expressed as mean counts per 
minute + SD (error bars) of triplicate  
                 wells and are representative of two 
                 independent experiments. 
0
50000
100000
150000
200000
250000
Peptide (µg/ml)
0 0,1 1
Pr
ol
ife
ra
tio
n
(c
pm
)
Pr
ol
ife
ra
tio
n
(c
pm
)
 
 
 
Clearly, alveolar type II epithelial cells from murine lung are able to present the MHC 
class-I restricted HA-peptide to CD8+ T cells and provoke a dose dependent antigen 
specific T cell proliferation.  
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Zissel and colleagues described the upregulation of MHC class-II molecules for 
AECII under inflammatory settings and as shown in figure 24, MHC II expression is 
also observed in AECII from healthy mice. To asses whether freshly isolated AECII 
have the ability to present the MHC class-II restricted peptide HA110-120 to CD4+ T 
cells from TCR-HA mice, 1 x 105 freshly isolated AECII from BALB/c mice were 
loaded with the corresponding HA-peptide and incubated together with 2 x 105 CD4+ 
responder T cells isolated from TCR-HA mice. T cell proliferation was measured by 
3[H]-thymidine incorporation. 
 
Figure 28: AECII mediate CD4+ T cell 
proliferation. 1 x 105 freshly isolated 
AECII from BALB/c mice were loaded 
with the corresponding HA-peptide and 
cocultured together with 2 x 105 CD4+ T 
cells from TCR-HA mice. Proliferation 
of responder T cells was measured by 
3[H]-thymidine incorporation. Results 
are expressed as mean counts per 
minute + SD (error bars) of triplicate 
wells and are representative of two  
                           independent experiments. 
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Data revealed that not only MHC class-I, but also the MHC class-II restricted peptide 
HA110-120 was presented by AECII to 6.5+CD4+ T cells and resulted in the 
stimulation and proliferation of responder T cells (figure 27, figure 28). 
 
It was interesting to analyze, whether endogenous HA expressed by type II epithelial 
cells in SPC-HA transgenic mice could also be MHC class-II presented by AECII 
themselves to stimulate MHCII restricted autoreactive T cells. To test this, alveolar 
type II epithelial cells from SPC-HA transgenic mice were isolated and used as APC 
without the addition of further APC to stimulate CD4+ T cells isolated from TCR-HA 
mice. 1 x 105 AECII were cocultured together with 2.5 x 105 naïve CD4+ T cells to 
determine the stimulatory capacity of antigen expressing AECII. AECII from BALB/c 
mice were used as a negative control. After 48h T cell proliferation was measured by 
3[H]-thymidine incorporation. Alternatively, the same assay was performed with T 
cells previously activated in vitro with the corresponding peptide.  
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Figure 29: Stimulatory capacity of 
AECII from SPC-HA transgenic mice. 
1 x 105 freshly isolated AECII from 
SPC-HA transgenic mice were 
cocultured with 2.5 x 105 naïve CD4+ T 
cells (A) or activated CD4+ T cells (B) 
isolated from TCR-HA mice. After 48h T 
cell proliferation was determined by 
3[H]-thymidine incorporation. Results 
are expressed as mean counts per 
minute + SD (error bars) of triplicate   
wells and are representative of two 
independent experiments. P-values 
calculated by unpaired Student´s test 
are indicated ( * ) < 0.002. 
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The data obtained demonstrate that alveolar type II epithelial cells have the inherent 
capacity to present endogenous antigen on MHC class-II molecules and to stimulate 
naïve as well as activated CD4+ T cells (figure 29). These results suggest that self-
antigen presentation in the lung of SPC-HA x TCR-HA double transgenic mice may 
not exclusively be dependent on professional APC like dendritic cells, but that HA 
expressing AECII might themselves contribute to the stimulation of antigen-specific T 
cells and thus in the initiation of inflammation. This interesting aspect suggests a key 
role of the alveolar type II epithelial cells for the development of T cell mediated lung 
disease in the SPC-HA x TCR-HA mouse model.  
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4.8 Reduced stimulatory capacity of AECII from SPC-HA x TCR-HA double  
 transgenic mice 
 
To examine the role of AECII for the induction and regulation of autoreactive T cells 
responses in more detail, further experiments were performed to compare the 
stimulatory capacity of AECII derived from SPC-HA x TCR-HA double transgenic 
diseased mice with AECII from SPC-HA transgenic healthy mice. To this end, 1 x 105 
freshly isolated AECII from either SPC-HA x TCR-HA double transgenic mice, SPC-
HA transgenic mice or BALB/c mice were cocultured together with naïve or activated 
CD4+ T cells from TCR-HA mice. After 48h the proliferation of the responder T cells 
was measured by 3[H]-thymidine incorporation (figure 30). 
 
Again it was found, that alveolar type II epithelial cells from SPC-HA mice were able 
to stimulate HA-specific T cells. However, data presented in figure 30 demonstrate a 
significant difference in the stimulatory capacity of AECII derived from healthy SPC-
HA and diseased SPC-HA x TCR-HA. AECII from diseased mice exhibit a 
significantly reduced stimulatory capacity in comparison to AECII from healthy SPC-
HA mice. The proliferation of naïve T cells cocultured together with AECII from SPC-
HA x TCR-HA double transgenic mice was decreased to background level of the 
BALB/c control and even lower, suggesting not only reduced stimulatory capacity, but 
also inhibition of T cell proliferation by AECII from diseased mice. Similar results 
were obtained when pre-activated T cells were used as responder cells (figure 30). 
 
Analyses of the activation/memory phenotype of 6.5+CD4+ T cells re-isolated after 
coculture with alveolar type II epithelial cells from healthy and diseased mice by 
FACS underline the proliferation data from coculture experiments. Summarizing 
these findings, 6.5+CD4+ T cells cocultured with AECII from SPC-HA transgenic mice 
have shown a more activation/memory phenotype compared to T cells cocultured 
with AECII from diseased SPC-HA x TCR-HA mice (data not shown). 
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Figure 30: Reduced stimulatory 
capacity of AECII from SPC-HA x 
TCR-HA double transgenic mice. 1 x 
105 AECII from SPC-HA x TCR-HA 
double transgenic mice, SPC-HA 
transgenic mice and BALB/c mice were 
freshly isolated and cocultured together 
with naïve (A) or activated (B) CD4+ T 
cells from TCR-HA mice. After 48h the 
proliferation of responder T cells was 
measured by 3[H]-thymidine 
incorporation. Results are expressed as 
mean counts per minute + SD (error 
bars) of triplicate   wells and are 
representative of three independent 
experiments. P-values calculated by 
unpaired Student´s test are indicated 
( * ) < 0.001. 
 
 
 
 
4.9 Analysis of hemagglutinin expression in AECII SPC-HA x TCR-HA double  
transgenic mice and SPC-HA transgenic mice 
 
The self-antigen hemagglutinin (HA) is expressed under the surfactant protein C 
promoter in alveolar type II epithelial cells of SPC-HA transgenic mice. To asses 
whether the reduced stimulatory capacity was simply the consequence of a loss of 
HA expression in AECII from SPC-HA x TCR-HA mice, the level of HA expression in 
AECII under inflamed and noninflamed conditions was determined. Therefore, total 
mRNA was isolated and analyzed with specific primer pairs by RT-PCR. RPS9 was 
used as housekeeping gene to test the RNA quality and quantity (figure 31). 
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Figure 31: Semi-quantitaive RT-PCR analysis of AECII 
from SPC-HA x TCR-HA mice and SPC-HA control mice to 
estimate the HA expression. mRNA from AECII derived 
from SPC-HA x TCR-HA double transgenic mice and SPC-HA 
transgenic mice was isolated and analyzed for the 
hemagglutinin (HA) expression by RT-PCR. Different 
amounts of cDNA were used. (1 = undiluted; 1:3 diluted and 
1:6 diluted). RPS9 was used as a housekeeping gene. 
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Results of the RT-PCR indicates a decreased HA mRNA expression level in SPC-HA 
x TCR-HA double transgenic mice compared to healthy SPC-HA transgenic mice. 
However, also in the inflamed environment HA expression was clearly detectable, 
thus reduced antigen expression alone could not explain the complete loss of HA-
specific T cell stimulation. 
 
 
4.10 The impact of AECII conditioned media on CD4+ T cell proliferation 
 
Data presented above demonstrate, that alveolar type II epithelial cells derived from 
the inflamed lung tissue of SPC-HA x TCR-HA double transgenic mice have a 
reduced T cell stimulatory capacity. Moreover, cocultured responder T cells exhibited 
a less activation/memory phenotype compared to autoreactive T cells cocultured 
together with AECII from healthy SPC-HA transgenic mice.  
The reduced stimulatory capacity of AECII or the suppression of T cell proliferation 
respectively could be the result of cell-cell contact dependent mechanisms or depend 
on soluble factors, secreted by AECII. To assess the impact of soluble factors 
derived from AECII on T cell activation and proliferation, freshly isolated AECII from 
SPC-HA x TCR-HA double transgenic mice, SPC-HA transgenic mice and BALB/c 
control mice were cultured for 48h. The culture supernatants were collected and used 
as culture medium for naïve CD4+ T cells stimulated with anti-CD3ε antibodies. 
Proliferation of the anti-CD3ε stimulated CD4+ T cell was measured by 3[H]-thymidine 
incorporation. Fresh IMDM culture medium was used as a control to estimate the 
proliferation of anti-CD3ε stimulated CD4+ T cells under standard conditions. 
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Figure 32: AECII conditioned media   
suppressed proliferation of naïve T 
cells. 1 x 105 AECII isolated from 
BALB/c, SPC-HA and SPC-HA x TCR-
HA mice were cultured for 48h. 1 x 105 
naïve CD4+ T cell were stimulated in 
vitro with anti-CD3ε antibodies in the 
presence of conditioned media derived 
from different AECII cultures. 
Proliferation was measured by 3[H]-
thymidine incorporation after 72h.  
Results are expressed as mean counts      
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          per minute + SD (error bars) of triplicate     
          wells and are representative of three  
          independent experiments. P-values  
         calculated by unpaired Student´s test     
         are indicated ( * ) < 0.001. 
 
As shown in figure 32, T cells cultured in conditioned medium of AECII derived from 
SPC-HA x TCR-HA exhibit a 50% reduced proliferation rate in comparison to T cells 
cultured in AECII conditioned medium from SPC-HA, BALB/c control mice or fresh 
control media. 
These results strongly suggest that AECII derived from SPC-HA x TCR-HA diseased 
mice do not only have a reduced capacity to stimulate CD4+ T cells, but furthermore 
actively suppress T cell proliferation at least in part by soluble factors secreted in the 
culture medium. 
 
 
4.11 Differences in the surfactant protein expression in AECII from SPC-HA x  
TCR-HA double transgenic mice and SPC-HA transgenic mice. 
 
Pulmonary surfactant was initially identified as a lipoprotein complex that reduces 
surface tension at the air-liquid interface of the lung (Clements, 1957; Pattle, 1955). 
This definition has been reassessed in light of recent studies that show that 
surfactant also functions in pulmonary host defence and that surfactant proteins are 
expressed also in non-pulmonary sites. The host defence functions of surfactant are 
primarily mediated by SP-A and SP-D, which are members of the collectin family of 
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proteins. An emphasis is placed on recent studies showing that, in addition to their 
well-established role as opsonsins, SP-A and SP-D also have novel functions in 
initiating parturition, facilitating clearance of apoptotic cells and directly killing bacteria. 
Furthermore, immunoregulatory functions of the surfactant proteins A und D on T 
cells are discussed (Wright, 2005). 
 
To asses the expression level of the surfactant proteins A, C and D under 
inflammatory condition RNA was purified form sorted AECII isolated from SPC-HA x 
TCR-HA double transgenic and SPC-HA transgenic mice. Real-time RT-PCR 
analyses were performed with specific primer pairs for RPS9, SP-A, SP-C and SP-D 
to determine the gene expression of the surfactant proteins in comparison with the 
re 33). 
 
expression of the housekeeping gene RPS9 (figu
igure 33: Surfactant protein F
expression in AECII derived from SPC-
HA x TCR-HA double transgenic mice 
and SPC-HA transgenic mice. Real-time 
RT-PCR analyses for SP-A, SP-C and SP-
D expression in sorted AECII from SPC-
HA x TCR-HA and SPC-HA mice. Relative 
mRNA levels were normalized with respect 
to expression levels in AECII derived from 
SPC-HA transgenic mice (fold change = 1). 
The mean regulation is indicated. 
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Results of the real-time RT-PCR analysis for the surfactant proteins SP-A, SP-C and 
ess in the lungs of SPC-HA x 
.12 The effect of AECII/CD4+ T cell coculture on the T cell phenotype and  
 
ata above suggested an immune modulatory role of AECII in SPC-HA x TCR-HA 
o directly examine the effect of AECII derived from diseased SPC-HA x TCR-HA 
 
SP-D demonstrate an increased mRNA expression for SP-A and SP-D in AECII from 
SPC-HA x TCR-HA mice compared to AECII from SPC-HA mice. Analysis of the 
relative mRNA expression level of SP-C indicates no significant regulation when 
diseased and healthy mice were compared (figure 33). 
These data suggested that due to the inflammatory proc
TCR-HA transgenic mice expression of SP-A and SP-D were increased in alveolar 
type II epithelial cells and may contribute to the suppression of T cell proliferation 
observed after T cell stimulation in AECII conditioned medium (figure 32). 
 
 
4
function 
D
double transgenic mice. The coculture experiments above demonstrated a reduced 
proliferative capacity of CD4+ T cells (figure 30) and the suppression of CD4+ T cell 
proliferation by AECII conditioned medium (figure 32). Furthermore, the ex vivo 
analysis of lung lymphocytes from diseased mice indicates the induction of regulatory 
T cells with a typical Treg1 phenotype in the lung. 
 
T
and healthy SPC-HA on the phenotype and function of autoreactive T cells, 5 x 105 
freshly isolated AECII from either SPC-HA x TCR-HA double transgenic mice, SPC-
HA transgenic mice or BALB/c mice were cocultured together with 1.4 x 106 naïve 
CD4+ T cells isolated from TCR-HA mice. After 48h the responder T cells were re-
isolated by ficoll density gradient centrifugation and total RNA was isolated for gene 
expression analyses by RT-PCR (figure 34). 
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Figure 34: Semi-quantitaive RT-PCR analysis of re-isolated CD4+ T cells prior cocultured with 
AECII from SPC-HA x TCR-HA, SPC-HA and BALB/c mice. To assess the effect of AECII derived 
from SPC-HA x TCR-HA double transgenic mice, SPC-HA transgenic mice and BALB/c control mice 
on the phenotype of antigen-specific CD4+ T cells the expression of different molecular marker genes 
for regulatory T cells including CD103 (alphaEbeta7), Neuropilin-1, GITR (TNFRSF18), Foxp3, Galectin, 
PD-1 and IL-10 was analyzed. RPS9 was used as a housekeeping gene. Different amounts of cDNA 
(undiluted (1) and 1:6 diluted) were used for the semi-quantitative RT-PCR analyses. 
 
 
Alternatively, CD4+ T cells were re-isolated after coculture with AECII and used as 
effector cells in standard inhibition assay. Therefore, 5 x 104 freshly isolated CD4+ 
responder T cells were plated together with the same number of T cells re-isolated 
after AECII coculture in 96-well flat-bottom plates in a final volume of 200µl IMDM in 
the presence of 0.75µg/ml soluble α-CD3ε and 5 x 105 irradiated BALB/c splenocytes. 
As control, the proliferatory capacity of re-isolated CD4+ T cell alone was determined 
by restimulation with soluble α-CD3ε. To this end, 5 x 104 T cells re-isolated after the 
coculture with AECII were plated in 96-well flat-bottom plates in a final volume of 
200µl IMDM in the presence of 0.75µg/ml soluble α-CD3ε and 5 x 105 irradiated 
BALB/c splenocytes. Cells were cultured at 37°C for 48h. Over the last 8h of the 
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experiment 3[H]-thymidine incorporation was measured by scintillation counting to 
asses proliferation (figure 35, figure 36). As a further internal control, 105 naïve 
responder T cells were cultured in the presence of 5 x 105 irradiated BALB/c 
splenocytes to asses the proliferation of naïve T cells alone. 
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Figure 35: AECII cocultured CD4+ T cells show no inhibitory effect on the proliferation of naïve 
CD4+ T cells. 5 x 104 naïve CD4+ responder T cells were plated together with the same number of T 
cells re-isolated after coculture with AECII from BALB/c, SPC-HA and SPC-HA x TCR-HA mice in the 
presence of 0.75µg/ml soluble α-CD3ε and 5 x 105 irradiated BALB/c splenocytes. As internal control 
105 naïve responder T cells were cultured in the presence of irradiated BALB/c splenocytes. Cells 
were cultured at 37°C for 48h. 3[H]-thymidine incorporation was measured by scintillation counting to 
asses the proliferation of responder T cells. Results are expressed as mean counts per minute + SD 
(error bars) of triplicate wells and are representative of three independent experiments. 
 
 
The analysis of CD4+ T cell re-isolated after coculture with AECII derived from SPC-
HA x TCR-HA, SPC-HA and BALB/c mice did not result in significant differences of 
gene expression pattern (figure 34). Although molecular marker genes specific for 
regulatory T cells could be detected on mRNA level by RT-PCR, no significant 
differences regarding their expression level could be observed comparing re-isolated 
T cells after cocultur with AECII from diseased SPC-HA x TCR-HA or healthy SPC-
HA or BALB/c control mice. Only the expression of PD-1 was increased in T cells 
cocultured with AECII from SPC-HA x TCR-HA mice and SPC-HA mice compared to 
AECII derived from BALB/c mice. Furthermore, increased mRNA expression was 
found for the transcription factor Foxp3 in T cells re-isolated form cocultures with 
AECII derived from SPC-HA transgenic mice in comparison to AECII from diseased 
SPC-HA x TCR-HA or BALB/c control mice. 
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Figure 36: Reduced proliferation of T 
cells re-isolated after AECII 
coculture. CD4+ T cells re-isolated 
after coculture with AECII from BALB/c, 
SPC-HA and SPC-HA x TCR-HA mice 
were restimulated with 0.75µg/ml 
soluble α-CD3ε. 3[H]-thymidine 
incorporation was measured by 
scintillation counting to asses the 
proliferation. Results are expressed as 
mean counts per minute + SD (error  
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          representative of three independent  
          experiments. 
 
The functional characterization of re-isolated T cell concerning their putative 
inhibitory ability after coculture with AECII indicates no suppressive effect of T cells 
on responder T cells activated in vitro. In any case the responder T cells proliferated 
equally well in the presence of soluble α-CD3ε as freshly isolated CD4+ T cells alone. 
The increased proliferation rate of naïve CD4+ T cells alone was caused by the 
higher numbers of responder T cells used for the assay to get equal cell numbers. 
Furthermore, a reduced proliferative capacitiy was observed upon restimulation of T 
cells prior cocultured with AECII (figure 35). 
 
Nevertheless the proliferative capacity of T cells cocultured with AECII derived from 
SPC-HA x TCR-HA double transgenic mice was reduced in comparison to T cells 
cocultured with AECII from SPC-HA transgenic mice and BALB/c control mice 
(Figure 36). 
In conclusion, data obtained from these in vitro coculture experiments did not 
unreveal the direct effect of AECII on the induction of a certain T cell phenotype. The 
analyses of the expression levels of molecular marker genes specific for regulatory T 
cells did not result in significant differences depending on the AECII used for 
coculture. Moreover, no suppressor function could be detected for re-isolated T cells. 
However, T cells re-isolated after coculture with AECII from diseased mice exhibit a 
reduced proliferative capacity when compared with T cells isolated after SPC-HA or 
BALB/c AECII coculture, thus suggesting an active role of AECII isolated from an 
inflammatory environment in the induction of T cell unresponsiveness and anergy. 
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1 Discussion 
 
The respiratory mucosa as well as immunity in the respiratory tract is a wide area for 
scientific investigations. In comparison to the gastrointestinal tract and its 
immunological function little is known about the immune system of the respiratory 
tract. The respiratory tract is a fragile tissue with architecture that is finely designed 
for gas exchange. Due to this main function the lung is exposed to numerous 
pathogens and other harmful air pollutions and developed many mechanisms to 
prevent infectious and inflammations. In the first line of defence are structural 
mechanisms coming from barriers such as epithelial cell layers, mucus and cilia, 
which avoid the invasion of pathogens or antigens. A battery of mediators that 
constitute the innate response including lactoferin, lysozyme, collectins and 
defensins is followed. Activation of these molecules can lead directly to lysis of 
pathogens, or to destruction through opsonisation or the recruitment of inflammatory 
cells (Boyton et al., 2002). A further mechanism for the respiratory defence is the 
adaptive immune response including the production of neutralising antibodies and 
the response of T lymphocytes. To guarantee the gas exchange even in situations of 
infections and inflammations, the lung has to balance immune responses to avoid 
immunological collapses and/or caused tissue damages. Therefore, the lung creates 
a tolerogenic and suppressive milieu to prevent consequences of an uncontrolled 
immune response. 
 
A significant number of lung diseases are presumed to be T cell mediated based in 
part on the observation of T cell accumulation in sites of disease activity. These 
accumulations can be mediated by CD8+ T cells as well as CD4+ T cells like in 
interstitial lung diseases (ILD). ILD represent a large class of heterogeneous 
disorders involving the lung parenchyma, that is to say, the alveolar epithelium, the 
interstitial connective tissue, vasculature, and lymphatic tissue. However, the 
different aspects influencing the balance of lymphocyte immigration, local 
proliferation, and apoptosis, and thereby the numbers of lymphocytes in the lung 
under disease conditions, are only partially understood in interstitial lung disease 
(Pabst et al., 1999). 
Even less understood are the mechanisms regulating CD4+ T cell responses directed 
to lung specific proteins and the regulation of their effector activity, because lung 
lymphocyte reactions can not be reflected by the situation of lymphocytes in the 
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blood. Therefore, the well established and described SPC-HA x TCR-HA transgenic 
mouse model (Bruder et al., 2004) is an important tool to get further insights into the 
mechanisms underlying the induction and regulation of T cell mediated immune 
reactions in the lung. The SPC-HA x TCR-HA double transgenic mouse model 
combines important features of a variety of lung diseases and can be used to get a 
better understanding of the requirements for, and consequences of chronic T cell-
mediated lung injury.  
 
The outcome of autoimmune diseases is caused by an inefficient deletion of self-
reactive T cells in the thymus and insufficient self-tolerance to self-antigens in the 
periphery. In SPC-HA x TCR-HA double transgenic mice, 6.5+CD4+ self-reactive T 
cells could be detected in the peripheral lymphatic organs including spleen, 
mesenteric lymph nodes (MLN), bronchial lymph nodes (BLN), cervical lymph nodes 
(CVLN), axillary lymph nodes (AXLN), inguinal lymph nodes (INLN) and the lung as 
the self-antigen expressing organ (figure 11). These finding was not unexpected, as it 
has been described previously that expression of the HA-antigen in pancreas 
(Degermann et al., 1994; Sarukhan et al., 1998) and in hemapoetic cells (Lanoue et 
al., 1997) of INS-HA x TCR-HA and IgHA x TCR-HA double transgenic mice does not 
lead to complete deletion of 6.5+ 
 
T cells. A possible explanation for the escape from 
central tolerance might involve coexpression of two different T cell receptors by the 
same cell. Due to allelic inclusion of TCRα genes self-reactive T cells may leave the 
thymus resulting in induction of autoimmunity in the periphery (Sarukhan et al., 1998).  
 
Flow cytometry analysis revealed an increased number of 6.5+CD4+ T cells in SPC-
HA x TCR-HA double transgenic mice in lung and BLN in comparison to healthy 
TCR-HA transgenic control mice. Other examined lymphoid organs did not show 
increased numbers of autoreactive T cells (figure 11). The detailed analysis of 
6.5+CD4+ T cells in SPC-HA x TCR-HA double transgenic mice by Flow cytometry 
showed that autoreactive T cells isolated from the lung exhibited an activated 
phenotype. As shown, before the activation markers CD69 and CD25 were 
significantly increased as well as the expression of the CD45RB and CD62L memory 
markers was reduced (figure 12). This is consistent with the hypothesis, that HA-
specific CD4+ T cells encounter their specific antigen which is expressed exclusively 
by alveolar type II epithelial cells (AECII). Surprisingly, no enhanced/reduced 
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expression of activation/memory markers could be shown for the BLN, which are the 
lymph nodes draining the lung (figure 12). This finding could be an indication for a 
locally limited inflammatory response and may indicate that the lung itself and not the 
draining lymph nodes represent the immunological compartment were autoimmune T 
cell activation is induced and immune regulation takes place.  
Also, in contrast to lung lymphocytes the expression level for CD25 and CD69 of 
lymphocytes from other peripheral tissues like spleen, MLN, AXLN, CVLN and INLN 
was not increased when the different compartments from SPC-HA x TCR-HA mice 
and TCR-HA mice were compared. The same could be observed for the expression 
of CD45RB and CD62L. Exceptions for the expression of these two memory markers 
were the lymphocytes from spleen and MLN, which exhibited decreased expression 
of CD45RB and CD62L in SPC-HA x TCR-HA mice compared to TCR-HA transgenic 
mice (figure 12).  
Taken together, in SPC-HA x TCR-HA double transgenic mice the lung epithelium 
expresses the self-antigen hemagglutinin and the lung appears to be the place were 
primary T cell activation occurs. Autoreactive 6.5+CD4+ T cells proliferate in and/or 
infiltrate the lung and exhibit a strongly activated phenotype in the presence of the 
self-antigen HA. No evidence was found that the inflammation overlaps to other 
tissues or lymphatic organs, thus in SPC-HA x TCR-HA mice disease is exclusively 
restricted to the lung. 
 
In SPC-HA x TCR-HA double transgenic mice the lung inflammation did not progress 
uncontrolled, i.e. inflammation did not result in complete tissue destruction or death. 
Thus, although multifocal acute alveolar necrosis with hemorrhage, intraalveolar 
fibrin deposition, consistent with acute tissue damage could be observed in 9-day-old 
SPC-HA x TCR-HA double transgenic mice, inflammation reached a plateau which 
was characterized by primarily diffuse to follicular lymphocytic infiltration in elder mice 
(Bruder et al., 2004). These results suggested regulatory mechanism that may exist 
and/or develop under autoimmune conditions to counteract the progression of 
inflammatory processes in the lung, thus preventing uncontrolled tissue destruction 
and lethal physiological derangement.  
In previously works it could be shown that expression of HA under the control of the 
Ig κ promoter by hemapoetic cells resulted in tolerance rather than inflammation due 
to the permantent antigen expression both in thymus and in the periphery (Buer et al., 
 -88-
CHAPTER III  Discussion 
1998). Therefore, detailed analysis was reasonable to assess whether mature 
6.5+CD4+ T cells found in peripheral lymphoid organs of SPC-HA x TCR-HA double 
transgenic mice are still functional with respect to their proliferative capacity upon 
antigen encounter. Because of the finding that mature 6.5+CD4+ T cells from SPC-HA 
x TCR-HA double transgenic mice can be activated with the corresponding peptide in 
vitro, Bruder and colleagues could exclude the possibility that the self-reactive 
peripheral T cells from SPC-HA x TCR-HA double transgenic mice were rendered in 
an anergic state. However, they could also show that the proliferative capacity of lung 
lymphocytes from SPC-HA x TCR-HA mice was reduced by approximately 50% 
when compared with lung T cells from TCR-HA control mice. Further molecular 
analysis of 6.5+CD4+ T cells isolated from inflamed lung of SPC-HA x TCR-HA 
double transgenic mice resulted in a changed chemokine and gene expression 
profile compared to autoreactive T cells isolated from TCR-HA control mice. This 
phenotype is resembles that of Treg 1 cells. To verify the results obtained by global 
gene expression profiling of 6.5+CD4+ lung lymphocytes derived from SPC-HA x 
TCR-HA mice, the expression of specific marker genes for regulatory T cells was 
tested by RT-PCR (figure 13). RT-PCR results confirmed array data obtained from 
the autoreactive T cells isolated from diseased mice and demonstrated an elevated 
expression of CTLA4, PD-1, ICOS, GITR and alphaEbeta7 (CD103) in autoreactive T 
cells from double transgenic mice compared to naïve T cells from the TCR-HA mice. 
It is known that these genes are not exclusively expressed on regulatory T cells but 
on activated T cells, too (O´Garra and Vieira, 2004). Nevertheless a strong 
upregulation of the activation independent genes Neuropilin-1 and Foxp3 was 
detectable. These molecular marker genes are discussed to be specific for regulatory 
T cells (Bruder et al., 2004; O´Garra and Vieira, 2004) thus these data clearly 
indicate the induction of self-antigen-specific regulatory T cells in the lung of 
diseased SPC-HA x TCR-HA mice. Thus the SPC-HA x TCR-HA double transgenic 
mouse model represents an important tool to examine the mechanisms underlying 
the induction and the function of regulatory T cells induced in vivo in the respiratory 
tract. 
 
The adoptive transfer experiments that were performed in this study demonstrated 
the enormous impact of naturally occurring regulatory T cells and/or in vivo induced 
regulatory T cells on the proliferation of autoreactive T cells in the lung. The 
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immunohistochemistry of the lung (figure 14) shows the fast progress of the 
infiltration of autoreactive T cells in SPC-HA transgenic mice after adoptive transfer 
of CD4+ T cells from TCR-HA transgenic mice. Within seven days a rapid and distinct 
lymphocyte infiltration took place and revealed the strong impact of autoreactive 
CD4+ T cells on disease development and progression. The infiltration was antigen-
specific because the documented lymphocytic invasion was completely absent in 
BALB/c control mice (data not shown). Using this adoptive transfer system, further 
analysis to study the influence of antigen specific naturally occurring T cells and in 
vivo induced regulatory T cells could be performed. 
 
Adoptive transfer experiments into SPC-HA transgenic mice demonstrated that the 
small proportion of naturally occurring regulatory T cells was sufficient to efficiently 
reduce the proliferation of naïve transgenic T cells in vivo (figure 15). In most of the 
published transfer experiments which were performed to characterize the properties 
of regulatory T cells, the hosts are lymphopenic and the transferred T cell subsets 
are polyclonal with unknown antigen specificity (Asseman et al., 2003; Maloy et al., 
2003). Therefore, physiological regulatory functions cannot be distinguished easily 
from effects that are caused by homeostatic proliferation and clonal expansion of 
transferred cells (Bach, 2003; Barthlott et al., 2003). Transfer experiments into SPC-
HA mice are based on the use of animals with an intact immune cell repertoire. Thus, 
the results summarized in figure 16 demonstrate that the effect of transferred T cells 
on antigen specific proliferation and clonal expansion is due to suppressor function of 
Treg cells and not a result of homeostatic proliferation in a lymphopenic host. Due to 
the fact, that no proliferation of re-isolated transferred T cell could detect in other 
organs (figure 15, figure 16) the observed T cell proliferation in lung and BLN is 
based on the antigen specificity of the transferred T cells. Summarizing, the data 
obtained from this adoptive transfer suggest the active suppression of proliferation of 
autoreactive T cells in the lung after antigen encounter by HA specific 
6.5+CD4+CD25+ regulatory T cells and underlines the importance of Treg cells for the 
control of autoimmune mediated T cell responses in the lung. 
Similar to naturally occurring regulatory T cells adaptive or induced Treg cells are 
discussed to have suppressive functions in vivo and in vitro (Maloy and Powrie, 2001; 
Wraith et al., 2004). Adoptive transfer of autoreactive CD4+ T cells in SPC-HA x TCR-
HA double transgenic mice demonstrated the impact of induced regulatory T cells on 
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autoreactive T cell proliferation. Data shown in figure 17 clearly indicate a strong 
inhibition/suppression of the proliferation of adoptively transferred 6.5+CD4+ T cells in 
lung and BLN of SPC-HA x TCR-HA double transgenic mice, whereas transferred 
autoreactive T cells in SPC-HA transgenic mice underwent a strong proliferation. 
Thus it could be shown, that the lung specific 6.5+CD4+ T cells from SPC-HA x TCR-
HA double transgenic mice not only correspond to the phenotype of Treg 1 cells, but 
that these in vivo induced HA-specific Treg cells have the capacity to suppress the 
proliferation of autoreactive T cells in vivo. This small proportion of induced 
regulatory T cells was able to control the proliferation of autoreactive T cells in vivo 
like natural Treg cells (figure 15). 
The SPC-HA x TCR-HA double transgenic mouse exhibits as an autoimmune 
disease model the possibility to examine immune responses and immune regulation. 
Furthermore, this model provides insights into antigen-specific AECII/CD4+ T cell 
crosstalk to clarify the role of the antigen expressing alveolar type II epithelial cells in 
disease induction and regulation. Therefore, it was necessary to establish a new 
protocol to isolate these cells from mice for ex vivo studies. Several isolation 
protocols are already published for AECII for other organisms, which can not be used 
for the isolation of murine AECII. Despite the lack of suitable surface molecules it 
was possible to obtain a highly pure and vital AECII population from mice using the 
newly established protocol. FACS, immunofluorescence, and PCR analysis revealed 
that purified AECII exhibited only a minimal contamination of CD45+ cells. Isolated 
cells were positive for AECII specific gene expression on mRNA and protein level 
(figure 19, figure 21). Furthermore, the vitality of the isolated AECII was high, despite 
physical stress caused by tissue disintegration and FACS-sorting (figure 20). The 
minor contamination of hemapoetic CD45+ cells was classified as a small 
macrophage population by RT-PCR (figure 21) and visually observations by 
microscopy (data not shown). The data revealed that the newly established protocol 
for isolation of AECII from mice is an efficient method to obtain a pure and vital 
population of murine alveolar type II epithelial cells with the required features for ex 
vivo analysis. 
After establishing the AECII isolation protocol comparative transcriptional analysis of 
type II alveolar epithelial cells were performed to bring further insights into the 
molecular mechanism of type II pneumocyte-CD4+ T cell interaction. Thereby, a 
heterogeneous set of genes differentially expressed in AECII under inflammatory 
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conditions was identified. More than 400 genes were regulated in AECII from 
diseased mice compared the healthy control, which could be classified in different 
groups (figure 22). Interestingly, the expression levels for molecules involved in 
antigen presentation were upregulated in AECII obtained from SPC-HA x TCR-HA 
double transgenic mice. Especially, increased expression of molecules needed for 
the MHC class-II restricted antigen presentation, like H2-Ea and H2-Ab1 (table 4) 
were of interest and could be confirmed by RT-PCR analysis (figure 24), which in 
addition to the presence of MHC class-II molecules also demonstrates elevated 
expression of costimulatory molecules as CD86 and CD80. Furthermore, expression 
of the genes encoding for TAP1 and proteasomal subunits were increased, thus 
suggesting an enhanced efficiency of MHC class-I restricted antigen presentation 
(table 4). 
Genes responsible for cell cycle activity like cyclin A2 and cyclin D2 (Wu et al., 1995; 
Bui et al., 1993) were regulated in AECII derived from SPC-HA x TCR-HA transgenic 
mice suggesting a controlled proliferation of AECII in inflamed tissue, which could be 
underlined by the differential expression of matrix metalloproteinases (MMP) and 
tissue inhibitor metalloproteinases (TIMP). These proteins are linked to airway 
remodulation in pulmonary pathology and could be detected in AECII of patients with 
diffuse alveolar damage and idiopathic pulmonary fibrosis (Chakrabarti and Patel, 
2005; Hayashi et al., 1996). RT-PCR results (figure 24) revealed the presence of 
MMP in AECII and demonstrated an increased expression of MMP-9, which was 
similar to MMP-2 discussed in the context of pathogenesis of inflammatory, infectious 
and neoplastic diseases in many organs including the lung (Chakrabarti and Patel, 
2005). 
The differential expression of different chemokines and other immune modulating 
molecules like TGF-β3 and TGF-β2 (table 4) underlines, that AECII interact with 
resident and mobile neighbour cells via secreted and diffusible signals (Fehrenbach, 
2001). Members of the transforming growth factor-beta family are linked to 
proliferation or secretion activities of AECII. For TGF-β3 it could be shown that the 
production of TGF-β3 by AECII is dynamically downregulated during the proliferative 
phase of recovery from acute hyperoxid injury (Buckley et al., 1996). Similar findings 
could be shown for the TGF-β3 and TGF-β2 expression in AECII from SPC-HA x 
TCR-HA double transgenic mice. Both molecules were downregulated and 
suggested an enhanced proliferative activity of AECII controlled by TGF-β derivates. 
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All these data linked to proliferation of AECII and remodulation of lung tissue 
correspond to the fact, that AECII are the stem cells for alveolar type I epithelial cells 
(AECI). To compensate the loss of AECI caused by lung injury through inflammation 
or tissue damage, AECII have to proliferate and differentiate into AECI suggesting 
that the observed tissue damage in SPC-HA x TCR-HA mice could be the reason for 
an enhanced proliferative activity demonstrated by the increased or decreased 
expression level of genes involved in proliferation of AECII. 
Additionally, the CXC chemokines like CXCL2, CXCL13 and CXCL12 were regulated 
in AECII from SPC-HA x TCR-HA double transgenic mice compared to AECII from 
SPC-HA transgenic mice. The main function of these chemokines is the attraction of 
different cell types. For CXCL12 and CXCL13 it is described that these ligands bind 
to CXCR4 and CXCR5, which are mainly expressed on T lymphocytes or fibrocytes 
(Ebert et al., 2004). The downregulation of CXCL12 in AECII of SPC-HA x TCR-HA 
mice could be an indicator of a controlled immune response. CXCL12 is an attractant 
molecule for T cells and signals through the orphan receptor RDC1 in T lymphocytes 
(Balabanian et al., 2005). Downregulation of T cell attractant substances could 
minimize the infiltration of newly developed autoreactive T cells. According to this it is 
shown, that CXCL13 has a key role in the development of inducible bronchus 
associated lymphoid tissue (iBALT) in respiratory immunity (Moyron-Quiroz et al., 
2004) by attracting T lymphocytes. The role of BALT in mouse and humans are 
controversialy discussed and it is reported that infection or inflammation triggers the 
organization of lymphoid structures in the lung of both species (Chvatchko et al., 
1996; Delventhal et al., 1992; Tschernig and Pabst, 2000). These structures do not fit 
the classical definition of BALT, as they are not formed independently of antigen 
(Bienenstock and Johnston, 1976; Plesch et al., 1983). Because the inducible BALT 
(iBALT) appears in the lung only after infection or inflammation, it is generally 
assumed that iBALT is simply an accumulation of effector cells that were initially 
primed in conventional lymphoid organs. The neo-formation of iBALT is caused by 
inflammatory responses, which directly promote the recruitment, priming and 
expansion of antigen-specific lymphocytes (Moyron-Quiroz et al., 2004). Concerning 
these aspects it could be possible that AECII in SPC-HA x TCR-HA double 
transgenic mice, after the first inflammatory responses, downregulate CXCL13 
expression to counteract new formation of iBALT and T cell infiltrations of naïve 
autoreactive T cells. 
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The chemokine CXCL2 is involved in attraction of polymorphonuclear granulocytes to 
sites of infection (Matzer et al., 2004). These neutrophiles play an important role as 
regulators of immune responses through release of cytokines such as IL-1, IL-3, IL-6, 
IL-12, tumor necrosis factor-α (TNF-α) or TGF-β as well as chemokines such as 
CCL2 (MCP-1) or CCL20 (MIP-3α) (Cassatella, 1995; Galligan and Yoshimura, 
2003). Thus, increased expression of CXCL2 in AECII of diseased mice could attract 
neutrophils that are known to act as a kind of control unit of inflammation. 
Elevated expression of CCL20 and CCL9/10 by AECII has been shown to attract 
other proinflammatory cells (Maurer and Stebut, 2004). Both chemokines were found 
to be upregulated in AECII derived from diseased SPC-HA x TCR-HA mice (table 4). 
In case of CCL20 it could be shown that AECII constitutively produce this chemokine 
that can attract immature dendritic cells (imDC) to the lungs (Dieu-Nosjean et al., 
2000; Reibman et al., 2003). These immature dendritc cells might be involved in the 
induction of regulatory T cells (Jonuleit et al., 2000) and provoke a controlled immune 
response in SPC-HA x TCR-HA double transgenic mice. CCL11 (eotaxin) was 
drastically downregulated in AECII from diseased mice. CCL11 is an attractant 
molecule for eosinophils. Blocking experiments with anti-CCL11 revealed a reduced 
eosinophils infiltration into the lung of respiratory syncytical virus (RSV) infected mice. 
In addition, anti-CCL11 caused an inhibition of CD4-T-cell influx (Matthews et al., 
2004). These experiments suggested that the decreased CCL11 transcription in 
AECII from diseased mice is a further step to regulate the inflammatory process in 
SPC-HA x TCR-HA double transgenic mice. Summarizing these facts, data suggest 
an active immune regulatory role of AECII in SPC-HA x TCR-HA transgenic mice by 
regulating the expression and secretion of certain chemokines, that may affect other 
immune cells, which could establish a tolerogenic environment in the lung, with 
regulatory features to control the inflammatory response. 
Further RT-PCR data (figure 24) demonstrate a consitutive expression of ICOS-L 
and PD1-L in AECII. These molecules are ligands for ICOS and PD-1 expressed on 
T cells and, which showed elevated expression on autoreactive T cells isolated from 
diseased lungs of SPC-HA x TCR-HA double transgenic mice (figure 13). The 
ICOS:ICOS-L pathway appears to be particularly important for stimulating effector T 
cell responses and T cell tolerance. In addition, the PD1:PD1-L pathway plays a 
critical role in regulating T cell activation and tolerance. The CD28 homolog ICOS is 
upregualted on T cells after activation (Yoshinaga et al., 1999; Coyle et al., 2000). 
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Additionally, in recent studies it could be shown, that ICOS regulates the outcome of 
autoimmune diseases in the murine model of Mutiple Sclerosis. However, ICOS 
appears to have distinct roles at different times during the pathogenesis of 
experimental allergic encephalomyelitis (EAE) (Chapoval et al., 2001; Rottman et al., 
2001; Sporici et al., 2001). Moreover, ICOS also may control Treg function in 
autoimmune disease, particularly IL-10-producing Treg cells. In a murine model of 
type 1 diabetes, Treg played a critical role in regulating the progression of diabetes 
from prediabetic lesion (Herman et al., 2004). Blockade of ICOS alters the balance 
between T effector and Treg cells, resulting in progression from a prediabetic insulitis 
to diabetes. These findings suggest that Treg cells regulate autoimmune development 
in an ICOS-dependent manner. Furthermore, ICOS may also be important in the 
generation of Treg cells. The development of IL-10-producing Treg cells was 
dependent on ICOS:ICOS-L interactions. These cells have suppressor function in the 
development of asthma-associated airway hyperreactivity. Thus, these findings 
suggest a novel mechanism by which ICOS and IL-10 reduce airway inflammation 
associated with asthma and implicate ICOS in regulating respiratory tolerance 
(Greenwald et al., 2004). 
PD1 (Programmed death-1) is a member of the Ig superfamily related to CD28 and 
CTLA-4 (Ishida et al., 1992; Vibhakar et al., 1997). The roles of PD1 and its ligands 
in regulating autoimmune disease have been investigated in animal models of 
diabetes, colitis, and Multiple Sclerosis. Thus, it could be shown that the PD1:PD1-L 
interactions regulate both the initiation and progression of autoimmune diabetes in 
NOD mice. The expression of PD1-L on islet cells in diabetic NOD mice (Ansari et al., 
2003; Liang et al., 2003) suggests that PD1-L may critically control the response of 
self-reactive T cells in the target organ (Liang et al., 2003) and demonstrates that 
PD1 and its ligands have an important role in regulating T cell activation and 
tolerance (Greenwald et al., 2004). Considering these facts, AECII could interfere 
with inflammatory responses in SPC-HA x TCR-HA double transgenic mice by 
expressing ICOS-L and PD1-L and could have an important role in controlling 
immune responses and inducing T cell tolerance in the respiratory tract. 
Further data of this study deal with in the antigen presenting capacity of alveolar type 
II epithelial cells. In the SPC-HA transgenic mouse the AECII express the self-
antigen hemagglutinin HA. Therefore, these cells represent the target of self-reactive 
6.5+CD4+ T cells and could even involved in the induction of CD4+ T cell mediated 
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inflammation in SPC-HA x TCR-HA double transgenic mice. Antigen presentation in 
the respiratory tract plays a key role for effective adaptive immune response. The 
small proportions of inhaled antigens and pathogens that escape the first 
mechanisms for antigenic clearance in the lung and penetrate into the underlying 
epithelial layer are then dealt with via specialized antigen-presenting cells (APC). In 
particular these APC are dendritic cell (DC) populations, within and below the 
epithelium. The alveolar surfaces in the deep lung are policed instead by 
macrophage populations, again supported by APC populations below the alveolar 
epithelium. The mechanism for the uptake or presentation of endogenous or self-
antigens like the HA in the SPC-HA mouse is still unclear. Dendritic cells and 
macrophages are discussed to act as professional APC which are able to take up 
and cross-present self-antigens from surrounding cells to other immune cells. To this 
end, the antigen presenting capacity of professional antigen-presenting cells (APC) 
was examined to clarify which kind of APC have the ability to cross-present the HA 
expressed by AECII to autoreactive T cells (figure 25, figure 26). Data obtained from 
these experiments indicate, that obviously only DC have the ability to take up and 
cross-present HA to 6.5+CD4+ T cells (figure 25) in vitro, whereas macrophages or B 
lymphocytes derived from the peritoneum of BALB/c mice could not take over this 
function in vitro (figure 26). Additional data clearly demonstrated that peptide loaded 
AECII derived from BALB/c mice themselves were able to stimulate antigen specific 
CD4+ and CD8+ T cells (figure 27, figure 28) suggesting their role as antigen-
presenting cells. 
The question, whether the self-antigen HA expressed by alveolar type II epithelial 
cells in SPC-HA transgenic mice could also be presented by AECII themselves via 
MHC class-II molecules to stimulate MHCII restricted autoreactive T cells could be 
affirmed. Data in figure 29 demonstrate that the HA expressing alveolar type II 
epithelial cells have stimulatory capacity and are able to stimulate naïve as well as 
activated CD4+ T cells. The possibility that the contaminating macrophage population 
in the AECII preparation could mediate the stimulation of autoreactive T cells could 
be excluded by the fact, that macrophages were not able to cross-present HA to 
antigen-specific T cells (figure 26). These results strongly suggest that antigen 
presentation in the lung of the SPC-HA x TCR-HA double transgenic mice may not 
exclusively be dependent on professional APC like dendritic cells, but that HA 
expressing AECII might themselves contribute to the stimulation of antigen-specific T 
 -96-
CHAPTER III  Discussion 
cells and thus in the initiation of inflammation. This interesting aspect suggests a key 
role of the alveolar type II epithelial cells for the development of T cell mediated lung 
disease in the SPC-HA x TCR-HA mouse model. Comparative analysis of the 
stimulatory capacity of AECII from SPC-HA transgenic mice and AECII from SPC-HA 
x TCR-HA double transgenic mice revealed a reduced stimulatory capacity of AECII 
derived from diseased mice for naïve as well as pre-activated autoreactive T cells 
(figure 30). Although previous data demonstrated an elevated expression of 
costimulatory molecules on AECII from SPC-HA x TCR-HA double transgenic mice 
(table 4 and figure 24) these cells were not able to stimulate 6.5+CD4+ T cells to 
induce antigen-specific proliferation, and that so far undefined soluble or cell-cell 
contact dependent factors could interfere with the stimulatory capacity of AECII or 
even the proliferative response of the T cells in vitro. To asses the impact of AECII 
conditioned medium on CD4+ T cell proliferation AECII culture supernatants from 
SPC-HA x TCR-HA double transgenic mice and healthy donor mice were collected 
and used as culture medium for anti-CD3ε stimulated CD4+ T cells. The results 
clearly point out that AECII derived from diseased mice secrete factors which 
suppress the proliferation of activated T cells (figure 32) and suggest that the 
reduced proliferation of autoreactive T cells in vitro is at least in part mediated by 
soluble factors secreted by AECII. 
To exclude that loss of HA expression may be a reason for the reduced stimulatory 
capacity of AECII in SPC-HA x TCR-HA double transgenic mice the expression of the 
self-antigen HA by AECII from SPC-HA x TCR-HA double transgenic mice and SPC-
HA transgenic mice was analyzed on mRNA level. Results indeed indicate a reduced 
HA expression in AECII derived from diseased mice (figure 31). Nevertheless, 
minimal amounts of internalized hemagglutinin are necessary to provoke an efficient 
antigen presentation by MHC class-II molecules so that even a reduced HA 
expression should be sufficient to stimulate HA-specific T cells. Furthermore, mRNA 
does not reflect the real protein expression at the cell surface. Moreover, the data 
above demonstrate that T cell suppression was at least in part mediated by AECII 
secreted factors (figure 30), thus a putative decreased HA expression could not 
explain the suppressed proliferation of T cells cultured in AECII supernatants from 
diseased mice. 
The tolerogenic and suppressive environment of the respiratory tract is widely 
discussed in the literature and in the meantime different factors were found that may 
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play a role in establishing this regulatory milieu. Candidates which could interfere 
with the immune response in respiratory tract and are linked to alveolar type II 
epithelial cells are surfactant proteins. These components of the surfactant fluid have 
many regulatory functions by opsonizing pathogens and enhancing their uptake and 
clearing by macrophages but also affecting immune cells directly (Wright, 2005). The 
surfactant proteins A and D (SP-A and SP-D) secreted by AECII have a key role by 
modulating the adaptive immunity in the lung. For both proteins elevated mRNA 
levels could be detected in AECII from SPC-HA x TCR-HA double transgenic mice 
compared to control mice (figure 33). These data suggest an increased protein 
expression and secretion of SP-A and SP-D by AECII from diseased mice and 
assume a regulatory function. It could be shown that surfactant protein A inhibits T 
cell proliferation via its collagen-like tail and the 210kDA receptor SPR210 (Borron et 
al., 1998) and that SP-D have the same feature by inhibiting human T lymphocyte 
proliferation and IL-2 production (Borron et al., 1998). These studies suggest that 
increased amounts of SP-A and SP-D secreted by AECII from diseased mice in 
culture supernatants may be involved in suppression of T cell proliferation (figure 30). 
Furthermore, Brinker and colleagues could show that SP-A modulates the 
differentiation of murine bone marrow-derived dendritic cells. DC which are the most 
potent antigen-presenting cells with the unique capacity to activate naïve T cells and 
initiate adaptive immunity were affected in their maturation into potent T cell 
stimulators by SP-A treatment and interfere with T cell activation (Brinker et al., 2003). 
To this end, these data and studies could be an important indication for a further 
regulatory role of AECII in the SPC-HA x TCR-HA double transgenic mouse model 
by modulating DC and T cell functions. The fact that AECII derived from diseased 
mice produced elevated levels of CCL20 (figure 23), a chemokine which attracts 
immature DC, and the capacity of SP-A to modulate differentiation of immature DC 
leads to the assumption that immigrated immature DC in the respiratory tract may be 
affected by high SP-A concentrations and develop a regulatory phenotype which 
could influence T cell response or even T cell differentiation into an adaptive Treg 
phenotype. The fact that stimulation of T cells with immature DC leads to the 
development of T cells with regulatory property underlines this assumption 
(Dhodapkar et al., 2001; Jonuleit et al., 2000; Maloy and Powrie, 2001). 
Another interesting fact is that AECII derived from diseased mice produce elevated 
mRNA levels of platelet factor 4 (PF-4) (figure 23). Platelet factor 4 is a platelet-
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derived CXC chemokine and induces the differentiation of monocytes into a subset of 
macrophages that lack the expression of HLA-DR which suggests a potential role of 
PF-4 in the modulation of monocyte-dependent T cell activation. Furthermore, 
studies revealed that PF-4 inhibits T cell proliferation and IL-2 production after anti-
CD3ε mediated T cell stimulation (Fleischer et al., 2002). Summarizing these data, 
AECII derived from SPC-HA x TCR-HA double transgenic mice produce increased 
levels of SP-A, SP-D and PF-4 mRNA and all these molecules are discussed in the 
context of inhibiting T cell proliferation. Together, these data strongly suggest a 
functional role of AECII in regulating T cell proliferation, thus counteracting 
uncontrolled disease progression. 
 
To get further insights into the influence of AECII derived from diseased or healthy 
mice on the phenotype of CD4+ T cells functional and molecular analyses were 
performed on T cells re-isolated after AECII coculture. Re-isolated T cell from 
cocultures were either used in inhibition assays to asses adaptive suppressive 
functions to responder cells or these primed T cells were used for RT-PCR analysis 
to examine a distinct expression pattern for Treg markers. The results did not indicate 
any differences in gene expression or acquired suppressive function of T cells 
cocultured with AECII obtained from diseased mice in comparison to healthy donors 
(figure 34, figure 35). However, the re-stimulation of T cells resulted in a decreased 
proliferation of CD4+ T cells after coculture with AECII from SPC-HA x TCR-HA 
double transgenic mice (figure 36) suggesting that of AECII coculture may induce 
long term T cell unresponsiveness or anergy. 
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2 Summary 
 
The mechanisms underlying the induction and regulation of T cell mediated immune 
reactions in the respiratory tract are still unclear. To get further insights into the 
immunological and molecular mechanisms of antigen specific CD4+ T cell responses 
in the lung the SPC-HA transgenic mouse expressing hemagglutinin (HA) in alveolar 
type II epithelial cells of the lung was used. Concomitant expression of HA and 
presence of MHC class-II restricted HA-specific autoreactive T cells resulted in an 
autoimmune mediated progressive lung inflammation in SPC-HA x TCR-HA double 
transgenic mice. This inflammation was accompanied by a massive infiltration and 
activation of HA-specific CD4+ lymphocytes in the lung tissue. The lung inflammation 
observed in SPC-HA x TCR-HA double transgenic mice did not progress 
uncontrolled and reached a plateau in elder mice suggesting regulatory mechanism 
that may exist and/or develop under autoimmune conditions to counteract the 
progression of inflammatory process in the lung. This assumption was underlined by 
gene expression profiling of 6.5+CD4+ isolated lung lymphocytes from diseased mice 
which revealed a regulatory phenotype.  
Transfer of naïve HA-specific 6.5+CD4+ and 6.5+CD4+CD25- transgenic T cells 
depleted from CD25+ T cells into SPC-HA transgenic mice demonstrated the 
regulatory potential of the small proportion of naturally occurring CD4+CD25+ T cells 
by suppressing the antigen specific proliferation of autoreactive T cells in vivo. In 
addition, the transfer of autoreactive T cells in SPC-HA x TCR-HA double transgenic 
mice, but not in healthy control mice resulted in suppression of HA specific T cell 
proliferation, suggesting regulatory mechanisms established in the lung of diseased 
mice counterbalancing disease progression. The observed inhibition of proliferation 
of autoreactive T cells in diseased mice could be an effect of induced regulatory T 
cells, soluble mediators secreted by AECII or other so far unknown regulatory 
mechanisms preventing an uncontrolled inflammation or most probably the synergy 
between both options. 
A further aspect of this study was to clarify the role of the antigen expressing alveolar 
type II epithelial cells in disease induction and regulation and to get insights into 
antigen-specific AECII/CD4+ T cell crosstalk. Therefore, the newly established 
protocol for isolation of murine type II pneumocytes was essential for functional and 
molecular analyses of AECII in SPC-HA x TCR-HA double transgenic mice. HA 
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expressing AECII from SPC-HA transgenic mice induced antigen-specific T cell 
proliferation, whereas the AECII derived from diseased mice had a reduced 
stimulatory capacity. Additionally, AECII from SPC-HA x TCR-HA secreted soluble 
factors inhibiting T cell proliferation. Comparative gene expression profiling of AECII 
from SPC-HA and SPC-HA x TCR-HA mice revealed a heterogeneous set of 
differentially expressed genes, upon other several molecules linked to regulatory 
mechanisms that may compensate overwhelming immune responses. Furthermore, 
analyses by real-time RT-PCR exhibited an elevated expression of surfactant protein 
A and D as well as platelet factor 4. These gene products can inhibit T cell 
proliferation and could play an active role in regulating the immune response and 
may act in concert with induced regulatory T cells observed in diseased SPC-HA x 
TCR-HA mice. 
Together, these findings indicate an active role of antigen expressing alveolar type II 
epithelial cells not only in the induction but importantly, also in the regulation of CD4+ 
T cell mediated lung inflammation. Therefore, AECII should be considered as 
potential target cells for strategies aiming to interfere with or modulate the CD4+ T 
cell/AECII crosstalk in order to positively influence the course of such diseases. 
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1 Materials and Methods 
 
1.1 Mice 
 
BALB/c mice were obtained from Harlan (Borchen, Germany). TCR-HA transgenic mice 
expressing a TCR αβ specific for the peptide 110-120 from influenza HA presented by I-
Ed
 
have been described previously (Kirberg et al., 1994). CL4 transgenic mice 
expressing a TCR specific for the peptide 512-523 from influenza HA presented by H-
2Kd have been described previously (Morgan et al., 1996). SPC-HA transgenic animals 
were generated using a construct containing the surfactant protein C promoter to 
achieve lung specific HA expression in alveolar type II epithelial cells and have been 
described previously (Bruder et al., 2004). Transgene expression was analyzed by PCR 
screening on genomic tail DNA. PCR was performed using a surfactant protein C 
promotor specific 5’ primer (5’-CTG GAG GGC CAG GAA CAA ACA GGC-3’) and a HA 
specific 3’ primer (5’-ATA GTT TTC CGT TGT GGC TGT CTT-3’). TCR-HA and SPC-HA 
mice were bred in the animal facility at the German Research Centre for Biotechnology. 
Mice aged 16 to 20 weeks were used for experiments which were all performed 
according to National and Institutional Guidelines. Extensive microbial and serological 
studies were performed to exclude the presence of pathogenic bacteria, viruses, fungi 
and parasites which could potentially cause mucosal inflammation in these mice. No 
pathogens could be detected in all clinical samples studied.  
 
 
1.2 Preparation of lymphocyte populations  
 
Spleens were rinsed with erythrocyte lysis buffer (Qiagen, Hilden, Germany). 
Lymphnodes were disaggregated by passing through a 100µm mesh. Cells were 
washed with FACS buffer (PBS, 2% FCS, 2mM EDTA) and collected by centrifugation. 
For FACS analysis lung lymphocytes were isolated by passing the lungs through a 
100µm mesh and subsequent treatment of cells with erythrocyte lysis buffer. For gene 
expression analysis lung lymphocytes were isolated as described previously (Bruder et 
al., 2004). Briefly, perfused lungs were excised and finely minced on ice, followed by a 
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60-90min digestion at 37°C with collagenase/dispase (0.2mg/ml of each) in RPMI 
medium with 5% fetal calf serum (FCS), in the presence of 0.25µg/ml DNase. To 
improve tissue disintegration, lungs were pipetted every 5min using a Pasteur pipet. 
Ethylenediaminetetraacetic acid (EDTA) was added to a final concentration of 5mM, 
followed by additional 5min incubation at 37°C. Cells were passed through a 70µm cell 
strainer, washed, and lung lymphocytes were isolated by ficoll density gradient 
centrifugation (Bruder D. et al., 2004). 
 
 
1.3 Primary Type II Pneumocytes Preparation 
 
Primary alveolar type II epithelial cells (AECII) were prepared using a modified protocol 
of a previously published method (Corti et al., 1996). Briefly, mice were killed and 
exsanguinated by serving the inferior vena cava and left renal artery. The tracheae was 
exposed and cannulated, and lungs were perfused with 10 to 20ml sterile phosphate 
buffered saline via the pulmonary artery until visually free of blood. Dispase (BD 
Biosciences, Heidelberg, Germany) was instilled into lungs via the tracheal catheter, 
followed by 1% low-melt agarose warmed to 45°C. The lungs were immediately covered 
with ice and incubated for 2min to gel the agarose. Lungs were then dissected out, put 
in a culture tube containing an aditional 1ml of Disapase, and incubated for 45min at 
room temperature. Lungs were then transferred to a culture dish containing 7ml serum 
free DMEM + 25mM HEPES (GIBCO, Eggenstein, Germany) and DNAse I (Sigma, 
Hannover, Germany). The tissue was gently teased away from the airways. The 
suspension was sequentially filtered and then peleted. For the sorting of alveolar type II 
epithelial cells the crude cell suspensions were washed with serum free DMEM + 25mM 
HEPES and the cells were labled with anti-CD45, anti-CD32/CD16, anti CD11b and anti-
F4/80 antibodies and goat anti rabbit-IgG as secondary antibodies. After staining the cell 
suspension was washed with PBS containing 2% fetal calf serum and 2mM EDTA for 
cell sorting. Alveolar type II epithelial cells were separated as  CD45-/CD32-/CD16-
/CD11b-/F4/80- - fraction with a MoFLOW and a purity >97% was obtained. Isolated cells 
were either used for RNA preparation or in vitro culture assays. For that purpose cells 
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were resuspended and cultered in Iscolve´s Modified Dulbeccos´s Medium (IMDM) 
containing 10% FCS. 
 
 
1.4 Antibodies and flow cytometry  
 
The monoclonal antibody 6.5 (α-TCR-HA) was purified from hybridoma supernatant and 
was used in fluorescein isothiocyanate (FITC)-labeled or biotinylated form. Monoclonal 
antibodies α-CD4 (GK1.5 and L3T4), α-CD25 (PC61), α-CD45RB (16A), α-CD62L 
(MEL-14), and α-CD69 (H1.2F3) were used as biotin, FITC, allophycocyanin (APC) or 
phycoerythrin (PE) conjugates. α-CD45 (30-F11), α-CD16/CD32 (2.4G2), α-CD11b 
(M1/70) and α-F4/80 were used unconjugated or phycoerythrin (PE) conjugates. As 
secondary antibodies a polyclonal serum inclucing antibodies goat α-rat IgM+IgG+IgA 
were used as phycoerythrin (PE) conjugates. Monoclonal antibodies α-CD80 (16-10A1), 
α-CD86 (GL1), α-MHCII and α-MHCI were used as biotin or FITC conjugates. PE-
streptavidin- or APC-(Allophycocyanin)-streptavidin-conjugates were used as secondary 
reagents (BD Bioscience, San Jose, CA). Two- and three colour flow cytometry was 
performed on a FACSCalibur (BD Bioscience, Heidelberg, Germany). Data were 
analyzed with CellQuestPro software (BD Biosciences, Heidelberg, Germany). For gene 
expression profiling and functional assays alveolar type II epithelial cells and 6.5+CD4+ 
lung lymphocytes were sorted with the MoFlow cells sorter (Cytomation, Fort Collins, 
CO). 
 
 
1.5 Carboxyfluorescein diacetate, succinimidyl ester (CFSE) labeling  
 of lymphocytes  
 
Cell suspensions were prepared as described above. Cells were washed in RPMI 
without FCS, resuspended at a concentration of 107
 
lymphocytes/ml and incubated with 
2.5µM CFSE (Molecular Probes, Göttingen, Germany) for 8min at 37°C. Two volumes 
FCS were added and cells were incubated for additional 5min at 37°C. After CFSE 
labeling the cells were washed twice with PBS to remove excess of CFSE and FCS.  
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1.6 Adoptive transfer  
 
For adoptive transfer experiments in BALB/c, SPC-HA or SPC-HA x TCR-HA mice, red 
blood cell-depleted splenocytes and/or lymphocytes isolated from mesenteric lymph 
nodes of TCR-HA mice were enriched by AutoMACS using the CD4+
 
T cell Isolation Kit 
(MACS, Miltenyi Biotec, Bergisch Gladbach, Germany) following the manufacturers 
instructions. In case CD25+ cells were depleted from the CD4+
 
T cell population, 
biotinylated α-CD25 antibody was added to the biotin antibody cocktail of the CD4+
 
T cell 
Isolation Kit. The percentage of 6.5+CD4+ T cells obtained after MACS separation was 
determined by flow cytometry analysis as described above. Enriched transgenic cells, 
either unlabeled or CFSE labeled, were injected into age and sex matched BALB/c, 
SPC-HA or SPC-HA x TCR-HA mice.  
For transfer of activated transgenic T cells splenocytes isolated from TCR-HA mice were 
stimulated in vitro with 10 µg/ml HA110-120 peptide (SSFERFEIFPK) (Hackett et al., 
1983) and cultured for 4 days. Dead cells were removed by ficoll density gradient and 
viable cells were cultured for an additional day. Flow cytometric analysis were performed 
to determine the percentage of 6.5+CD4+ lymphocytes and the activation status of the 
HA specific CD4+T cells was characterized by staining with α-CD25 and α-CD69.  
 
 
1.7 Histology  
 
Mice were sacrificed and the lungs were immersion fixed in buffered formalin, 
embedded in paraffin, sectioned at 4µm thicknesses and stained with hematoxylin and 
eosin (H&E). Immunohistochemistry for T lymphocytes was performed using the rat-anti-
human-CD3 antibody clone CD3-12 (Serotec Ltd., Kidlington, UK) at 1:1.600 dilutions 
and the avidin-biotin-complex (ABC) method with diaminobenzidin as chromogen. 
Immunohisto-chemistry sections were counterstained with hematoxylin. 
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1.8 Proliferation assay and cocultures experiments 
 
For coculture experiments 1 x 105 AECII were plated in 96-well flat-bottom plates in a 
final volume of 200µl IMDM containing 10% FCS. 2.5 x 105 CD4+ T cells from TCR-HA 
transgenic mice or CD8+ T cells from CL4 transgenic mice were added as responder 
cells and were cultured at 37°C. For standard proliferation assays cells were cultured for 
48h and proliferation was determined by 3[H]-thymidine incorporation over the last 15h 
and was measured by scintillation counting. For CD8+ T cell proliferation assay cell 
suspensions were incubated in the presence or absence of different concentrations of 
HA512-523 peptide (IYSTVASSLVLL) (Morgan et al., 1996). 
In case of coculture assays of AECII and professional APC 1 x 105 AECII were plated 
together with 2.5 x 104 immature DC or 2 x 104 PEC. After 48h CD4+ T cells isolated 
from TCR-HA transgenic mice were added as responder cells. Therefore the 
supernatants were discarded and 2.5 x 105 T cells were added with fresh medium to a 
final volume of 200µl and cultured at 37°C for additional 48h. 
For proliferation assays of CD4+ T cells in AECII conditioned media 1 x 105 CD4+ T cells 
were cultured in 200µl AECII conditioned media in the presence of 1µg/ml plate-bound 
α-CD3ε (145-2C11) (BD Bioscience, San Jose, CA) at 37°C for 48h. 3[H]-thymidine was 
added for the last 15h of culture and incorporation was measured by scintillation 
counting to asses proliferation. AECII conditioned media were generated by culturing 
freshly isolated AECII in IMDM with 10% FCS for 48h. 
In case T cells were re-isolated after coculture with AECII, cells were harvested after 
48h coculture and subjected to ficoll density gradient centrifugation. Re-isolated cells 
were counted and used either for inhibition assays or were used for RNA isolation and 
subsequent gene expression profiling. 
 
 
1.9 Inhibition assay 
 
For standard inhibition assay 5 x 104 CD4+ responder T cells were plated together with 
the same amount of T cells re-isolated after AECII coculture in 96-well flat-bottom plates 
in a final volume of 200µl IMDM (GIBCO, Eggenstein, Germany) in the presence of 
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0.75µg/ml soluble α-CD3ε (145-2C11) (BD Bioscience, San Jose, CA) and 5 x 105 
irradiated BALB/c splenocytes. Cells were cultured at 37°C for 48h. Over the last 8h of 
the experiment 3[H]-thymidine incorporation was measured by scintillation counting to 
asses proliferation. 
 
 
1.10 Expression analysis by RT-PCR and real time RT-PCR 
 
To analyse expression of different genes in alveolar type II epithelial cells and 6.5+CD4+ 
T cells of TCR-HA transgenic, SPC-HA transgenic and SPC-HAxTCR-HA double 
transgenic mice, mRNA was isolated from the different cell populations using the 
RNeasy Kit (Quiagen, Hilden, Germany) following the manufacturer´s instructions. cDNA 
were synthesised using a mixture of oligo-dT primers and oligo-random hexamer 
primers and SuperScriptTM II RNase H-reverse transcriptase (Invitrogen, Karlsruhe, 
Germany). 
PCR was performed using AmpliTaqGold-polymerase (Applied Biosystem, Hamburg, 
Germany) and gene specific primers (table 6). Amplified PCR products were visualised 
after electrophoresis in 2% agarose gels containing ethidum bromide. Reactions were 
run on a PCR thermo cycler (Biorad, München, Germany) using the following conditions: 
94°C for 10 minutes followed by amplification. Each cycle of amplification included 
45sec denaturation at 94°C, 45sec annealing at 58 or 55°C and 1min synthesis at 72°C. 
Every PCR was run with 30, 34 or 40 amplification cycles for opitmisation of the 
procedure. Unspecific amplification products were not detected in any of the PCR runs.  
Real time RT-PCR for analyzing the expression of SP-A, SP-D, SP-C, CCL20, CCL11 
and PF4 were conducted using a Brilliant SYBR Green QPCR Core Reagent Kit 
(Stratagenene, Heidelberg, Germany) in the GeneAmp 5700 Sequence Detection 
System (Perkin Elmer, Rodgau-Jügesheim, Germany) according to manufacture´s 
instructions. The PCR primer sequences are shown in table 6. Results were normalized 
using the housekeeping gene RPS9. 
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Tabel 6: RT-PCR and real-time RT-PCR primer sequences. 
Primer Sequence (5´ → 3´) Size of PCR 
product (bp) 
   
SP-A mm 5´ CAC CAA TGG GCA GTC AGT CAA C 
SP-A mm 3´ ACA GAA GCC CCA TCC AGG TAG TG 
198 
SP-C mm 5´ CGC CTT CTC ATC GTG GTT GTG 
SP-C mm 3´ CGG GGC TAG GCG TTT CTG AG 
150 
SP-D mm 5´ ATG GCC TGC CTG GTC GTG ATG 
SP-D mm 3´ GTC CAG GTT CGC CAG CAG AGC 
159 
CD80 mm 5´ AGT GGC TTT TGC TCT TTG GAT A 
CD80 mm 3´ CAT TTC TTT GGG GCA CAT TGA T 
188 
CD86 mm 5´ AGG GAA AGC AGA AAT CAC AAC ACT 
CD86 mm 3´ AGC CCT GCC AGC GGA ATA 
245 
MHCII mm 5´ GGC CAC AAT TGG AGC CCT GG 
MHCII mm 3´ TGG GCT CTC CCA GGT TCA C 
200 
PF4 mm 5´ CAG CGC TGG TCC CGA AGA AA 
PF4 mm 3´ AAC CGCACA GTG GCG TCC TG 
127 
CCL11 mm 5´ TCCCAACTTCCTGCTGCTTTATC 
CCL11 mm 3´ CATCCTGGACCCACTTCTTCTTG 
168 
CCL20 mm 5´ GTACTGCTGGCTCACCTCTGC 
CCL20 mm 3´ AGCTTCATCGGCCATCTGTCTT 
129 
Alkal. phosphatase mm 5´ CCC CGG GGC AAC TCC ATC TTT 
Alkal. phosphatase mm 3´ CCC GTT CAC CGT CCA CCA CCT T 
118 
RPS9 mm 5´ CTGGACGAGGGCAAGATGAAGC 
RPS9 mm 3´ TGACGTTGGCGGATGAGCACA 
143 
Foxp3 mm 5´ CTGGCGAAGGGCTCGGTAGTCCT 
Foxp3 mm 3´ CTCCCAGAGCCCATGGCAGAAGT 
250 
GITR mm 5´ GAACGCGGGGAGCAGACAGA 
GITR mm 3´ CATAGGGCCCAATCGTAACTCACC 
222 
Neuropilin-1 mm 5´ GCCTGCTTTCTTCTCTTGGTTTCA 
Neuropilin-1 mm 3´ GCTCTGGGCACTGGGCTACA 
221 
ICOS mm 5´ TGC CAG ACT ACA GCC ACA CTT TG 
ICOS mm 3´ GTA CTT CCC AGA TCC CAG AGA CCA 
148 
PD-1 mm 5´ GGAAATTCGTAGACTGGGGGACTG 
PD-1 mm 3´ TCACGGAGCTTTTGCCTGGTAA 
125 
Galectin mm 5´ AACCTGCCTTCCCCTTCC 
Galectin mm 3´ TCCGCCGCCATGTAGTTGAT 
148 
CTLA4 mm 5´ GGGCTGGGTCTTTACACTCATTTT 
CTLA4 mm 3´ CTTCCTGTGGCATTAACTTTGTGT 
230 
αEβ7 Integrin mm 5´ GAACTGCCGATCCTTGGTGAAATA 
αEβ7 Integrin mm 3´ GCTGGGCCCTCCTTGTGCTCT 
250 
CD3 mm 5´ ACACCAGCCTCAAATAAAAACACG 
CD3 mm 3´ AAGGGGGCAGGGAGGAGGTATGG 
825 
CD19 mm 5´ TGACCCCGCCAGGAGATTC 
CD19 mm 3´ GCAGGGTGAGCAGGGATGG 
1121 
CD14 mm 5´ CATTTGCATCCTCCTGGTTTCTGA 
CD14 mm 3´ GAGTGAGTTTTCCCCTTCCGTGTG 
182 
 
MCP-1 mm 5´ CTGTGCTGACCCCAAGAAGG 
MCP-1 mm 3´ TAAGGCATCACAGTCCGAGTCACA 
250 
MMP-2 mm 5´ TCC CGG GTG CTG CTT CTC CTT CC 
MMP-2 mm 3´ CAC TGC CCC ATG CCA GGC TGT TA 
206 
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Tabel 6 (continued): RT-PCR and real-time RT-PCR primer sequences. 
Primer Sequence (5´ → 3´) Size of PCR 
product (bp) 
   
MMP-3 mm 5´ CTC CCT  GCA ACC GTG AAG AAG A 
MMP-3 mm 3´ CAA CTG CGA AGA TCC ACT GAA GA 
228 
MMP-9 mm 5´ ACT CCG CCT TTG AGG ATC CGC AGA C 
MMP-9 mm 3´ GAA GCC CGC TGA CGT GGG TTA CCT C 
147 
HA mm 5´ GTCCGGCATCATCACCTCAAAC 
HA mm 3´ AACCGGCAATGGCTCCAAATAGAC 
221 
ICOS-L mm 5´ TGG GCT CAG GAC TAG GAA GAC C 
ICOS-L mm 3´ AGC TGC CAA CTC AAG ACC CAT AAC 
181 
PD1-L mm 5´ GTG TCC ACG GTC CTC CTC TTC TTG 
PD1-L mm 3´ TCC CAT GGG CCC TTT CTT TCA 
182 
IL-10 mm 5´ CTG GAC AAC ATA CTG CTA ACC GAC TC 
IL-10 mm 3´ ATT TCT GGG CCA TGC TTC TCT GC 
134 
TGF-β mm 5´ ACCTGGGTTGGAAGTGGAT 
TGF-β mm 3´ GAAGCGCCCGGGTTGTGTTGGTT 
139 
SP-R210 mm 5´ CCG GGT CGA CAG GGT CAA GTC C 
SP-R210 mm 3´ TGG CCT CTG TGT CGC TGT CAC TCA 
209 
 
 
1.11 DNA microarray hybridization and analysis  
 
Total RNA from sorted AECII was isolated using the RNAeasy kit (Qiagen, Hilden, 
Germany). Quality and integrity of total RNA isolated from 2 x 105
 
sorted AECII cells was 
assessed by running all samples on an Agilent Technologies 2100 Bioanalyser (Agilent 
Technologies, Waldbronn, Germany). For RNA amplification the first round was done 
according to Affymetrix without biotinylated nucleotides using the Promega P1300 
RiboMax Kit (Promega, Mannheim, Germany) for T7 amplification. For the second round 
of amplification the precipitated and purified RNA was converted to cDNA primed with 
random hexamers (Pharmacia, Freiburg, Germany). Second strand synthesis and probe 
amplification were done as in the first round with two exceptions: incubation with RNAse 
H preceeded the first strand synthesis to digest the aRNA, and the T7T23V oligo for 
initiation of the second strand synthesis was used. 12.5µg biotinylated cRNA preparation 
was fragmented and placed in a hybridization cocktail containing four biotinylated 
hybridization controls (BioB, BioC, BioD, and Cre) as recommended by the 
manufacturer. Samples were hybridized to an identical lot of Affymetrix MG-U74Av2 
chips for 16 hours. After hybridization, GeneChips were washed, stained with 
streptavidin-PE and read using an Affymetrix GeneChip fluidic station scanner. Analysis 
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was done with gene expression software (GeneChip, MicroDB, and Data Mining Tool, all 
Affymetrix). 
 
 
1.12 Immunofluorescence  
 
For immunofluorescence staining sorted AECII were mounted onto glass cover slips 
with a density of 2 x 105 cells using a cytospin apparatus, and were fixed with methanol-
aceton (1:1) mixture at -20°C for 5min. Rabbit anti SP-A, SP-B, pro-SPC and SP-D 
antibodies (Chemicon Europe, Hampshire, UK) were all diluted 1:100 and incubated 
with the fixed cells over night at 4°C. As secondary antibody a FITC coupled goat anti 
rabbit IgG (Dianova, Hamburg, Germany) was used at a dilution of 1:80 and  incubation 
for 30min at 37°C. All washing steps were performed in PBS and stained cells were 
embedded in glycerol-PBS. 
 
 
1.13 Isolation of Dendritic cells (DC) 
 
DC were cultured and purified as described (Brinker et al., 2001). Briefly, bone marrow 
cells were flushed from the tibiae and femurs of BALB/c mice and differentiated in DC 
medium (RPMI 1640 containing 5% FCS, 100U/ml penicillin-streptomycin, 20µg/ml 
gentamicin, and 50µM 2-mercaptoethanol (all GIBCO, Eggenstein, Germany)) in the 
presence of 25µM granulocyte macrophage-colony stimulating factor (GM-CSF) (R&D 
Systems, Wiesbaden-Nordenstadt, Germany). Immature bone marrow-derived DC were 
collected on day 5 and purified further by positive selection with AutoMACS using the 
anti-CD11c Isolation Kit (MACS, Miltenyi Biotec, Bergisch Gladbach, Germany). The 
cells were used for coculture experiments.  
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1 Abbreviations 
 
AECI Alveolar type I epithelial cell 
AECII Alveolar type II epithelial cell 
AM Alveolar macrophage 
APC Antigen presenting cell 
AXLN Axillary lymph node 
BAL Bronchoalveolar lavage 
BALT Bronchus-associated lymphoid tissue 
BLN Bronchial lymph node 
Bp Base pairs 
CCL Chemokine ligand 
CCR Chemokine receptor 
cDNA  copy Desoxyribonucleic acid 
CFSE  5’-Carboxyfluorescein diacetat succinimidylester 
cpm Counts per minute 
CVLN Cervical lymph node 
CXCL Chemokine ligand 
CXCR Chemokine receptor 
DNA Desoxyribonucleic acid 
DC Dendritic cell 
EDTA Ethylene diamine tetraacetic acid 
FACS Fluorescence activated cell sorter 
FCS Fetal calf serum 
GALT Gut-associated lymphoid tissue 
HA Hemagglutinin 
HEPES N-2-Hydroxyethylpiperazine-N’-2-ethane sulfonic acid 
HEV High endothelial venules 
i.p.  Intraperitonal 
i.v. Intravenous 
IEL  Intraepithelial lymphocyte 
IFN  Interferon 
Ig Immunoglobulin 
IL  Interleukin 
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ILD Interstitial lung disease 
INLN Inguinal lymph node 
l Liter 
LPL  Lamina propria lymphocyte 
LPS Lipopolysaccharid 
µ Micro 
M Molar 
MALT  Mucosa-associated lymphoid tissue 
MHC  Major histocompatibility complex 
MLN  Mesenteric lymph node 
MMP Matrix metalloproteinase 
NO Nitric oxid 
PBS Phosphate buffered saline 
PCR  Polymerase chain reaction 
PEC Peritoneal excudate cell 
RNA Ribonucleic acid 
TCR  T cell receptor 
TGF  Tumor growth factor 
TH cell  T helper cell 
TIMP Tissue inhibitor metalloproteinase 
TNF  Tumor necrosis factor 
Tnfrs  Tumor necrosis factor receptor family 
Treg  Regulatory T cell 
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